farmaco,term,count
pembrolizumab,MALIGNANT NEOPLASM PROGRESSION,7917
pembrolizumab,DEATH,4111
pembrolizumab,DIARRHOEA,3462
pembrolizumab,FATIGUE,3389
pembrolizumab,OFF LABEL USE,3002
pembrolizumab,PRODUCT USE IN UNAPPROVED INDICATION,2744
pembrolizumab,PYREXIA,2463
pembrolizumab,NAUSEA,2252
pembrolizumab,RASH,2145
pembrolizumab,DECREASED APPETITE,2014
pembrolizumab,HYPERTENSION,1881
pembrolizumab,ASTHENIA,1670
pembrolizumab,HYPOTHYROIDISM,1638
pembrolizumab,DYSPNOEA,1629
pembrolizumab,DRUG INEFFECTIVE,1590
pembrolizumab,PRODUCT USE ISSUE,1590
pembrolizumab,INTERSTITIAL LUNG DISEASE,1514
pembrolizumab,PNEUMONIA,1474
pembrolizumab,PNEUMONITIS,1439
pembrolizumab,VOMITING,1435
pembrolizumab,MALAISE,1429
pembrolizumab,ANAEMIA,1418
pembrolizumab,ACUTE KIDNEY INJURY,1349
pembrolizumab,NEUTROPENIA,1233
pembrolizumab,ADVERSE EVENT,1213
pembrolizumab,ARTHRALGIA,1207
pembrolizumab,COLITIS,1201
pembrolizumab,WEIGHT DECREASED,1146
pembrolizumab,THROMBOCYTOPENIA,1086
pembrolizumab,RENAL IMPAIRMENT,1018
pembrolizumab,PLATELET COUNT DECREASED,1007
pembrolizumab,PRURITUS,997
pembrolizumab,PAIN,902
pembrolizumab,CONSTIPATION,884
pembrolizumab,HEADACHE,870
pembrolizumab,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,866
pembrolizumab,GENERAL PHYSICAL HEALTH DETERIORATION,826
pembrolizumab,ADRENAL INSUFFICIENCY,820
pembrolizumab,ABDOMINAL PAIN,812
pembrolizumab,HEPATIC FUNCTION ABNORMAL,808
pembrolizumab,NEUROPATHY PERIPHERAL,790
pembrolizumab,BLOOD PRESSURE INCREASED,784
pembrolizumab,DEHYDRATION,759
pembrolizumab,COUGH,751
pembrolizumab,FEBRILE NEUTROPENIA,738
pembrolizumab,DISEASE PROGRESSION,729
pembrolizumab,HEPATITIS,705
pembrolizumab,STOMATITIS,705
pembrolizumab,PLEURAL EFFUSION,703
pembrolizumab,SEPSIS,689
pembrolizumab,PANCYTOPENIA,644
pembrolizumab,MYALGIA,633
pembrolizumab,PULMONARY EMBOLISM,632
pembrolizumab,MYOCARDITIS,625
pembrolizumab,DYSPHONIA,611
pembrolizumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,605
pembrolizumab,RENAL FAILURE,598
pembrolizumab,THERAPY PARTIAL RESPONDER,577
pembrolizumab,HYPOTENSION,559
pembrolizumab,TUBULOINTERSTITIAL NEPHRITIS,557
pembrolizumab,RESPIRATORY FAILURE,552
pembrolizumab,NEOPLASM PROGRESSION,547
pembrolizumab,ALANINE AMINOTRANSFERASE INCREASED,543
pembrolizumab,BACK PAIN,542
pembrolizumab,HYPERTHYROIDISM,541
pembrolizumab,PAIN IN EXTREMITY,540
pembrolizumab,HYPONATRAEMIA,520
pembrolizumab,DIZZINESS,519
pembrolizumab,ASPARTATE AMINOTRANSFERASE INCREASED,512
pembrolizumab,IMMUNE-MEDIATED HEPATIC DISORDER,511
pembrolizumab,IMMUNE-MEDIATED ENTEROCOLITIS,499
pembrolizumab,MYELOSUPPRESSION,494
pembrolizumab,PROTEINURIA,492
pembrolizumab,IMMUNE-MEDIATED ADVERSE REACTION,481
pembrolizumab,URINARY TRACT INFECTION,479
pembrolizumab,CARDIAC FAILURE,476
pembrolizumab,NEUTROPHIL COUNT DECREASED,457
pembrolizumab,NO ADVERSE EVENT,456
pembrolizumab,MUSCULAR WEAKNESS,445
pembrolizumab,DYSPHAGIA,425
pembrolizumab,WHITE BLOOD CELL COUNT DECREASED,422
pembrolizumab,CONFUSIONAL STATE,415
pembrolizumab,CONDITION AGGRAVATED,411
pembrolizumab,LIVER DISORDER,404
pembrolizumab,BLOOD CREATININE INCREASED,402
pembrolizumab,TYPE 1 DIABETES MELLITUS,402
pembrolizumab,MYOSITIS,401
pembrolizumab,DIABETES MELLITUS,399
pembrolizumab,HEPATIC ENZYME INCREASED,393
pembrolizumab,TOXICITY TO VARIOUS AGENTS,391
pembrolizumab,INFECTION,389
pembrolizumab,HEPATOTOXICITY,379
pembrolizumab,OEDEMA PERIPHERAL,370
pembrolizumab,LUNG DISORDER,361
pembrolizumab,MUCOSAL INFLAMMATION,356
pembrolizumab,ERYTHEMA,355
pembrolizumab,MYASTHENIA GRAVIS,355
pembrolizumab,ATRIAL FIBRILLATION,353
pembrolizumab,FALL,352
pembrolizumab,GAIT DISTURBANCE,349
osimertinib,DEATH,8491
osimertinib,MALIGNANT NEOPLASM PROGRESSION,2457
osimertinib,DIARRHOEA,1080
osimertinib,DRUG RESISTANCE,873
osimertinib,RASH,623
osimertinib,FATIGUE,575
osimertinib,DECREASED APPETITE,536
osimertinib,OFF LABEL USE,514
osimertinib,DRUG INEFFECTIVE,507
osimertinib,INTERSTITIAL LUNG DISEASE,497
osimertinib,NAUSEA,467
osimertinib,DYSPNOEA,466
osimertinib,METASTASES TO CENTRAL NERVOUS SYSTEM,452
osimertinib,DISEASE PROGRESSION,419
osimertinib,PLEURAL EFFUSION,383
osimertinib,ACQUIRED GENE MUTATION,368
osimertinib,MYELOSUPPRESSION,324
osimertinib,ASTHENIA,311
osimertinib,PNEUMONIA,295
osimertinib,VOMITING,294
osimertinib,WEIGHT DECREASED,285
osimertinib,PNEUMONITIS,272
osimertinib,COUGH,270
osimertinib,PYREXIA,263
osimertinib,DRY SKIN,239
osimertinib,PLATELET COUNT DECREASED,237
osimertinib,PULMONARY EMBOLISM,221
osimertinib,METASTASES TO BONE,219
osimertinib,PAIN,209
osimertinib,HEPATIC FUNCTION ABNORMAL,203
osimertinib,LUNG DISORDER,203
osimertinib,PRURITUS,195
osimertinib,MUSCLE SPASMS,194
osimertinib,MALAISE,191
osimertinib,STOMATITIS,190
osimertinib,METASTASES TO MENINGES,189
osimertinib,CARDIAC FAILURE,182
osimertinib,HEADACHE,181
osimertinib,THROMBOCYTOPENIA,178
osimertinib,ANAEMIA,176
osimertinib,DIZZINESS,175
osimertinib,METASTASES TO LIVER,166
osimertinib,PARONYCHIA,158
osimertinib,ELECTROCARDIOGRAM QT PROLONGED,156
osimertinib,FALL,147
osimertinib,DEHYDRATION,146
osimertinib,RESPIRATORY FAILURE,146
osimertinib,CONSTIPATION,144
osimertinib,THROMBOSIS,143
osimertinib,EGFR GENE MUTATION,138
osimertinib,LUNG NEOPLASM MALIGNANT,136
osimertinib,ALOPECIA,131
osimertinib,CEREBROVASCULAR ACCIDENT,131
osimertinib,NEOPLASM PROGRESSION,126
osimertinib,DEEP VEIN THROMBOSIS,125
osimertinib,CONDITION AGGRAVATED,121
osimertinib,LIVER DISORDER,114
osimertinib,ONYCHOCLASIS,113
osimertinib,DYSPHAGIA,112
osimertinib,ATRIAL FIBRILLATION,111
osimertinib,WHITE BLOOD CELL COUNT DECREASED,111
osimertinib,NAIL DISORDER,110
osimertinib,GENERAL PHYSICAL HEALTH DETERIORATION,107
osimertinib,PAIN IN EXTREMITY,107
osimertinib,BACK PAIN,106
osimertinib,GAIT DISTURBANCE,102
osimertinib,METASTASES TO LUNG,102
osimertinib,PERIPHERAL SWELLING,102
osimertinib,PRODUCT DOSE OMISSION ISSUE,100
osimertinib,ARTHRALGIA,99
osimertinib,TOXICITY TO VARIOUS AGENTS,96
osimertinib,METASTASIS,95
osimertinib,PRODUCT USE ISSUE,95
osimertinib,CHEST PAIN,94
osimertinib,RENAL IMPAIRMENT,93
osimertinib,CARDIAC DISORDER,92
osimertinib,ERYTHEMA,90
osimertinib,PRODUCT USE IN UNAPPROVED INDICATION,89
osimertinib,PULMONARY OEDEMA,88
osimertinib,INSOMNIA,86
osimertinib,EJECTION FRACTION DECREASED,84
osimertinib,SKIN DISORDER,84
osimertinib,PERICARDIAL EFFUSION,82
osimertinib,SEIZURE,81
osimertinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,79
osimertinib,MYALGIA,79
osimertinib,MYOCARDIAL INFARCTION,79
osimertinib,DERMATITIS ACNEIFORM,78
osimertinib,HYPOTENSION,78
osimertinib,URINARY TRACT INFECTION,77
osimertinib,MALIGNANT TRANSFORMATION,76
osimertinib,DRUG-INDUCED LIVER INJURY,75
osimertinib,ABDOMINAL DISCOMFORT,74
osimertinib,CEREBRAL INFARCTION,74
osimertinib,COVID-19,72
osimertinib,HYPONATRAEMIA,72
osimertinib,RENAL FAILURE,72
osimertinib,URTICARIA,72
osimertinib,DRUG INTERACTION,70
osimertinib,HEPATOTOXICITY,70
nivolumab,DEATH,10445
nivolumab,MALIGNANT NEOPLASM PROGRESSION,8918
nivolumab,OFF LABEL USE,4163
nivolumab,DIARRHOEA,4070
nivolumab,INTENTIONAL PRODUCT USE ISSUE,3327
nivolumab,FATIGUE,3287
nivolumab,PYREXIA,3211
nivolumab,RASH,2456
nivolumab,NAUSEA,2433
nivolumab,DYSPNOEA,2387
nivolumab,DECREASED APPETITE,2296
nivolumab,PNEUMONIA,2092
nivolumab,COLITIS,1978
nivolumab,PNEUMONITIS,1924
nivolumab,ASTHENIA,1714
nivolumab,VOMITING,1693
nivolumab,HYPOTHYROIDISM,1634
nivolumab,ACUTE KIDNEY INJURY,1592
nivolumab,WEIGHT DECREASED,1478
nivolumab,ANAEMIA,1473
nivolumab,PRURITUS,1425
nivolumab,DRUG INEFFECTIVE,1402
nivolumab,GENERAL PHYSICAL HEALTH DETERIORATION,1397
nivolumab,PRODUCT USE IN UNAPPROVED INDICATION,1343
nivolumab,INTERSTITIAL LUNG DISEASE,1316
nivolumab,ARTHRALGIA,1286
nivolumab,MALAISE,1286
nivolumab,ADRENAL INSUFFICIENCY,1118
nivolumab,SEPSIS,1117
nivolumab,HEADACHE,1107
nivolumab,PAIN,1067
nivolumab,CONSTIPATION,1060
nivolumab,ADVERSE EVENT,1055
nivolumab,COUGH,1002
nivolumab,PLEURAL EFFUSION,976
nivolumab,BACK PAIN,967
nivolumab,HEPATIC FUNCTION ABNORMAL,961
nivolumab,THROMBOCYTOPENIA,942
nivolumab,DEHYDRATION,883
nivolumab,IMMUNE-MEDIATED ENTEROCOLITIS,876
nivolumab,LIVER DISORDER,818
nivolumab,MYOCARDITIS,818
nivolumab,HYPERTHYROIDISM,785
nivolumab,RESPIRATORY FAILURE,782
nivolumab,HYPOTENSION,781
nivolumab,ABDOMINAL PAIN,777
nivolumab,HEPATITIS,765
nivolumab,HYPONATRAEMIA,752
nivolumab,HYPOPHYSITIS,702
nivolumab,FEBRILE NEUTROPENIA,698
nivolumab,NEUTROPENIA,697
nivolumab,ALANINE AMINOTRANSFERASE INCREASED,689
nivolumab,ASPARTATE AMINOTRANSFERASE INCREASED,689
nivolumab,FALL,681
nivolumab,RENAL FAILURE,681
nivolumab,DIZZINESS,673
nivolumab,PULMONARY EMBOLISM,628
nivolumab,MYALGIA,609
nivolumab,HYPERTENSION,600
nivolumab,STOMATITIS,600
nivolumab,DISEASE PROGRESSION,599
nivolumab,CHILLS,591
nivolumab,MUSCULAR WEAKNESS,589
nivolumab,MYOSITIS,585
nivolumab,LUNG DISORDER,581
nivolumab,DIABETIC KETOACIDOSIS,579
nivolumab,PRODUCT USE ISSUE,575
nivolumab,PLATELET COUNT DECREASED,572
nivolumab,INFUSION RELATED REACTION,571
nivolumab,CARDIAC FAILURE,569
nivolumab,URINARY TRACT INFECTION,567
nivolumab,PEMPHIGOID,563
nivolumab,PRESCRIBED UNDERDOSE,539
nivolumab,ATRIAL FIBRILLATION,535
nivolumab,PAIN IN EXTREMITY,530
nivolumab,CONDITION AGGRAVATED,529
nivolumab,NEUROPATHY PERIPHERAL,527
nivolumab,DIABETES MELLITUS,524
nivolumab,CONFUSIONAL STATE,519
nivolumab,METASTASES TO CENTRAL NERVOUS SYSTEM,512
nivolumab,TYPE 1 DIABETES MELLITUS,511
nivolumab,AUTOIMMUNE DISORDER,501
nivolumab,CHEST PAIN,498
nivolumab,DYSPHAGIA,493
nivolumab,ARTHRITIS,490
nivolumab,OEDEMA PERIPHERAL,475
nivolumab,ERYTHEMA,474
nivolumab,HYPOKALAEMIA,458
nivolumab,HYPERGLYCAEMIA,456
nivolumab,AUTOIMMUNE HEPATITIS,448
nivolumab,THYROIDITIS,448
nivolumab,FULMINANT TYPE 1 DIABETES MELLITUS,447
nivolumab,IMMUNE-MEDIATED HEPATITIS,440
nivolumab,SEIZURE,440
nivolumab,INFECTION,439
nivolumab,BLOOD CREATININE INCREASED,436
nivolumab,RENAL IMPAIRMENT,429
nivolumab,ASCITES,423
nivolumab,SOMNOLENCE,422
nivolumab,TUBULOINTERSTITIAL NEPHRITIS,420
abemaciclib,DIARRHOEA,2948
abemaciclib,FATIGUE,949
abemaciclib,NAUSEA,926
abemaciclib,VOMITING,618
abemaciclib,MALIGNANT NEOPLASM PROGRESSION,597
abemaciclib,DRUG INEFFECTIVE,562
abemaciclib,DEATH,548
abemaciclib,DECREASED APPETITE,470
abemaciclib,WHITE BLOOD CELL COUNT DECREASED,343
abemaciclib,DEHYDRATION,342
abemaciclib,ASTHENIA,341
abemaciclib,NEUTROPENIA,338
abemaciclib,ANAEMIA,313
abemaciclib,DISEASE PROGRESSION,280
abemaciclib,CONSTIPATION,256
abemaciclib,ALOPECIA,248
abemaciclib,WEIGHT DECREASED,248
abemaciclib,ABDOMINAL PAIN,244
abemaciclib,DYSPNOEA,238
abemaciclib,BLOOD CREATININE INCREASED,236
abemaciclib,ABDOMINAL PAIN UPPER,233
abemaciclib,THERAPY CESSATION,226
abemaciclib,HEADACHE,218
abemaciclib,RASH,218
abemaciclib,INTERSTITIAL LUNG DISEASE,217
abemaciclib,MYELOSUPPRESSION,211
abemaciclib,MALAISE,203
abemaciclib,THERAPY INTERRUPTED,201
abemaciclib,DIZZINESS,192
abemaciclib,PLATELET COUNT DECREASED,185
abemaciclib,PAIN,182
abemaciclib,PNEUMONIA,181
abemaciclib,ACUTE KIDNEY INJURY,171
abemaciclib,ARTHRALGIA,160
abemaciclib,PNEUMONITIS,148
abemaciclib,OFF LABEL USE,147
abemaciclib,COUGH,142
abemaciclib,PYREXIA,139
abemaciclib,DRUG INTOLERANCE,138
abemaciclib,COVID-19,135
abemaciclib,PULMONARY EMBOLISM,134
abemaciclib,ABDOMINAL DISCOMFORT,133
abemaciclib,HAEMOGLOBIN DECREASED,130
abemaciclib,PRURITUS,112
abemaciclib,NEUTROPHIL COUNT DECREASED,111
abemaciclib,HEPATIC FUNCTION ABNORMAL,109
abemaciclib,METASTASES TO BONE,109
abemaciclib,THROMBOCYTOPENIA,109
abemaciclib,FEELING ABNORMAL,103
abemaciclib,URINARY TRACT INFECTION,103
abemaciclib,RENAL IMPAIRMENT,102
abemaciclib,HOSPITALISATION,100
abemaciclib,METASTASES TO LIVER,96
abemaciclib,THROMBOSIS,95
abemaciclib,INSOMNIA,94
abemaciclib,PRODUCT DOSE OMISSION ISSUE,94
abemaciclib,ALANINE AMINOTRANSFERASE INCREASED,92
abemaciclib,STOMATITIS,92
abemaciclib,ASPARTATE AMINOTRANSFERASE INCREASED,90
abemaciclib,RED BLOOD CELL COUNT DECREASED,88
abemaciclib,PAIN IN EXTREMITY,83
abemaciclib,BACK PAIN,81
abemaciclib,ILLNESS,81
abemaciclib,RENAL FAILURE,81
abemaciclib,HOT FLUSH,80
abemaciclib,FALL,78
abemaciclib,THERAPY CHANGE,78
abemaciclib,PLEURAL EFFUSION,76
abemaciclib,HEPATOTOXICITY,75
abemaciclib,PERIPHERAL SWELLING,73
abemaciclib,MUSCLE SPASMS,72
abemaciclib,HYPOKALAEMIA,71
abemaciclib,TASTE DISORDER,70
abemaciclib,SEPSIS,69
abemaciclib,LIVER DISORDER,68
abemaciclib,GAIT DISTURBANCE,67
abemaciclib,DEEP VEIN THROMBOSIS,66
abemaciclib,FULL BLOOD COUNT DECREASED,66
abemaciclib,BREAST CANCER METASTATIC,65
abemaciclib,DYSPEPSIA,65
abemaciclib,INFECTION,65
abemaciclib,GASTROINTESTINAL DISORDER,62
abemaciclib,BONE PAIN,61
abemaciclib,LEUKOPENIA,61
abemaciclib,MYALGIA,61
abemaciclib,DYSPHAGIA,60
abemaciclib,NEUROPATHY PERIPHERAL,60
abemaciclib,HYPOTENSION,59
abemaciclib,HEPATIC ENZYME INCREASED,56
abemaciclib,TUMOUR MARKER INCREASED,56
abemaciclib,ANXIETY,55
abemaciclib,DRUG INTERACTION,55
abemaciclib,GENERAL PHYSICAL HEALTH DETERIORATION,55
abemaciclib,METASTASES TO LUNG,55
abemaciclib,PANCYTOPENIA,55
abemaciclib,ABDOMINAL DISTENSION,54
abemaciclib,DRY SKIN,54
abemaciclib,DRUG-INDUCED LIVER INJURY,53
abemaciclib,DEPRESSION,52
abemaciclib,HEPATIC FAILURE,52
pertuzumab,DIARRHOEA,3269
pertuzumab,OFF LABEL USE,1681
pertuzumab,FATIGUE,1613
pertuzumab,NAUSEA,1550
pertuzumab,ALOPECIA,1451
pertuzumab,DYSPNOEA,1039
pertuzumab,VOMITING,1015
pertuzumab,DISEASE PROGRESSION,1007
pertuzumab,NEUROPATHY PERIPHERAL,999
pertuzumab,DEATH,983
pertuzumab,PYREXIA,892
pertuzumab,NEUTROPENIA,844
pertuzumab,RASH,805
pertuzumab,MYELOSUPPRESSION,776
pertuzumab,ANAEMIA,718
pertuzumab,ASTHENIA,661
pertuzumab,FEBRILE NEUTROPENIA,658
pertuzumab,HEADACHE,650
pertuzumab,EJECTION FRACTION DECREASED,613
pertuzumab,DECREASED APPETITE,604
pertuzumab,PAIN,564
pertuzumab,PNEUMONIA,545
pertuzumab,WEIGHT DECREASED,489
pertuzumab,CONSTIPATION,488
pertuzumab,MUCOSAL INFLAMMATION,455
pertuzumab,COUGH,454
pertuzumab,METASTASES TO CENTRAL NERVOUS SYSTEM,450
pertuzumab,NO ADVERSE EVENT,449
pertuzumab,DRUG INEFFECTIVE,445
pertuzumab,CHILLS,444
pertuzumab,ABDOMINAL PAIN,424
pertuzumab,PRURITUS,420
pertuzumab,URINARY TRACT INFECTION,418
pertuzumab,MALAISE,411
pertuzumab,BACK PAIN,400
pertuzumab,HAIR COLOUR CHANGES,397
pertuzumab,HAIR TEXTURE ABNORMAL,397
pertuzumab,DIZZINESS,396
pertuzumab,ARTHRALGIA,393
pertuzumab,THROMBOCYTOPENIA,392
pertuzumab,MADAROSIS,388
pertuzumab,STOMATITIS,385
pertuzumab,DEHYDRATION,381
pertuzumab,INFUSION RELATED REACTION,373
pertuzumab,HYPOKALAEMIA,359
pertuzumab,PLATELET COUNT DECREASED,357
pertuzumab,EPISTAXIS,354
pertuzumab,HAIR DISORDER,336
pertuzumab,HYPOTENSION,334
pertuzumab,PARAESTHESIA,329
pertuzumab,POLYNEUROPATHY,325
pertuzumab,CARDIAC FAILURE,323
pertuzumab,MYALGIA,323
pertuzumab,WHITE BLOOD CELL COUNT DECREASED,314
pertuzumab,HYPOAESTHESIA,313
pertuzumab,GENERAL PHYSICAL HEALTH DETERIORATION,305
pertuzumab,INTERSTITIAL LUNG DISEASE,292
pertuzumab,PLEURAL EFFUSION,292
pertuzumab,HYPERTENSION,291
pertuzumab,ACUTE KIDNEY INJURY,276
pertuzumab,CARDIOTOXICITY,276
pertuzumab,PAIN IN EXTREMITY,276
pertuzumab,SEPSIS,260
pertuzumab,ERYTHEMA,259
pertuzumab,CELLULITIS,257
pertuzumab,HYPERSENSITIVITY,257
pertuzumab,ANXIETY,256
pertuzumab,MALIGNANT NEOPLASM PROGRESSION,256
pertuzumab,BONE PAIN,253
pertuzumab,BREAST CANCER METASTATIC,250
pertuzumab,NASOPHARYNGITIS,247
pertuzumab,INSOMNIA,246
pertuzumab,CHEST PAIN,243
pertuzumab,NEUTROPHIL COUNT DECREASED,241
pertuzumab,LEUKOPENIA,239
pertuzumab,CHEST DISCOMFORT,237
pertuzumab,TACHYCARDIA,234
pertuzumab,OEDEMA PERIPHERAL,231
pertuzumab,BREAST CANCER,229
pertuzumab,SEIZURE,227
pertuzumab,DYSGEUSIA,225
pertuzumab,DYSPEPSIA,225
pertuzumab,METASTASES TO BONE,219
pertuzumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,219
pertuzumab,ABDOMINAL PAIN UPPER,211
pertuzumab,PNEUMONITIS,205
pertuzumab,PULMONARY EMBOLISM,205
pertuzumab,COVID-19,203
pertuzumab,INFECTION,202
pertuzumab,LOWER RESPIRATORY TRACT INFECTION,200
pertuzumab,MUSCLE SPASMS,199
pertuzumab,PSYCHOLOGICAL TRAUMA,194
pertuzumab,TREMOR,194
pertuzumab,METASTASES TO LIVER,193
pertuzumab,DRY SKIN,191
pertuzumab,LEFT VENTRICULAR DYSFUNCTION,191
pertuzumab,NEOPLASM PROGRESSION,186
pertuzumab,METASTASES TO LUNG,183
pertuzumab,LACRIMATION INCREASED,181
pertuzumab,INTENTIONAL PRODUCT USE ISSUE,178
panitumumab,RASH,1453
panitumumab,DIARRHOEA,1347
panitumumab,DERMATITIS ACNEIFORM,898
panitumumab,DEATH,831
panitumumab,NEUTROPENIA,794
panitumumab,NAUSEA,687
panitumumab,SKIN TOXICITY,671
panitumumab,HYPOMAGNESAEMIA,666
panitumumab,DISEASE PROGRESSION,654
panitumumab,NEUROPATHY PERIPHERAL,549
panitumumab,FATIGUE,546
panitumumab,VOMITING,534
panitumumab,PARONYCHIA,518
panitumumab,STOMATITIS,515
panitumumab,THROMBOCYTOPENIA,484
panitumumab,DECREASED APPETITE,467
panitumumab,OFF LABEL USE,464
panitumumab,COLORECTAL CANCER METASTATIC,441
panitumumab,PYREXIA,441
panitumumab,DRY SKIN,439
panitumumab,ASTHENIA,411
panitumumab,ANAEMIA,406
panitumumab,INTERSTITIAL LUNG DISEASE,333
panitumumab,DYSPNOEA,320
panitumumab,PRURITUS,311
panitumumab,ERYTHEMA,308
panitumumab,DEHYDRATION,301
panitumumab,METASTASES TO LIVER,290
panitumumab,FEBRILE NEUTROPENIA,286
panitumumab,MUCOSAL INFLAMMATION,279
panitumumab,RASH PUSTULAR,258
panitumumab,THERAPY PARTIAL RESPONDER,258
panitumumab,SKIN DISORDER,256
panitumumab,ABDOMINAL PAIN,250
panitumumab,PULMONARY EMBOLISM,248
panitumumab,MALAISE,243
panitumumab,SKIN REACTION,241
panitumumab,NEUTROPHIL COUNT DECREASED,221
panitumumab,COLON CANCER,216
panitumumab,MALIGNANT NEOPLASM PROGRESSION,215
panitumumab,HYPERSENSITIVITY,212
panitumumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,209
panitumumab,ACNE,205
panitumumab,GENERAL PHYSICAL HEALTH DETERIORATION,199
panitumumab,HYPOKALAEMIA,194
panitumumab,HYPERTENSION,193
panitumumab,COLORECTAL CANCER,191
panitumumab,SKIN FISSURES,189
panitumumab,LEUKOPENIA,185
panitumumab,CONSTIPATION,181
panitumumab,PNEUMONIA,172
panitumumab,WEIGHT DECREASED,170
panitumumab,POLYNEUROPATHY,164
panitumumab,HYPOCALCAEMIA,163
panitumumab,DRUG INEFFECTIVE,157
panitumumab,NEUROTOXICITY,156
panitumumab,SEPSIS,155
panitumumab,PAIN,153
panitumumab,INFECTION,151
panitumumab,HYPOTENSION,149
panitumumab,ALOPECIA,148
panitumumab,URINARY TRACT INFECTION,143
panitumumab,ACUTE KIDNEY INJURY,142
panitumumab,CONJUNCTIVITIS,138
panitumumab,METASTASES TO LUNG,138
panitumumab,PLATELET COUNT DECREASED,136
panitumumab,WHITE BLOOD CELL COUNT DECREASED,136
panitumumab,INFUSION RELATED REACTION,133
panitumumab,PRODUCT STORAGE ERROR,129
panitumumab,BLOOD MAGNESIUM DECREASED,126
panitumumab,FOLLICULITIS,118
panitumumab,PERIPHERAL SENSORY NEUROPATHY,118
panitumumab,DEEP VEIN THROMBOSIS,116
panitumumab,DERMATITIS,114
panitumumab,SKIN EXFOLIATION,112
panitumumab,BACK PAIN,111
panitumumab,CHILLS,111
panitumumab,CONDITION AGGRAVATED,111
panitumumab,INTESTINAL OBSTRUCTION,107
panitumumab,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,105
panitumumab,HAEMOGLOBIN DECREASED,102
panitumumab,HEADACHE,101
panitumumab,NEOPLASM PROGRESSION,99
panitumumab,DIZZINESS,98
panitumumab,ASCITES,97
panitumumab,SKIN LESION,95
panitumumab,TOXICITY TO VARIOUS AGENTS,95
panitumumab,EPISTAXIS,94
panitumumab,PARAESTHESIA,94
panitumumab,RENAL FAILURE,93
panitumumab,ILEUS,88
panitumumab,CHEST PAIN,85
panitumumab,COVID-19,85
panitumumab,RASH MACULO-PAPULAR,80
panitumumab,ATRIAL FIBRILLATION,79
panitumumab,DYSGEUSIA,79
panitumumab,HEPATIC FAILURE,75
panitumumab,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,75
panitumumab,OEDEMA PERIPHERAL,74
panitumumab,DEVICE RELATED INFECTION,73
alectinib,DEATH,578
alectinib,FATIGUE,403
alectinib,CONSTIPATION,314
alectinib,DISEASE PROGRESSION,260
alectinib,OFF LABEL USE,242
alectinib,DYSPNOEA,213
alectinib,RASH,211
alectinib,DRUG INEFFECTIVE,204
alectinib,NO ADVERSE EVENT,194
alectinib,MYALGIA,173
alectinib,NAUSEA,173
alectinib,PNEUMONIA,160
alectinib,WEIGHT INCREASED,144
alectinib,DIARRHOEA,142
alectinib,PERIPHERAL SWELLING,133
alectinib,ASTHENIA,131
alectinib,METASTASES TO CENTRAL NERVOUS SYSTEM,131
alectinib,NEOPLASM PROGRESSION,126
alectinib,ANAEMIA,118
alectinib,OEDEMA PERIPHERAL,108
alectinib,HEADACHE,107
alectinib,PAIN,101
alectinib,OEDEMA,100
alectinib,PLEURAL EFFUSION,98
alectinib,PYREXIA,97
alectinib,DIZZINESS,93
alectinib,COUGH,91
alectinib,COVID-19,90
alectinib,DECREASED APPETITE,88
alectinib,PNEUMONITIS,88
alectinib,VOMITING,88
alectinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,87
alectinib,INTERSTITIAL LUNG DISEASE,86
alectinib,MALIGNANT NEOPLASM PROGRESSION,85
alectinib,BRADYCARDIA,82
alectinib,ARTHRALGIA,77
alectinib,INTENTIONAL PRODUCT USE ISSUE,76
alectinib,BLOOD BILIRUBIN INCREASED,74
alectinib,BLOOD CREATININE INCREASED,74
alectinib,PRURITUS,64
alectinib,HEPATIC FUNCTION ABNORMAL,63
alectinib,ASPARTATE AMINOTRANSFERASE INCREASED,60
alectinib,BACK PAIN,59
alectinib,PULMONARY OEDEMA,59
alectinib,DRUG RESISTANCE,58
alectinib,MUSCULAR WEAKNESS,57
alectinib,DYSPHAGIA,56
alectinib,NEUROPATHY PERIPHERAL,56
alectinib,PERICARDIAL EFFUSION,56
alectinib,FALL,55
alectinib,PAIN IN EXTREMITY,55
alectinib,ALOPECIA,54
alectinib,LIVER DISORDER,54
alectinib,RENAL FAILURE,54
alectinib,HEPATIC ENZYME INCREASED,52
alectinib,PHOTOSENSITIVITY REACTION,51
alectinib,ACUTE KIDNEY INJURY,50
alectinib,HAEMOGLOBIN DECREASED,50
alectinib,RENAL IMPAIRMENT,50
alectinib,ALANINE AMINOTRANSFERASE INCREASED,49
alectinib,HAEMOLYSIS,49
alectinib,HAEMOLYTIC ANAEMIA,49
alectinib,PULMONARY EMBOLISM,49
alectinib,DRUG INTERACTION,48
alectinib,LUNG NEOPLASM MALIGNANT,48
alectinib,NEOPLASM MALIGNANT,48
alectinib,SWELLING,48
alectinib,SEIZURE,47
alectinib,JOINT SWELLING,46
alectinib,MEMORY IMPAIRMENT,46
alectinib,FLUID RETENTION,44
alectinib,RHABDOMYOLYSIS,44
alectinib,MALAISE,42
alectinib,WEIGHT DECREASED,42
alectinib,METASTASES TO BONE,41
alectinib,NON-SMALL CELL LUNG CANCER,41
alectinib,THROMBOSIS,41
alectinib,GENERAL PHYSICAL HEALTH DETERIORATION,40
alectinib,CEREBROVASCULAR ACCIDENT,39
alectinib,LUNG DISORDER,39
alectinib,MUSCLE SPASMS,39
alectinib,INSOMNIA,38
alectinib,TRANSAMINASES INCREASED,38
alectinib,CHEST PAIN,37
alectinib,VISUAL IMPAIRMENT,36
alectinib,HYPERBILIRUBINAEMIA,35
alectinib,HYPOTENSION,35
alectinib,CARDIAC FAILURE,34
alectinib,CONFUSIONAL STATE,34
alectinib,HYPOAESTHESIA,34
alectinib,METASTASES TO LIVER,34
alectinib,URINARY TRACT INFECTION,34
alectinib,ABDOMINAL DISTENSION,33
alectinib,BRAIN NEOPLASM,33
alectinib,DEEP VEIN THROMBOSIS,33
alectinib,PRODUCT STORAGE ERROR,33
alectinib,ABDOMINAL PAIN UPPER,32
alectinib,VISION BLURRED,32
alectinib,ABDOMINAL PAIN,31
alectinib,ATRIAL FIBRILLATION,31
dabrafenib,PYREXIA,3690
dabrafenib,DEATH,2658
dabrafenib,MALIGNANT NEOPLASM PROGRESSION,1548
dabrafenib,FATIGUE,1224
dabrafenib,NAUSEA,1215
dabrafenib,CHILLS,1189
dabrafenib,RASH,1031
dabrafenib,VOMITING,869
dabrafenib,DIARRHOEA,838
dabrafenib,HEADACHE,654
dabrafenib,ASTHENIA,621
dabrafenib,MALAISE,573
dabrafenib,DECREASED APPETITE,516
dabrafenib,ARTHRALGIA,515
dabrafenib,PRODUCT USE IN UNAPPROVED INDICATION,496
dabrafenib,DRUG INEFFECTIVE,436
dabrafenib,METASTATIC MALIGNANT MELANOMA,435
dabrafenib,METASTASES TO CENTRAL NERVOUS SYSTEM,430
dabrafenib,PAIN,423
dabrafenib,VISUAL IMPAIRMENT,400
dabrafenib,MALIGNANT MELANOMA,393
dabrafenib,DISEASE PROGRESSION,385
dabrafenib,DYSPNOEA,371
dabrafenib,DIZZINESS,347
dabrafenib,DEHYDRATION,332
dabrafenib,COUGH,321
dabrafenib,PNEUMONIA,313
dabrafenib,GENERAL PHYSICAL HEALTH DETERIORATION,298
dabrafenib,HYPOTENSION,284
dabrafenib,VISION BLURRED,282
dabrafenib,CONSTIPATION,274
dabrafenib,WEIGHT DECREASED,268
dabrafenib,PRURITUS,263
dabrafenib,DYSPHAGIA,259
dabrafenib,PAIN IN EXTREMITY,258
dabrafenib,ABDOMINAL PAIN,246
dabrafenib,MYALGIA,241
dabrafenib,ANAEMIA,238
dabrafenib,UVEITIS,232
dabrafenib,PERIPHERAL SWELLING,226
dabrafenib,EJECTION FRACTION DECREASED,221
dabrafenib,BLOOD CREATINE PHOSPHOKINASE INCREASED,216
dabrafenib,CONFUSIONAL STATE,215
dabrafenib,SEIZURE,213
dabrafenib,NEUTROPENIA,202
dabrafenib,OFF LABEL USE,199
dabrafenib,ACUTE KIDNEY INJURY,196
dabrafenib,INFECTION,196
dabrafenib,ASPARTATE AMINOTRANSFERASE INCREASED,188
dabrafenib,FALL,187
dabrafenib,TREMOR,184
dabrafenib,URINARY TRACT INFECTION,184
dabrafenib,SEPSIS,179
dabrafenib,ALOPECIA,177
dabrafenib,NEOPLASM MALIGNANT,175
dabrafenib,C-REACTIVE PROTEIN INCREASED,172
dabrafenib,ALANINE AMINOTRANSFERASE INCREASED,171
dabrafenib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,171
dabrafenib,THROMBOCYTOPENIA,171
dabrafenib,ERYTHEMA,167
dabrafenib,DRY SKIN,164
dabrafenib,OEDEMA PERIPHERAL,164
dabrafenib,BACK PAIN,159
dabrafenib,DRUG INTOLERANCE,158
dabrafenib,RENAL FAILURE,158
dabrafenib,INCORRECT DOSE ADMINISTERED,151
dabrafenib,ABDOMINAL PAIN UPPER,149
dabrafenib,HYPERHIDROSIS,148
dabrafenib,PULMONARY EMBOLISM,143
dabrafenib,HEPATIC ENZYME INCREASED,142
dabrafenib,SYNCOPE,140
dabrafenib,GAIT DISTURBANCE,135
dabrafenib,ABDOMINAL DISCOMFORT,131
dabrafenib,METASTASES TO LIVER,129
dabrafenib,METASTASES TO LUNG,128
dabrafenib,RHABDOMYOLYSIS,128
dabrafenib,HYPERTENSION,125
dabrafenib,ILLNESS,123
dabrafenib,FEELING ABNORMAL,122
dabrafenib,PRODUCT USE ISSUE,122
dabrafenib,INFLUENZA LIKE ILLNESS,121
dabrafenib,BLOOD LACTATE DEHYDROGENASE INCREASED,120
dabrafenib,ATRIAL FIBRILLATION,119
dabrafenib,SOMNOLENCE,119
dabrafenib,PNEUMONITIS,116
dabrafenib,HYPONATRAEMIA,115
dabrafenib,SECOND PRIMARY MALIGNANCY,113
dabrafenib,HOSPITALISATION,112
dabrafenib,BASAL CELL CARCINOMA,110
dabrafenib,NASOPHARYNGITIS,110
dabrafenib,PANNICULITIS,110
dabrafenib,LYMPHADENOPATHY,109
dabrafenib,HYPERSENSITIVITY,106
dabrafenib,CONDITION AGGRAVATED,105
dabrafenib,BLOOD ALKALINE PHOSPHATASE INCREASED,103
dabrafenib,CARDIAC FAILURE,103
dabrafenib,BLOOD CREATININE INCREASED,102
dabrafenib,SPEECH DISORDER,101
dabrafenib,TOXICITY TO VARIOUS AGENTS,101
dabrafenib,BODY TEMPERATURE INCREASED,100
niraparib,NAUSEA,5296
niraparib,FATIGUE,4835
niraparib,CONSTIPATION,3819
niraparib,PLATELET COUNT DECREASED,3699
niraparib,INSOMNIA,2643
niraparib,BLOOD PRESSURE INCREASED,2298
niraparib,HEADACHE,2148
niraparib,OFF LABEL USE,2083
niraparib,VOMITING,1837
niraparib,CARBOHYDRATE ANTIGEN 125 INCREASED,1794
niraparib,ASTHENIA,1734
niraparib,DECREASED APPETITE,1730
niraparib,PRODUCT DOSE OMISSION ISSUE,1650
niraparib,HAEMOGLOBIN DECREASED,1625
niraparib,DIZZINESS,1458
niraparib,DYSPNOEA,1332
niraparib,WHITE BLOOD CELL COUNT DECREASED,1285
niraparib,ANAEMIA,1272
niraparib,RED BLOOD CELL COUNT DECREASED,1254
niraparib,HYPERTENSION,1185
niraparib,MALIGNANT NEOPLASM PROGRESSION,1176
niraparib,HEART RATE INCREASED,1158
niraparib,ARTHRALGIA,1116
niraparib,DIARRHOEA,1045
niraparib,NEUROPATHY PERIPHERAL,1013
niraparib,MALAISE,1005
niraparib,DRUG INEFFECTIVE,992
niraparib,PAIN,954
niraparib,THROMBOCYTOPENIA,922
niraparib,WEIGHT DECREASED,871
niraparib,DISEASE PROGRESSION,848
niraparib,DRY MOUTH,819
niraparib,ANXIETY,815
niraparib,DEATH,813
niraparib,ABDOMINAL PAIN UPPER,798
niraparib,ABDOMINAL DISCOMFORT,791
niraparib,ADVERSE DRUG REACTION,791
niraparib,FEELING ABNORMAL,786
niraparib,BACK PAIN,783
niraparib,COUGH,712
niraparib,RECURRENT CANCER,700
niraparib,INTENTIONAL UNDERDOSE,677
niraparib,PAIN IN EXTREMITY,655
niraparib,ABDOMINAL PAIN,628
niraparib,CONDITION AGGRAVATED,626
niraparib,PRURITUS,622
niraparib,RENAL IMPAIRMENT,600
niraparib,PALPITATIONS,599
niraparib,HOSPITALISATION,583
niraparib,DYSPEPSIA,565
niraparib,DECREASED ACTIVITY,563
niraparib,DEHYDRATION,561
niraparib,SLEEP DISORDER,552
niraparib,RASH,547
niraparib,URINARY TRACT INFECTION,537
niraparib,LABORATORY TEST ABNORMAL,510
niraparib,BLOOD CREATININE INCREASED,507
niraparib,MYALGIA,507
niraparib,CONTUSION,500
niraparib,STOMATITIS,490
niraparib,ABDOMINAL DISTENSION,456
niraparib,MUSCLE SPASMS,450
niraparib,EMOTIONAL DISTRESS,444
niraparib,BLOOD COUNT ABNORMAL,441
niraparib,PRODUCT USE IN UNAPPROVED INDICATION,432
niraparib,NASOPHARYNGITIS,420
niraparib,OVARIAN CANCER,417
niraparib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,404
niraparib,ILLNESS,401
niraparib,FALL,397
niraparib,PRODUCT DOSE OMISSION IN ERROR,393
niraparib,HAEMATOCRIT DECREASED,377
niraparib,PERIPHERAL SWELLING,372
niraparib,OVARIAN CANCER RECURRENT,362
niraparib,HOT FLUSH,359
niraparib,UNDERDOSE,357
niraparib,BLOOD GLUCOSE INCREASED,356
niraparib,HYPOAESTHESIA,352
niraparib,NEUTROPHIL COUNT DECREASED,343
niraparib,PHOTOSENSITIVITY REACTION,342
niraparib,INTESTINAL OBSTRUCTION,340
niraparib,BALANCE DISORDER,338
niraparib,ALOPECIA,334
niraparib,GAIT DISTURBANCE,332
niraparib,PRODUCT DOSE OMISSION,332
niraparib,TUMOUR MARKER INCREASED,329
niraparib,FULL BLOOD COUNT DECREASED,326
niraparib,DRUG INTOLERANCE,324
niraparib,MEMORY IMPAIRMENT,318
niraparib,PYREXIA,318
niraparib,FLATULENCE,313
niraparib,TREMOR,310
niraparib,OROPHARYNGEAL PAIN,307
niraparib,FULL BLOOD COUNT ABNORMAL,289
niraparib,BLOOD PRESSURE FLUCTUATION,279
niraparib,DYSGEUSIA,276
niraparib,TASTE DISORDER,275
niraparib,HYPERHIDROSIS,270
niraparib,WEIGHT INCREASED,268
niraparib,BONE PAIN,261
trastuzumab,DIARRHOEA,6249
trastuzumab,ALOPECIA,5066
trastuzumab,NAUSEA,4723
trastuzumab,FATIGUE,4505
trastuzumab,DEATH,4162
trastuzumab,DISEASE PROGRESSION,3647
trastuzumab,OFF LABEL USE,3596
trastuzumab,VOMITING,2963
trastuzumab,DYSPNOEA,2961
trastuzumab,PYREXIA,2476
trastuzumab,ASTHENIA,2194
trastuzumab,NEUTROPENIA,2134
trastuzumab,PAIN,2113
trastuzumab,NEUROPATHY PERIPHERAL,2066
trastuzumab,EJECTION FRACTION DECREASED,1948
trastuzumab,ANAEMIA,1892
trastuzumab,RASH,1846
trastuzumab,HEADACHE,1785
trastuzumab,DECREASED APPETITE,1702
trastuzumab,MYELOSUPPRESSION,1698
trastuzumab,FEBRILE NEUTROPENIA,1557
trastuzumab,HAIR COLOUR CHANGES,1510
trastuzumab,HAIR TEXTURE ABNORMAL,1508
trastuzumab,MADAROSIS,1429
trastuzumab,METASTASES TO CENTRAL NERVOUS SYSTEM,1427
trastuzumab,MALAISE,1420
trastuzumab,COUGH,1415
trastuzumab,PNEUMONIA,1373
trastuzumab,HAIR DISORDER,1368
trastuzumab,THROMBOCYTOPENIA,1361
trastuzumab,ARTHRALGIA,1290
trastuzumab,DRUG INEFFECTIVE,1257
trastuzumab,INTERSTITIAL LUNG DISEASE,1247
trastuzumab,PSYCHOLOGICAL TRAUMA,1243
trastuzumab,MALIGNANT NEOPLASM PROGRESSION,1231
trastuzumab,CONSTIPATION,1223
trastuzumab,CHILLS,1199
trastuzumab,ANXIETY,1181
trastuzumab,WEIGHT DECREASED,1168
trastuzumab,DIZZINESS,1153
trastuzumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1120
trastuzumab,ABDOMINAL PAIN,1046
trastuzumab,PLATELET COUNT DECREASED,1045
trastuzumab,CARDIAC FAILURE,990
trastuzumab,BACK PAIN,986
trastuzumab,DEHYDRATION,984
trastuzumab,PAIN IN EXTREMITY,948
trastuzumab,CARDIOTOXICITY,947
trastuzumab,STOMATITIS,947
trastuzumab,WHITE BLOOD CELL COUNT DECREASED,920
trastuzumab,MYALGIA,913
trastuzumab,PLEURAL EFFUSION,906
trastuzumab,NO ADVERSE EVENT,897
trastuzumab,PRURITUS,878
trastuzumab,INFUSION RELATED REACTION,864
trastuzumab,MUCOSAL INFLAMMATION,864
trastuzumab,EPISTAXIS,861
trastuzumab,HYPERTENSION,826
trastuzumab,ERYTHEMA,813
trastuzumab,PARAESTHESIA,810
trastuzumab,URINARY TRACT INFECTION,808
trastuzumab,HYPOKALAEMIA,787
trastuzumab,HYPOTENSION,782
trastuzumab,GENERAL PHYSICAL HEALTH DETERIORATION,769
trastuzumab,METASTASES TO LIVER,734
trastuzumab,HYPOAESTHESIA,728
trastuzumab,EMOTIONAL DISTRESS,719
trastuzumab,SEPSIS,715
trastuzumab,CHEST PAIN,714
trastuzumab,PNEUMONITIS,714
trastuzumab,LEUKOPENIA,710
trastuzumab,METASTASES TO BONE,706
trastuzumab,HYPERSENSITIVITY,702
trastuzumab,BREAST CANCER METASTATIC,692
trastuzumab,ALANINE AMINOTRANSFERASE INCREASED,691
trastuzumab,INSOMNIA,669
trastuzumab,OEDEMA PERIPHERAL,658
trastuzumab,BREAST CANCER,651
trastuzumab,NEUTROPHIL COUNT DECREASED,649
trastuzumab,ASPARTATE AMINOTRANSFERASE INCREASED,625
trastuzumab,PULMONARY EMBOLISM,615
trastuzumab,BONE PAIN,612
trastuzumab,INFECTION,598
trastuzumab,TACHYCARDIA,590
trastuzumab,ABDOMINAL PAIN UPPER,566
trastuzumab,BONE MARROW FAILURE,566
trastuzumab,DEPRESSION,565
trastuzumab,METASTASES TO LUNG,561
trastuzumab,TREMOR,561
trastuzumab,CHEST DISCOMFORT,557
trastuzumab,NEOPLASM PROGRESSION,553
trastuzumab,NASOPHARYNGITIS,546
trastuzumab,CELLULITIS,545
trastuzumab,CARDIAC DISORDER,521
trastuzumab,INTENTIONAL PRODUCT USE ISSUE,518
trastuzumab,ACUTE KIDNEY INJURY,512
trastuzumab,MUSCLE SPASMS,511
trastuzumab,PERIPHERAL SWELLING,509
trastuzumab,IMPAIRED QUALITY OF LIFE,505
trastuzumab,HAEMOGLOBIN DECREASED,499
cabozantinib,DIARRHOEA,6668
cabozantinib,FATIGUE,5400
cabozantinib,NAUSEA,3532
cabozantinib,DECREASED APPETITE,3293
cabozantinib,OFF LABEL USE,3188
cabozantinib,DEATH,2502
cabozantinib,MALIGNANT NEOPLASM PROGRESSION,2210
cabozantinib,WEIGHT DECREASED,2115
cabozantinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2084
cabozantinib,STOMATITIS,2066
cabozantinib,BLOOD PRESSURE INCREASED,2062
cabozantinib,CONSTIPATION,1637
cabozantinib,VOMITING,1602
cabozantinib,BLISTER,1528
cabozantinib,ASTHENIA,1527
cabozantinib,HYPERTENSION,1357
cabozantinib,PAIN IN EXTREMITY,1298
cabozantinib,MALAISE,1241
cabozantinib,RASH,1241
cabozantinib,TASTE DISORDER,1192
cabozantinib,DYSPHONIA,1041
cabozantinib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,1002
cabozantinib,ORAL PAIN,925
cabozantinib,DRY SKIN,918
cabozantinib,ADVERSE DRUG REACTION,893
cabozantinib,SKIN ULCER,848
cabozantinib,PRURITUS,780
cabozantinib,HEADACHE,768
cabozantinib,PAIN,766
cabozantinib,DIZZINESS,758
cabozantinib,DEHYDRATION,743
cabozantinib,DRY MOUTH,729
cabozantinib,DYSPNOEA,716
cabozantinib,DYSGEUSIA,703
cabozantinib,ABDOMINAL DISCOMFORT,679
cabozantinib,ABDOMINAL PAIN UPPER,617
cabozantinib,ARTHRALGIA,612
cabozantinib,HEPATIC FUNCTION ABNORMAL,590
cabozantinib,SKIN EXFOLIATION,569
cabozantinib,ALOPECIA,555
cabozantinib,HYPOTHYROIDISM,543
cabozantinib,PRODUCT DOSE OMISSION ISSUE,531
cabozantinib,DRUG INEFFECTIVE,527
cabozantinib,ABDOMINAL PAIN,512
cabozantinib,AGEUSIA,509
cabozantinib,ERYTHEMA,509
cabozantinib,DRUG INTOLERANCE,506
cabozantinib,PERIPHERAL SWELLING,498
cabozantinib,PYREXIA,496
cabozantinib,BACK PAIN,491
cabozantinib,MUSCLE SPASMS,487
cabozantinib,DISEASE PROGRESSION,479
cabozantinib,OROPHARYNGEAL PAIN,479
cabozantinib,HAIR COLOUR CHANGES,469
cabozantinib,GLOSSODYNIA,453
cabozantinib,PNEUMONIA,451
cabozantinib,COUGH,418
cabozantinib,PULMONARY EMBOLISM,382
cabozantinib,HEPATIC ENZYME INCREASED,380
cabozantinib,DYSPEPSIA,362
cabozantinib,URINARY TRACT INFECTION,356
cabozantinib,FLATULENCE,355
cabozantinib,PLATELET COUNT DECREASED,337
cabozantinib,DYSPHAGIA,336
cabozantinib,FALL,331
cabozantinib,ANAEMIA,322
cabozantinib,PROTEINURIA,307
cabozantinib,HYPERKERATOSIS,306
cabozantinib,INSOMNIA,305
cabozantinib,PLEURAL EFFUSION,302
cabozantinib,CONFUSIONAL STATE,293
cabozantinib,GENERAL PHYSICAL HEALTH DETERIORATION,288
cabozantinib,EPISTAXIS,285
cabozantinib,GASTROOESOPHAGEAL REFLUX DISEASE,277
cabozantinib,LIVER DISORDER,277
cabozantinib,ALANINE AMINOTRANSFERASE INCREASED,275
cabozantinib,NEUROPATHY PERIPHERAL,269
cabozantinib,IMPAIRED HEALING,266
cabozantinib,ASPARTATE AMINOTRANSFERASE INCREASED,261
cabozantinib,THROMBOSIS,261
cabozantinib,SEPSIS,260
cabozantinib,MUCOSAL INFLAMMATION,259
cabozantinib,SOMNOLENCE,255
cabozantinib,RENAL CELL CARCINOMA,254
cabozantinib,CHEST PAIN,246
cabozantinib,MYALGIA,243
cabozantinib,TOOTH DISORDER,239
cabozantinib,GAIT DISTURBANCE,236
cabozantinib,MEMORY IMPAIRMENT,234
cabozantinib,ORAL DISCOMFORT,234
cabozantinib,ACNE,229
cabozantinib,PARAESTHESIA,226
cabozantinib,HYPOAESTHESIA,224
cabozantinib,FEELING ABNORMAL,223
cabozantinib,CEREBROVASCULAR ACCIDENT,219
cabozantinib,ILLNESS,218
cabozantinib,OEDEMA PERIPHERAL,215
cabozantinib,LIVER FUNCTION TEST INCREASED,212
cabozantinib,ACUTE KIDNEY INJURY,210
cabozantinib,NASOPHARYNGITIS,205
ramucirumab,MALIGNANT NEOPLASM PROGRESSION,715
ramucirumab,DEATH,459
ramucirumab,INTERSTITIAL LUNG DISEASE,260
ramucirumab,FEBRILE NEUTROPENIA,245
ramucirumab,NEUTROPENIA,226
ramucirumab,DIARRHOEA,191
ramucirumab,DECREASED APPETITE,187
ramucirumab,HYPERTENSION,165
ramucirumab,FATIGUE,164
ramucirumab,OFF LABEL USE,164
ramucirumab,NAUSEA,160
ramucirumab,DISEASE PROGRESSION,158
ramucirumab,PYREXIA,156
ramucirumab,NEUTROPHIL COUNT DECREASED,155
ramucirumab,NEUROPATHY PERIPHERAL,154
ramucirumab,ASCITES,144
ramucirumab,ANAEMIA,143
ramucirumab,PNEUMONIA,139
ramucirumab,DRUG INEFFECTIVE,126
ramucirumab,PROTEINURIA,122
ramucirumab,VOMITING,114
ramucirumab,ABDOMINAL PAIN,110
ramucirumab,DYSPNOEA,108
ramucirumab,PLATELET COUNT DECREASED,101
ramucirumab,MALAISE,99
ramucirumab,WHITE BLOOD CELL COUNT DECREASED,88
ramucirumab,EPISTAXIS,87
ramucirumab,PERITONITIS,85
ramucirumab,THROMBOCYTOPENIA,85
ramucirumab,SEPSIS,82
ramucirumab,PNEUMONITIS,81
ramucirumab,STOMATITIS,79
ramucirumab,GENERAL PHYSICAL HEALTH DETERIORATION,78
ramucirumab,PLEURAL EFFUSION,78
ramucirumab,ASTHENIA,77
ramucirumab,PULMONARY EMBOLISM,75
ramucirumab,GASTROINTESTINAL PERFORATION,74
ramucirumab,NEPHROTIC SYNDROME,74
ramucirumab,TUMOUR HAEMORRHAGE,69
ramucirumab,DISSEMINATED INTRAVASCULAR COAGULATION,67
ramucirumab,GASTROINTESTINAL HAEMORRHAGE,67
ramucirumab,HAEMOPTYSIS,66
ramucirumab,HAEMOGLOBIN DECREASED,63
ramucirumab,WEIGHT DECREASED,63
ramucirumab,RASH,61
ramucirumab,PRODUCT USE IN UNAPPROVED INDICATION,59
ramucirumab,CARDIAC FAILURE,55
ramucirumab,INFUSION RELATED REACTION,55
ramucirumab,OEDEMA PERIPHERAL,55
ramucirumab,SEPTIC SHOCK,54
ramucirumab,ACUTE KIDNEY INJURY,52
ramucirumab,OEDEMA,52
ramucirumab,GASTRIC PERFORATION,51
ramucirumab,MUCOSAL INFLAMMATION,50
ramucirumab,INFECTION,49
ramucirumab,RESPIRATORY FAILURE,49
ramucirumab,ALOPECIA,48
ramucirumab,DEHYDRATION,48
ramucirumab,PRURITUS,47
ramucirumab,ALANINE AMINOTRANSFERASE INCREASED,46
ramucirumab,ERYTHEMA,46
ramucirumab,HAEMORRHAGE,46
ramucirumab,METASTASES TO LIVER,46
ramucirumab,COUGH,45
ramucirumab,ABDOMINAL PAIN UPPER,44
ramucirumab,CONSTIPATION,44
ramucirumab,HYPERSENSITIVITY,44
ramucirumab,PAIN,44
ramucirumab,THERAPY PARTIAL RESPONDER,44
ramucirumab,DEEP VEIN THROMBOSIS,43
ramucirumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,43
ramucirumab,DYSPHAGIA,40
ramucirumab,HEADACHE,40
ramucirumab,CHEST PAIN,38
ramucirumab,FALL,38
ramucirumab,HAEMATEMESIS,38
ramucirumab,BACK PAIN,37
ramucirumab,C-REACTIVE PROTEIN INCREASED,37
ramucirumab,CEREBRAL HAEMORRHAGE,37
ramucirumab,LEUKOPENIA,37
ramucirumab,PNEUMOTHORAX,36
ramucirumab,HEPATIC FUNCTION ABNORMAL,35
ramucirumab,NEOPLASM PROGRESSION,35
ramucirumab,BLOOD PRESSURE INCREASED,34
ramucirumab,BONE MARROW FAILURE,34
ramucirumab,HEPATIC FAILURE,34
ramucirumab,HYPOAESTHESIA,34
ramucirumab,POLYNEUROPATHY,34
ramucirumab,HYPONATRAEMIA,33
ramucirumab,CONDITION AGGRAVATED,32
ramucirumab,ANAPHYLACTIC REACTION,31
ramucirumab,MYELOSUPPRESSION,30
ramucirumab,RENAL IMPAIRMENT,30
ramucirumab,INTESTINAL PERFORATION,29
ramucirumab,PNEUMONIA ASPIRATION,29
ramucirumab,ASPARTATE AMINOTRANSFERASE INCREASED,28
ramucirumab,CEREBROVASCULAR ACCIDENT,28
ramucirumab,LARGE INTESTINE PERFORATION,28
ramucirumab,LUNG DISORDER,28
ramucirumab,THROMBOSIS,28
atezolizumab,DEATH,2446
atezolizumab,OFF LABEL USE,1669
atezolizumab,PYREXIA,1340
atezolizumab,DISEASE PROGRESSION,1242
atezolizumab,DIARRHOEA,1196
atezolizumab,ANAEMIA,1017
atezolizumab,FATIGUE,995
atezolizumab,PNEUMONIA,844
atezolizumab,NAUSEA,787
atezolizumab,DYSPNOEA,764
atezolizumab,FEBRILE NEUTROPENIA,746
atezolizumab,DECREASED APPETITE,700
atezolizumab,HYPOTHYROIDISM,648
atezolizumab,PNEUMONITIS,647
atezolizumab,VOMITING,599
atezolizumab,RASH,594
atezolizumab,ASTHENIA,589
atezolizumab,INTERSTITIAL LUNG DISEASE,588
atezolizumab,ACUTE KIDNEY INJURY,587
atezolizumab,NEUTROPENIA,560
atezolizumab,PLATELET COUNT DECREASED,553
atezolizumab,HYPERTENSION,545
atezolizumab,NEUTROPHIL COUNT DECREASED,539
atezolizumab,THROMBOCYTOPENIA,535
atezolizumab,COLITIS,503
atezolizumab,INTENTIONAL PRODUCT USE ISSUE,501
atezolizumab,CONSTIPATION,498
atezolizumab,SEPSIS,482
atezolizumab,DRUG INEFFECTIVE,474
atezolizumab,WHITE BLOOD CELL COUNT DECREASED,393
atezolizumab,ABDOMINAL PAIN,389
atezolizumab,ALANINE AMINOTRANSFERASE INCREASED,386
atezolizumab,PROTEINURIA,386
atezolizumab,HEPATIC FUNCTION ABNORMAL,375
atezolizumab,ASCITES,372
atezolizumab,HYPONATRAEMIA,361
atezolizumab,GENERAL PHYSICAL HEALTH DETERIORATION,358
atezolizumab,ASPARTATE AMINOTRANSFERASE INCREASED,355
atezolizumab,ADRENAL INSUFFICIENCY,346
atezolizumab,NEUROPATHY PERIPHERAL,321
atezolizumab,PRURITUS,308
atezolizumab,COUGH,306
atezolizumab,HYPOKALAEMIA,305
atezolizumab,ARTHRALGIA,299
atezolizumab,MALAISE,298
atezolizumab,URINARY TRACT INFECTION,296
atezolizumab,HEPATITIS,295
atezolizumab,HYPERTHYROIDISM,286
atezolizumab,PLEURAL EFFUSION,280
atezolizumab,HEADACHE,277
atezolizumab,PAIN,274
atezolizumab,DEHYDRATION,273
atezolizumab,COVID-19,271
atezolizumab,HEPATIC FAILURE,266
atezolizumab,ALOPECIA,260
atezolizumab,NO ADVERSE EVENT,251
atezolizumab,PULMONARY EMBOLISM,248
atezolizumab,MYOCARDITIS,247
atezolizumab,INFUSION RELATED REACTION,244
atezolizumab,HEPATOCELLULAR CARCINOMA,243
atezolizumab,RESPIRATORY FAILURE,243
atezolizumab,WEIGHT DECREASED,242
atezolizumab,LIVER DISORDER,238
atezolizumab,RENAL IMPAIRMENT,237
atezolizumab,MALIGNANT NEOPLASM PROGRESSION,235
atezolizumab,BLOOD CREATININE INCREASED,234
atezolizumab,BACK PAIN,232
atezolizumab,HYPOTENSION,229
atezolizumab,STOMATITIS,228
atezolizumab,BLOOD BILIRUBIN INCREASED,223
atezolizumab,PANCYTOPENIA,220
atezolizumab,CARDIAC FAILURE,219
atezolizumab,MUSCULAR WEAKNESS,217
atezolizumab,MYELOSUPPRESSION,217
atezolizumab,OEDEMA PERIPHERAL,205
atezolizumab,DIZZINESS,200
atezolizumab,LYMPHOCYTE COUNT DECREASED,188
atezolizumab,MUCOSAL INFLAMMATION,187
atezolizumab,RENAL FAILURE,185
atezolizumab,ATRIAL FIBRILLATION,183
atezolizumab,ENCEPHALITIS,178
atezolizumab,INFECTION,178
atezolizumab,CHEST PAIN,171
atezolizumab,THERAPY PARTIAL RESPONDER,171
atezolizumab,MYOSITIS,169
atezolizumab,CONFUSIONAL STATE,167
atezolizumab,EPISTAXIS,164
atezolizumab,HYPERGLYCAEMIA,163
atezolizumab,DRUG-INDUCED LIVER INJURY,162
atezolizumab,METASTASES TO CENTRAL NERVOUS SYSTEM,162
atezolizumab,MYALGIA,162
atezolizumab,DYSPHAGIA,154
atezolizumab,FALL,154
atezolizumab,RASH MACULO-PAPULAR,152
atezolizumab,SEIZURE,149
atezolizumab,LEUKOPENIA,148
atezolizumab,ENCEPHALOPATHY,147
atezolizumab,HYPOXIA,146
atezolizumab,SEPTIC SHOCK,145
atezolizumab,NEUTROPENIC SEPSIS,144
bevacizumab,DEATH,11827
bevacizumab,OFF LABEL USE,10033
bevacizumab,DIARRHOEA,6634
bevacizumab,DISEASE PROGRESSION,6395
bevacizumab,NAUSEA,6119
bevacizumab,FATIGUE,5631
bevacizumab,HYPERTENSION,5123
bevacizumab,VOMITING,4691
bevacizumab,ANAEMIA,3830
bevacizumab,PYREXIA,3673
bevacizumab,NEUTROPENIA,3525
bevacizumab,ASTHENIA,3256
bevacizumab,DYSPNOEA,3252
bevacizumab,DECREASED APPETITE,2953
bevacizumab,THROMBOCYTOPENIA,2772
bevacizumab,ABDOMINAL PAIN,2765
bevacizumab,DRUG INEFFECTIVE,2600
bevacizumab,PROTEINURIA,2546
bevacizumab,NEUROPATHY PERIPHERAL,2438
bevacizumab,MALIGNANT NEOPLASM PROGRESSION,2329
bevacizumab,HEADACHE,2271
bevacizumab,DEHYDRATION,2180
bevacizumab,CONSTIPATION,2141
bevacizumab,PAIN,2096
bevacizumab,FEBRILE NEUTROPENIA,2058
bevacizumab,PLATELET COUNT DECREASED,2045
bevacizumab,RASH,2000
bevacizumab,EPISTAXIS,1963
bevacizumab,PULMONARY EMBOLISM,1948
bevacizumab,PNEUMONIA,1821
bevacizumab,WEIGHT DECREASED,1794
bevacizumab,INTENTIONAL PRODUCT USE ISSUE,1782
bevacizumab,GENERAL PHYSICAL HEALTH DETERIORATION,1734
bevacizumab,MALAISE,1696
bevacizumab,WHITE BLOOD CELL COUNT DECREASED,1605
bevacizumab,NEUTROPHIL COUNT DECREASED,1534
bevacizumab,BLOOD PRESSURE INCREASED,1483
bevacizumab,NO ADVERSE EVENT,1457
bevacizumab,SEPSIS,1422
bevacizumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1416
bevacizumab,STOMATITIS,1352
bevacizumab,MUCOSAL INFLAMMATION,1338
bevacizumab,COUGH,1325
bevacizumab,DIZZINESS,1282
bevacizumab,LEUKOPENIA,1279
bevacizumab,MYELOSUPPRESSION,1270
bevacizumab,ASCITES,1260
bevacizumab,PLEURAL EFFUSION,1251
bevacizumab,ARTHRALGIA,1239
bevacizumab,DEEP VEIN THROMBOSIS,1234
bevacizumab,HAEMOGLOBIN DECREASED,1199
bevacizumab,INFECTION,1184
bevacizumab,BACK PAIN,1180
bevacizumab,HAEMORRHAGE,1164
bevacizumab,HYPOTENSION,1155
bevacizumab,ALOPECIA,1125
bevacizumab,INTERSTITIAL LUNG DISEASE,1120
bevacizumab,NEOPLASM PROGRESSION,1099
bevacizumab,ENDOPHTHALMITIS,1079
bevacizumab,URINARY TRACT INFECTION,1061
bevacizumab,GASTROINTESTINAL PERFORATION,1055
bevacizumab,FALL,1042
bevacizumab,CONFUSIONAL STATE,1024
bevacizumab,VISUAL IMPAIRMENT,1021
bevacizumab,CHEST PAIN,1017
bevacizumab,BONE MARROW FAILURE,1006
bevacizumab,INTESTINAL OBSTRUCTION,1005
bevacizumab,CEREBROVASCULAR ACCIDENT,948
bevacizumab,BLINDNESS,945
bevacizumab,METASTASES TO LIVER,945
bevacizumab,RENAL FAILURE,901
bevacizumab,HYPOKALAEMIA,896
bevacizumab,ACUTE KIDNEY INJURY,895
bevacizumab,PAIN IN EXTREMITY,889
bevacizumab,INTESTINAL PERFORATION,881
bevacizumab,HYPERSENSITIVITY,874
bevacizumab,OEDEMA PERIPHERAL,859
bevacizumab,ERYTHEMA,835
bevacizumab,PARAESTHESIA,833
bevacizumab,HYPONATRAEMIA,829
bevacizumab,ABDOMINAL PAIN UPPER,824
bevacizumab,BLOOD CREATININE INCREASED,808
bevacizumab,THROMBOSIS,798
bevacizumab,RENAL IMPAIRMENT,787
bevacizumab,ALANINE AMINOTRANSFERASE INCREASED,786
bevacizumab,PRURITUS,771
bevacizumab,ASPARTATE AMINOTRANSFERASE INCREASED,766
bevacizumab,HYPOAESTHESIA,765
bevacizumab,CHILLS,740
bevacizumab,VISUAL ACUITY REDUCED,737
bevacizumab,CARDIAC FAILURE,730
bevacizumab,GASTROINTESTINAL HAEMORRHAGE,727
bevacizumab,HEPATIC FUNCTION ABNORMAL,727
bevacizumab,MUSCULAR WEAKNESS,704
bevacizumab,CONDITION AGGRAVATED,695
bevacizumab,RESPIRATORY FAILURE,690
bevacizumab,VISION BLURRED,689
bevacizumab,ATRIAL FIBRILLATION,685
bevacizumab,MYOCARDIAL INFARCTION,681
bevacizumab,METASTASES TO LUNG,678
olaparib,DEATH,3653
olaparib,MALIGNANT NEOPLASM PROGRESSION,1607
olaparib,NAUSEA,1211
olaparib,ANAEMIA,1186
olaparib,FATIGUE,1004
olaparib,OFF LABEL USE,698
olaparib,VOMITING,505
olaparib,DRUG INEFFECTIVE,463
olaparib,MYELODYSPLASTIC SYNDROME,389
olaparib,DIARRHOEA,376
olaparib,ASTHENIA,360
olaparib,DECREASED APPETITE,345
olaparib,DISEASE PROGRESSION,335
olaparib,PLATELET COUNT DECREASED,293
olaparib,ACUTE MYELOID LEUKAEMIA,285
olaparib,INTERSTITIAL LUNG DISEASE,282
olaparib,MALAISE,279
olaparib,THROMBOCYTOPENIA,277
olaparib,HAEMOGLOBIN DECREASED,261
olaparib,PRODUCT USE IN UNAPPROVED INDICATION,254
olaparib,PRODUCT USE ISSUE,252
olaparib,CARBOHYDRATE ANTIGEN 125 INCREASED,247
olaparib,CONSTIPATION,247
olaparib,MYELOSUPPRESSION,241
olaparib,DYSPNOEA,233
olaparib,HEADACHE,231
olaparib,OVARIAN CANCER RECURRENT,227
olaparib,PANCYTOPENIA,221
olaparib,DIZZINESS,206
olaparib,WHITE BLOOD CELL COUNT DECREASED,198
olaparib,PAIN,195
olaparib,ARTHRALGIA,187
olaparib,NEUROPATHY PERIPHERAL,181
olaparib,NEUTROPHIL COUNT DECREASED,179
olaparib,RASH,176
olaparib,RENAL IMPAIRMENT,172
olaparib,NEUTROPENIA,166
olaparib,PYREXIA,166
olaparib,METASTASES TO LIVER,164
olaparib,TOXICITY TO VARIOUS AGENTS,151
olaparib,WEIGHT DECREASED,150
olaparib,ABDOMINAL PAIN,145
olaparib,PNEUMONIA,131
olaparib,BLOOD CREATININE INCREASED,128
olaparib,TUMOUR MARKER INCREASED,126
olaparib,METASTASES TO BONE,125
olaparib,ABDOMINAL PAIN UPPER,124
olaparib,PROSTATIC SPECIFIC ANTIGEN INCREASED,124
olaparib,DRUG INTERACTION,123
olaparib,PRODUCT DOSE OMISSION ISSUE,122
olaparib,BACK PAIN,118
olaparib,COUGH,116
olaparib,ABDOMINAL DISCOMFORT,115
olaparib,HYPERTENSION,115
olaparib,MYALGIA,112
olaparib,HAEMATOTOXICITY,110
olaparib,RENAL FAILURE,110
olaparib,PNEUMONITIS,108
olaparib,DYSPEPSIA,105
olaparib,PRURITUS,103
olaparib,DYSPHAGIA,101
olaparib,DEHYDRATION,100
olaparib,PAIN IN EXTREMITY,98
olaparib,PLEURAL EFFUSION,97
olaparib,RED BLOOD CELL COUNT DECREASED,97
olaparib,DRUG INTOLERANCE,94
olaparib,ASCITES,93
olaparib,GENERAL PHYSICAL HEALTH DETERIORATION,93
olaparib,INSOMNIA,93
olaparib,PERIPHERAL SWELLING,93
olaparib,INTESTINAL OBSTRUCTION,92
olaparib,METASTASES TO CENTRAL NERVOUS SYSTEM,92
olaparib,FEELING ABNORMAL,91
olaparib,METASTASES TO LYMPH NODES,85
olaparib,COVID-19,84
olaparib,DYSGEUSIA,83
olaparib,ABDOMINAL DISTENSION,82
olaparib,BONE MARROW FAILURE,81
olaparib,FALL,81
olaparib,ILEUS,79
olaparib,SOMNOLENCE,78
olaparib,ALOPECIA,77
olaparib,INTENTIONAL PRODUCT MISUSE,74
olaparib,FEBRILE NEUTROPENIA,72
olaparib,STOMATITIS,72
olaparib,DRUG RESISTANCE,71
olaparib,FULL BLOOD COUNT DECREASED,70
olaparib,METASTASES TO LUNG,70
olaparib,TASTE DISORDER,70
olaparib,NEOPLASM MALIGNANT,69
olaparib,URINARY TRACT INFECTION,69
olaparib,MUSCLE SPASMS,68
olaparib,OVARIAN CANCER,68
olaparib,THROMBOSIS,67
olaparib,BONE PAIN,66
olaparib,METASTASIS,66
olaparib,METASTASES TO PERITONEUM,64
olaparib,PULMONARY EMBOLISM,64
olaparib,ANXIETY,63
olaparib,GAIT DISTURBANCE,62
trametinib,PYREXIA,3644
trametinib,DEATH,3141
trametinib,MALIGNANT NEOPLASM PROGRESSION,1755
trametinib,RASH,1441
trametinib,FATIGUE,1287
trametinib,NAUSEA,1278
trametinib,CHILLS,1152
trametinib,DIARRHOEA,1073
trametinib,PRODUCT USE IN UNAPPROVED INDICATION,943
trametinib,VOMITING,934
trametinib,HEADACHE,648
trametinib,ASTHENIA,636
trametinib,MALAISE,604
trametinib,DECREASED APPETITE,524
trametinib,DRUG INEFFECTIVE,513
trametinib,ARTHRALGIA,481
trametinib,VISUAL IMPAIRMENT,453
trametinib,DISEASE PROGRESSION,443
trametinib,DYSPNOEA,435
trametinib,METASTATIC MALIGNANT MELANOMA,429
trametinib,OFF LABEL USE,420
trametinib,PAIN,420
trametinib,METASTASES TO CENTRAL NERVOUS SYSTEM,419
trametinib,MALIGNANT MELANOMA,395
trametinib,PNEUMONIA,388
trametinib,DEHYDRATION,382
trametinib,DIZZINESS,341
trametinib,COUGH,332
trametinib,GENERAL PHYSICAL HEALTH DETERIORATION,316
trametinib,CONSTIPATION,311
trametinib,VISION BLURRED,304
trametinib,PRURITUS,303
trametinib,ABDOMINAL PAIN,297
trametinib,ANAEMIA,297
trametinib,HYPOTENSION,294
trametinib,WEIGHT DECREASED,277
trametinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,271
trametinib,PERIPHERAL SWELLING,267
trametinib,EJECTION FRACTION DECREASED,247
trametinib,PAIN IN EXTREMITY,246
trametinib,DRY SKIN,234
trametinib,DYSPHAGIA,226
trametinib,MYALGIA,226
trametinib,SEIZURE,226
trametinib,CONFUSIONAL STATE,225
trametinib,SEPSIS,225
trametinib,ASPARTATE AMINOTRANSFERASE INCREASED,221
trametinib,URINARY TRACT INFECTION,221
trametinib,UVEITIS,215
trametinib,INFECTION,212
trametinib,PRODUCT USE ISSUE,209
trametinib,NEUTROPENIA,205
trametinib,ALOPECIA,204
trametinib,ALANINE AMINOTRANSFERASE INCREASED,202
trametinib,ACUTE KIDNEY INJURY,200
trametinib,ACNE,195
trametinib,ERYTHEMA,195
trametinib,C-REACTIVE PROTEIN INCREASED,193
trametinib,NEOPLASM MALIGNANT,193
trametinib,FALL,191
trametinib,OEDEMA PERIPHERAL,190
trametinib,THROMBOCYTOPENIA,188
trametinib,TREMOR,187
trametinib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,177
trametinib,ABDOMINAL PAIN UPPER,174
trametinib,DRUG INTOLERANCE,165
trametinib,HYPERTENSION,160
trametinib,INCORRECT DOSE ADMINISTERED,160
trametinib,PULMONARY EMBOLISM,157
trametinib,BACK PAIN,156
trametinib,HEPATIC ENZYME INCREASED,150
trametinib,RENAL FAILURE,150
trametinib,SYNCOPE,148
trametinib,DERMATITIS ACNEIFORM,145
trametinib,GAIT DISTURBANCE,145
trametinib,ABDOMINAL DISCOMFORT,144
trametinib,METASTASES TO LIVER,143
trametinib,STOMATITIS,141
trametinib,HYPERHIDROSIS,136
trametinib,ILLNESS,136
trametinib,METASTASES TO LUNG,133
trametinib,PNEUMONITIS,132
trametinib,RHABDOMYOLYSIS,131
trametinib,BLOOD LACTATE DEHYDROGENASE INCREASED,128
trametinib,HYPONATRAEMIA,128
trametinib,ATRIAL FIBRILLATION,127
trametinib,PLEURAL EFFUSION,127
trametinib,FEELING ABNORMAL,126
trametinib,INFLUENZA LIKE ILLNESS,126
trametinib,SOMNOLENCE,124
trametinib,EPISTAXIS,121
trametinib,HYPERSENSITIVITY,121
trametinib,PLATELET COUNT DECREASED,120
trametinib,TOXICITY TO VARIOUS AGENTS,117
trametinib,CARDIAC FAILURE,115
trametinib,LYMPHADENOPATHY,115
trametinib,BLOOD CREATININE INCREASED,113
trametinib,HOSPITALISATION,111
trametinib,MUSCULAR WEAKNESS,111
trametinib,NEOPLASM PROGRESSION,111
ribociclib,NAUSEA,2714
ribociclib,NEUTROPENIA,2697
ribociclib,FATIGUE,2634
ribociclib,DEATH,2185
ribociclib,MALIGNANT NEOPLASM PROGRESSION,1811
ribociclib,VOMITING,1515
ribociclib,DIARRHOEA,1449
ribociclib,WHITE BLOOD CELL COUNT DECREASED,1307
ribociclib,PAIN,1223
ribociclib,DYSPNOEA,1157
ribociclib,METASTASES TO BONE,1138
ribociclib,BREAST CANCER METASTATIC,1126
ribociclib,MALAISE,1044
ribociclib,ALOPECIA,1028
ribociclib,ANAEMIA,1021
ribociclib,ASTHENIA,997
ribociclib,LEUKOPENIA,993
ribociclib,DECREASED APPETITE,971
ribociclib,RASH,946
ribociclib,PRURITUS,900
ribociclib,HEADACHE,896
ribociclib,ARTHRALGIA,877
ribociclib,DIZZINESS,816
ribociclib,COUGH,814
ribociclib,CONSTIPATION,795
ribociclib,GENERAL PHYSICAL HEALTH DETERIORATION,758
ribociclib,ELECTROCARDIOGRAM QT PROLONGED,746
ribociclib,BACK PAIN,738
ribociclib,METASTASES TO LIVER,737
ribociclib,DRUG INEFFECTIVE,734
ribociclib,PYREXIA,729
ribociclib,PAIN IN EXTREMITY,725
ribociclib,WEIGHT DECREASED,643
ribociclib,BREAST CANCER,609
ribociclib,ALANINE AMINOTRANSFERASE INCREASED,584
ribociclib,THROMBOCYTOPENIA,581
ribociclib,HAEMOGLOBIN DECREASED,574
ribociclib,DECREASED IMMUNE RESPONSIVENESS,571
ribociclib,ASPARTATE AMINOTRANSFERASE INCREASED,561
ribociclib,BONE PAIN,546
ribociclib,PLEURAL EFFUSION,521
ribociclib,NEUTROPHIL COUNT DECREASED,520
ribociclib,DISEASE PROGRESSION,512
ribociclib,METASTASES TO LUNG,468
ribociclib,PNEUMONIA,467
ribociclib,COVID-19,466
ribociclib,PLATELET COUNT DECREASED,447
ribociclib,FEELING ABNORMAL,442
ribociclib,DRY SKIN,435
ribociclib,ABDOMINAL PAIN UPPER,434
ribociclib,ABDOMINAL DISCOMFORT,429
ribociclib,PERIPHERAL SWELLING,429
ribociclib,BLOOD CREATININE INCREASED,428
ribociclib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,409
ribociclib,ABDOMINAL PAIN,406
ribociclib,INSOMNIA,384
ribociclib,HYPERTENSION,381
ribociclib,HEPATOTOXICITY,380
ribociclib,HYPERSENSITIVITY,368
ribociclib,ILLNESS,368
ribociclib,GAIT DISTURBANCE,367
ribociclib,NASOPHARYNGITIS,366
ribociclib,HOT FLUSH,363
ribociclib,URINARY TRACT INFECTION,358
ribociclib,FALL,347
ribociclib,HEPATIC ENZYME INCREASED,341
ribociclib,ANXIETY,326
ribociclib,METASTASIS,316
ribociclib,DRUG INTOLERANCE,310
ribociclib,OEDEMA PERIPHERAL,302
ribociclib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,298
ribociclib,ERYTHEMA,297
ribociclib,PRODUCT DOSE OMISSION ISSUE,291
ribociclib,DYSPEPSIA,289
ribociclib,LIVER FUNCTION TEST INCREASED,286
ribociclib,TUMOUR MARKER INCREASED,286
ribociclib,CHEST PAIN,277
ribociclib,DEPRESSION,275
ribociclib,RENAL IMPAIRMENT,272
ribociclib,INFLUENZA,269
ribociclib,DYSPHAGIA,260
ribociclib,VISUAL IMPAIRMENT,258
ribociclib,RENAL FAILURE,256
ribociclib,ATRIAL FIBRILLATION,252
ribociclib,RED BLOOD CELL COUNT DECREASED,249
ribociclib,NEOPLASM MALIGNANT,244
ribociclib,OFF LABEL USE,237
ribociclib,TRANSAMINASES INCREASED,237
ribociclib,SOMNOLENCE,234
ribociclib,ASCITES,233
ribociclib,MEMORY IMPAIRMENT,231
ribociclib,BLOOD ALKALINE PHOSPHATASE INCREASED,229
ribociclib,METASTASES TO SPINE,228
ribociclib,DEHYDRATION,225
ribociclib,WEIGHT INCREASED,216
ribociclib,BLOOD BILIRUBIN INCREASED,215
ribociclib,PRODUCT USE IN UNAPPROVED INDICATION,214
ribociclib,PULMONARY EMBOLISM,214
ribociclib,DISCOMFORT,213
ribociclib,SKIN EXFOLIATION,210
durvalumab,DEATH,1630
durvalumab,MALIGNANT NEOPLASM PROGRESSION,874
durvalumab,RADIATION PNEUMONITIS,717
durvalumab,PNEUMONITIS,653
durvalumab,PYREXIA,407
durvalumab,DYSPNOEA,353
durvalumab,PNEUMONIA,349
durvalumab,DIARRHOEA,303
durvalumab,INTERSTITIAL LUNG DISEASE,293
durvalumab,FEBRILE NEUTROPENIA,255
durvalumab,FATIGUE,243
durvalumab,NEUTROPHIL COUNT DECREASED,219
durvalumab,COLITIS,211
durvalumab,METASTASES TO CENTRAL NERVOUS SYSTEM,205
durvalumab,OFF LABEL USE,202
durvalumab,RASH,186
durvalumab,PLATELET COUNT DECREASED,185
durvalumab,DISEASE PROGRESSION,168
durvalumab,NAUSEA,166
durvalumab,ANAEMIA,165
durvalumab,VOMITING,165
durvalumab,PLEURAL EFFUSION,160
durvalumab,SEPSIS,153
durvalumab,MYELOSUPPRESSION,152
durvalumab,HYPOTHYROIDISM,145
durvalumab,THROMBOCYTOPENIA,143
durvalumab,COUGH,141
durvalumab,DRUG-INDUCED LIVER INJURY,140
durvalumab,ASTHENIA,133
durvalumab,DECREASED APPETITE,129
durvalumab,DRUG INEFFECTIVE,128
durvalumab,HEPATIC FUNCTION ABNORMAL,125
durvalumab,LUNG DISORDER,125
durvalumab,MYOCARDITIS,122
durvalumab,ACUTE KIDNEY INJURY,119
durvalumab,RESPIRATORY FAILURE,117
durvalumab,ARTHRALGIA,108
durvalumab,NEUTROPENIA,106
durvalumab,ABDOMINAL PAIN,103
durvalumab,WHITE BLOOD CELL COUNT DECREASED,102
durvalumab,MALAISE,99
durvalumab,HEPATITIS,93
durvalumab,PRURITUS,93
durvalumab,DEHYDRATION,90
durvalumab,PULMONARY EMBOLISM,85
durvalumab,HYPOTENSION,82
durvalumab,MUSCULAR WEAKNESS,80
durvalumab,ADRENAL INSUFFICIENCY,79
durvalumab,GENERAL PHYSICAL HEALTH DETERIORATION,79
durvalumab,MYOSITIS,78
durvalumab,HYPERTHYROIDISM,77
durvalumab,PANCYTOPENIA,76
durvalumab,ALANINE AMINOTRANSFERASE INCREASED,72
durvalumab,CHILLS,72
durvalumab,LIVER DISORDER,72
durvalumab,METASTASES TO BONE,71
durvalumab,METASTASES TO LIVER,71
durvalumab,TOXICITY TO VARIOUS AGENTS,71
durvalumab,WEIGHT DECREASED,71
durvalumab,BILIARY TRACT INFECTION,69
durvalumab,PULMONARY TOXICITY,69
durvalumab,COVID-19,68
durvalumab,IMMUNE-MEDIATED HEPATITIS,68
durvalumab,CEREBROVASCULAR ACCIDENT,65
durvalumab,FALL,65
durvalumab,ASPARTATE AMINOTRANSFERASE INCREASED,63
durvalumab,DIABETES MELLITUS,63
durvalumab,MYALGIA,63
durvalumab,PNEUMOTHORAX,62
durvalumab,DIZZINESS,61
durvalumab,HEADACHE,61
durvalumab,PANCREATITIS,61
durvalumab,CONSTIPATION,60
durvalumab,IMMUNE-MEDIATED LUNG DISEASE,60
durvalumab,MYASTHENIA GRAVIS,60
durvalumab,NEOPLASM PROGRESSION,60
durvalumab,CONDITION AGGRAVATED,59
durvalumab,NEUROPATHY PERIPHERAL,58
durvalumab,PAIN,58
durvalumab,ATRIAL FIBRILLATION,57
durvalumab,CARDIAC FAILURE,57
durvalumab,BACK PAIN,56
durvalumab,CONFUSIONAL STATE,56
durvalumab,PERICARDIAL EFFUSION,56
durvalumab,CHOLANGITIS,55
durvalumab,HAEMOPTYSIS,55
durvalumab,PRODUCT USE IN UNAPPROVED INDICATION,53
durvalumab,URINARY TRACT INFECTION,53
durvalumab,DIABETIC KETOACIDOSIS,50
durvalumab,HYPERTENSION,50
durvalumab,INFECTION,49
durvalumab,INFUSION RELATED REACTION,49
durvalumab,EMBOLISM,48
durvalumab,RENAL FAILURE,48
durvalumab,IMMUNE-MEDIATED ENTEROCOLITIS,47
durvalumab,LIVER FUNCTION TEST INCREASED,47
durvalumab,PEMPHIGOID,47
durvalumab,ARTHRITIS,46
durvalumab,HYPOXIA,46
durvalumab,CARDIAC ARREST,45
lenvatinib,DIARRHOEA,3487
lenvatinib,HYPERTENSION,3175
lenvatinib,FATIGUE,3119
lenvatinib,DECREASED APPETITE,2728
lenvatinib,MALIGNANT NEOPLASM PROGRESSION,2218
lenvatinib,NAUSEA,2149
lenvatinib,BLOOD PRESSURE INCREASED,1989
lenvatinib,VOMITING,1716
lenvatinib,ASTHENIA,1395
lenvatinib,DEHYDRATION,1320
lenvatinib,WEIGHT DECREASED,1313
lenvatinib,MALAISE,1221
lenvatinib,PYREXIA,1128
lenvatinib,HEADACHE,1076
lenvatinib,HYPOTHYROIDISM,934
lenvatinib,PLATELET COUNT DECREASED,915
lenvatinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,889
lenvatinib,STOMATITIS,878
lenvatinib,RASH,874
lenvatinib,PROTEINURIA,873
lenvatinib,ARTHRALGIA,848
lenvatinib,DYSPHONIA,833
lenvatinib,ABDOMINAL PAIN,801
lenvatinib,CONSTIPATION,782
lenvatinib,DEATH,772
lenvatinib,DYSPNOEA,730
lenvatinib,PAIN,627
lenvatinib,PNEUMONIA,582
lenvatinib,RENAL IMPAIRMENT,538
lenvatinib,DIZZINESS,534
lenvatinib,ABDOMINAL PAIN UPPER,518
lenvatinib,HEPATIC ENCEPHALOPATHY,468
lenvatinib,PAIN IN EXTREMITY,460
lenvatinib,HYPOTENSION,449
lenvatinib,BACK PAIN,445
lenvatinib,COUGH,433
lenvatinib,EPISTAXIS,427
lenvatinib,MYALGIA,418
lenvatinib,ANAEMIA,413
lenvatinib,ACUTE KIDNEY INJURY,404
lenvatinib,URINARY TRACT INFECTION,397
lenvatinib,INTERSTITIAL LUNG DISEASE,389
lenvatinib,OFF LABEL USE,378
lenvatinib,HEPATIC FUNCTION ABNORMAL,370
lenvatinib,DRUG INEFFECTIVE,364
lenvatinib,CARDIAC FAILURE,355
lenvatinib,CONFUSIONAL STATE,355
lenvatinib,ORAL PAIN,347
lenvatinib,ASCITES,332
lenvatinib,PULMONARY EMBOLISM,331
lenvatinib,PRURITUS,324
lenvatinib,DRY MOUTH,322
lenvatinib,THROMBOCYTOPENIA,322
lenvatinib,ABDOMINAL DISCOMFORT,314
lenvatinib,CEREBROVASCULAR ACCIDENT,309
lenvatinib,PERIPHERAL SWELLING,309
lenvatinib,HYPONATRAEMIA,292
lenvatinib,PRODUCT USE ISSUE,290
lenvatinib,RENAL FAILURE,283
lenvatinib,PRODUCT USE IN UNAPPROVED INDICATION,281
lenvatinib,ADRENAL INSUFFICIENCY,277
lenvatinib,COLITIS,275
lenvatinib,INSOMNIA,274
lenvatinib,PLEURAL EFFUSION,254
lenvatinib,FALL,252
lenvatinib,CHOLECYSTITIS,250
lenvatinib,PANCREATITIS,250
lenvatinib,BLOOD CREATININE INCREASED,247
lenvatinib,CHEST PAIN,246
lenvatinib,SEPSIS,245
lenvatinib,SOMNOLENCE,241
lenvatinib,BLOOD PRESSURE FLUCTUATION,225
lenvatinib,DYSPHAGIA,225
lenvatinib,OEDEMA PERIPHERAL,223
lenvatinib,MYOCARDIAL INFARCTION,221
lenvatinib,TASTE DISORDER,220
lenvatinib,GASTROINTESTINAL HAEMORRHAGE,218
lenvatinib,MUSCLE SPASMS,218
lenvatinib,OROPHARYNGEAL PAIN,211
lenvatinib,BLOOD BILIRUBIN INCREASED,207
lenvatinib,FEELING ABNORMAL,204
lenvatinib,HEPATIC FAILURE,203
lenvatinib,GENERAL PHYSICAL HEALTH DETERIORATION,200
lenvatinib,AMMONIA INCREASED,199
lenvatinib,INFECTION,198
lenvatinib,GAIT DISTURBANCE,195
lenvatinib,ASPARTATE AMINOTRANSFERASE INCREASED,192
lenvatinib,LIVER DISORDER,184
lenvatinib,HEPATIC ENZYME INCREASED,183
lenvatinib,PNEUMONITIS,183
lenvatinib,PNEUMOTHORAX,183
lenvatinib,BLOOD THYROID STIMULATING HORMONE INCREASED,182
lenvatinib,ALANINE AMINOTRANSFERASE INCREASED,181
lenvatinib,DRY SKIN,179
lenvatinib,ABDOMINAL DISTENSION,177
lenvatinib,HYPERTHYROIDISM,177
lenvatinib,BLISTER,176
lenvatinib,CEREBRAL HAEMORRHAGE,175
lenvatinib,HAEMORRHAGE,171
lenvatinib,SEIZURE,164
palbociclib,FATIGUE,13937
palbociclib,WHITE BLOOD CELL COUNT DECREASED,10258
palbociclib,NEOPLASM PROGRESSION,10207
palbociclib,NAUSEA,7603
palbociclib,DEATH,7415
palbociclib,ALOPECIA,5754
palbociclib,NEUTROPENIA,5749
palbociclib,DIARRHOEA,5193
palbociclib,ASTHENIA,3397
palbociclib,PAIN,3139
palbociclib,DECREASED APPETITE,3136
palbociclib,MALAISE,3058
palbociclib,DYSPNOEA,2974
palbociclib,VOMITING,2859
palbociclib,OFF LABEL USE,2823
palbociclib,ARTHRALGIA,2737
palbociclib,CONSTIPATION,2514
palbociclib,STOMATITIS,2509
palbociclib,HEADACHE,2486
palbociclib,DIZZINESS,2233
palbociclib,DISEASE PROGRESSION,2148
palbociclib,COUGH,2080
palbociclib,RASH,2076
palbociclib,PLATELET COUNT DECREASED,2064
palbociclib,PRODUCT DOSE OMISSION ISSUE,2062
palbociclib,NEUTROPHIL COUNT DECREASED,2006
palbociclib,ANAEMIA,1947
palbociclib,WEIGHT DECREASED,1749
palbociclib,HOT FLUSH,1732
palbociclib,MALIGNANT NEOPLASM PROGRESSION,1716
palbociclib,BACK PAIN,1682
palbociclib,FULL BLOOD COUNT DECREASED,1673
palbociclib,PYREXIA,1633
palbociclib,RED BLOOD CELL COUNT DECREASED,1573
palbociclib,PRURITUS,1549
palbociclib,PAIN IN EXTREMITY,1543
palbociclib,HAEMOGLOBIN DECREASED,1500
palbociclib,PRODUCT USE ISSUE,1455
palbociclib,PNEUMONIA,1324
palbociclib,INSOMNIA,1311
palbociclib,COVID-19,1301
palbociclib,LEUKOPENIA,1301
palbociclib,DRY SKIN,1284
palbociclib,THROMBOCYTOPENIA,1230
palbociclib,NEUROPATHY PERIPHERAL,1223
palbociclib,NASOPHARYNGITIS,1217
palbociclib,ABDOMINAL DISCOMFORT,1212
palbociclib,MEMORY IMPAIRMENT,1211
palbociclib,EPISTAXIS,1210
palbociclib,BLOOD COUNT ABNORMAL,1178
palbociclib,FEELING ABNORMAL,1152
palbociclib,BONE PAIN,1141
palbociclib,FALL,1103
palbociclib,URINARY TRACT INFECTION,1092
palbociclib,ILLNESS,1081
palbociclib,FULL BLOOD COUNT ABNORMAL,1029
palbociclib,PERIPHERAL SWELLING,1021
palbociclib,DRUG INEFFECTIVE,1016
palbociclib,BONE MARROW FAILURE,957
palbociclib,CONDITION AGGRAVATED,953
palbociclib,ABDOMINAL PAIN UPPER,935
palbociclib,ANXIETY,915
palbociclib,PRODUCT USE IN UNAPPROVED INDICATION,908
palbociclib,HYPOAESTHESIA,903
palbociclib,WEIGHT INCREASED,887
palbociclib,BREAST CANCER METASTATIC,860
palbociclib,HYPOACUSIS,841
palbociclib,DEHYDRATION,828
palbociclib,METASTASES TO BONE,814
palbociclib,MYALGIA,806
palbociclib,TUMOUR MARKER INCREASED,795
palbociclib,GAIT DISTURBANCE,794
palbociclib,PLEURAL EFFUSION,786
palbociclib,DEPRESSION,774
palbociclib,SOMNOLENCE,771
palbociclib,MUSCLE SPASMS,765
palbociclib,PARAESTHESIA,739
palbociclib,DYSPEPSIA,733
palbociclib,INFECTION,727
palbociclib,ORAL PAIN,721
palbociclib,ABDOMINAL PAIN,720
palbociclib,DYSPHAGIA,711
palbociclib,CONFUSIONAL STATE,651
palbociclib,OROPHARYNGEAL PAIN,641
palbociclib,CHILLS,620
palbociclib,BREAST CANCER,618
palbociclib,METASTASES TO LIVER,597
palbociclib,DYSGEUSIA,586
palbociclib,THERAPY CESSATION,580
palbociclib,SECOND PRIMARY MALIGNANCY,577
palbociclib,PULMONARY EMBOLISM,564
palbociclib,CHEST PAIN,563
palbociclib,THROMBOSIS,561
palbociclib,CONTUSION,560
palbociclib,PANCYTOPENIA,544
palbociclib,CEREBROVASCULAR ACCIDENT,543
palbociclib,DRY MOUTH,540
palbociclib,DRUG DOSE OMISSION,537
palbociclib,HYPERTENSION,537
palbociclib,INFLUENZA,536
trifluridine tipiracil,NEUTROPENIA,58
trifluridine tipiracil,DIARRHOEA,57
trifluridine tipiracil,ANAEMIA,33
trifluridine tipiracil,THROMBOCYTOPENIA,29
trifluridine tipiracil,FATIGUE,25
trifluridine tipiracil,NAUSEA,24
trifluridine tipiracil,NEUROTOXICITY,23
trifluridine tipiracil,DISEASE PROGRESSION,22
trifluridine tipiracil,VOMITING,20
trifluridine tipiracil,ASTHENIA,18
trifluridine tipiracil,HAEMATOTOXICITY,17
trifluridine tipiracil,HYPERTENSION,17
trifluridine tipiracil,COLORECTAL CANCER METASTATIC,15
trifluridine tipiracil,NEUROPATHY PERIPHERAL,15
trifluridine tipiracil,DECREASED APPETITE,14
trifluridine tipiracil,FEBRILE NEUTROPENIA,14
trifluridine tipiracil,DEATH,13
trifluridine tipiracil,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,13
trifluridine tipiracil,STOMATITIS,13
trifluridine tipiracil,DRUG INTOLERANCE,11
trifluridine tipiracil,LEUKOPENIA,11
trifluridine tipiracil,DRUG INEFFECTIVE,10
trifluridine tipiracil,PROTEINURIA,9
trifluridine tipiracil,GASTROINTESTINAL TOXICITY,8
trifluridine tipiracil,MALIGNANT NEOPLASM PROGRESSION,8
trifluridine tipiracil,PNEUMONIA,7
trifluridine tipiracil,SKIN TOXICITY,7
trifluridine tipiracil,TOXICITY TO VARIOUS AGENTS,7
trifluridine tipiracil,ABDOMINAL PAIN,6
trifluridine tipiracil,ALOPECIA,6
trifluridine tipiracil,CLOSTRIDIUM DIFFICILE INFECTION,6
trifluridine tipiracil,INFECTION,6
trifluridine tipiracil,PYREXIA,6
trifluridine tipiracil,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,6
trifluridine tipiracil,TRANSIENT ISCHAEMIC ATTACK,6
trifluridine tipiracil,WEIGHT DECREASED,6
trifluridine tipiracil,CONJUNCTIVITIS,5
trifluridine tipiracil,METASTASES TO LIVER,5
trifluridine tipiracil,METASTASES TO LUNG,5
trifluridine tipiracil,MUCOSAL INFLAMMATION,5
trifluridine tipiracil,MUSCLE SPASMS,5
trifluridine tipiracil,NEUTROPHIL COUNT DECREASED,5
trifluridine tipiracil,OFF LABEL USE,5
trifluridine tipiracil,THERAPY PARTIAL RESPONDER,5
trifluridine tipiracil,TOXIC CARDIOMYOPATHY,5
trifluridine tipiracil,ACUTE KIDNEY INJURY,4
trifluridine tipiracil,BLOOD BILIRUBIN INCREASED,4
trifluridine tipiracil,CIRCULATORY COLLAPSE,4
trifluridine tipiracil,HEPATOTOXICITY,4
trifluridine tipiracil,IGA NEPHROPATHY,4
trifluridine tipiracil,METABOLIC ACIDOSIS,4
trifluridine tipiracil,MUCOSAL TOXICITY,4
trifluridine tipiracil,MYELOSUPPRESSION,4
trifluridine tipiracil,PERIPHERAL SENSORY NEUROPATHY,4
trifluridine tipiracil,ALANINE AMINOTRANSFERASE INCREASED,3
trifluridine tipiracil,ANAL INFLAMMATION,3
trifluridine tipiracil,ASCITES,3
trifluridine tipiracil,BLOOD LACTATE DEHYDROGENASE INCREASED,3
trifluridine tipiracil,CONSTIPATION,3
trifluridine tipiracil,DISEASE RECURRENCE,3
trifluridine tipiracil,DYSAESTHESIA,3
trifluridine tipiracil,FACIAL BONES FRACTURE,3
trifluridine tipiracil,FALL,3
trifluridine tipiracil,HAEMORRHAGE,3
trifluridine tipiracil,HEADACHE,3
trifluridine tipiracil,LOSS OF CONSCIOUSNESS,3
trifluridine tipiracil,METABOLIC DISORDER,3
trifluridine tipiracil,METASTASES TO PERITONEUM,3
trifluridine tipiracil,PALPITATIONS,3
trifluridine tipiracil,PHOTOPHOBIA,3
trifluridine tipiracil,PLATELET COUNT DECREASED,3
trifluridine tipiracil,PNEUMONITIS,3
trifluridine tipiracil,PULMONARY EMBOLISM,3
trifluridine tipiracil,WHITE BLOOD CELL COUNT DECREASED,3
trifluridine tipiracil,ANAPHYLACTIC REACTION,2
trifluridine tipiracil,BACK PAIN,2
trifluridine tipiracil,BLOOD PRESSURE INCREASED,2
trifluridine tipiracil,CARDIAC DISORDER,2
trifluridine tipiracil,CONDITION AGGRAVATED,2
trifluridine tipiracil,DRY SKIN,2
trifluridine tipiracil,DYSGEUSIA,2
trifluridine tipiracil,DYSPNOEA,2
trifluridine tipiracil,EPISTAXIS,2
trifluridine tipiracil,FUNCTIONAL GASTROINTESTINAL DISORDER,2
trifluridine tipiracil,GASTRIC CANCER,2
trifluridine tipiracil,GASTROINTESTINAL DISORDER,2
trifluridine tipiracil,GASTROINTESTINAL PERFORATION,2
trifluridine tipiracil,HYPOKALAEMIA,2
trifluridine tipiracil,LYMPHOPENIA,2
trifluridine tipiracil,OBSTRUCTIVE PANCREATITIS,2
trifluridine tipiracil,PAIN,2
trifluridine tipiracil,PANCYTOPENIA,2
trifluridine tipiracil,POLYNEUROPATHY,2
trifluridine tipiracil,PRODUCT USE IN UNAPPROVED INDICATION,2
trifluridine tipiracil,PRURITUS,2
trifluridine tipiracil,RASH,2
trifluridine tipiracil,RESPIRATORY TRACT INFECTION,2
trifluridine tipiracil,STEVENS-JOHNSON SYNDROME,2
trifluridine tipiracil,TRANSAMINASES INCREASED,2
trifluridine tipiracil,UROGENITAL DISORDER,2
ipilimumab,DEATH,3537
ipilimumab,MALIGNANT NEOPLASM PROGRESSION,3368
ipilimumab,DIARRHOEA,2832
ipilimumab,COLITIS,2188
ipilimumab,PYREXIA,1841
ipilimumab,OFF LABEL USE,1641
ipilimumab,RASH,1576
ipilimumab,FATIGUE,1519
ipilimumab,INTENTIONAL PRODUCT USE ISSUE,1352
ipilimumab,NAUSEA,1201
ipilimumab,HYPOPHYSITIS,1015
ipilimumab,DECREASED APPETITE,964
ipilimumab,VOMITING,950
ipilimumab,DYSPNOEA,917
ipilimumab,PNEUMONITIS,857
ipilimumab,ADVERSE EVENT,855
ipilimumab,PNEUMONIA,840
ipilimumab,ADRENAL INSUFFICIENCY,813
ipilimumab,PRURITUS,790
ipilimumab,ACUTE KIDNEY INJURY,766
ipilimumab,HEADACHE,752
ipilimumab,HYPOTHYROIDISM,675
ipilimumab,DEHYDRATION,663
ipilimumab,IMMUNE-MEDIATED ENTEROCOLITIS,637
ipilimumab,ANAEMIA,630
ipilimumab,ASTHENIA,616
ipilimumab,MALAISE,607
ipilimumab,SEPSIS,598
ipilimumab,WEIGHT DECREASED,585
ipilimumab,HEPATITIS,527
ipilimumab,DRUG INEFFECTIVE,526
ipilimumab,GENERAL PHYSICAL HEALTH DETERIORATION,506
ipilimumab,HYPONATRAEMIA,504
ipilimumab,ARTHRALGIA,503
ipilimumab,ABDOMINAL PAIN,478
ipilimumab,LIVER DISORDER,467
ipilimumab,HEPATIC FUNCTION ABNORMAL,454
ipilimumab,HYPERTHYROIDISM,453
ipilimumab,HYPOTENSION,453
ipilimumab,PRODUCT USE IN UNAPPROVED INDICATION,428
ipilimumab,PRESCRIBED OVERDOSE,425
ipilimumab,INTERSTITIAL LUNG DISEASE,418
ipilimumab,ALANINE AMINOTRANSFERASE INCREASED,406
ipilimumab,ASPARTATE AMINOTRANSFERASE INCREASED,405
ipilimumab,MYOCARDITIS,403
ipilimumab,HYPOPITUITARISM,392
ipilimumab,CONSTIPATION,391
ipilimumab,PAIN,386
ipilimumab,PLEURAL EFFUSION,374
ipilimumab,COUGH,371
ipilimumab,AUTOIMMUNE HEPATITIS,363
ipilimumab,BACK PAIN,356
ipilimumab,THROMBOCYTOPENIA,335
ipilimumab,ENTEROCOLITIS,334
ipilimumab,IMMUNE-MEDIATED HEPATITIS,321
ipilimumab,PULMONARY EMBOLISM,320
ipilimumab,MUSCULAR WEAKNESS,310
ipilimumab,DIABETIC KETOACIDOSIS,304
ipilimumab,RENAL FAILURE,304
ipilimumab,DIZZINESS,292
ipilimumab,RESPIRATORY FAILURE,290
ipilimumab,THYROIDITIS,288
ipilimumab,ATRIAL FIBRILLATION,286
ipilimumab,CHILLS,285
ipilimumab,METASTASES TO CENTRAL NERVOUS SYSTEM,282
ipilimumab,NEUTROPENIA,277
ipilimumab,RASH MACULO-PAPULAR,270
ipilimumab,URINARY TRACT INFECTION,270
ipilimumab,TYPE 1 DIABETES MELLITUS,269
ipilimumab,HYPERGLYCAEMIA,268
ipilimumab,AUTOIMMUNE COLITIS,266
ipilimumab,FEBRILE NEUTROPENIA,257
ipilimumab,DIABETES MELLITUS,255
ipilimumab,MYOSITIS,254
ipilimumab,CONFUSIONAL STATE,252
ipilimumab,HYPOKALAEMIA,250
ipilimumab,AUTOIMMUNE DISORDER,249
ipilimumab,MYALGIA,245
ipilimumab,ARTHRITIS,240
ipilimumab,NEUROPATHY PERIPHERAL,229
ipilimumab,FALL,227
ipilimumab,IMMUNE-MEDIATED HEPATIC DISORDER,227
ipilimumab,PANCREATITIS,217
ipilimumab,HYPERTENSION,207
ipilimumab,INFUSION RELATED REACTION,206
ipilimumab,HEPATOTOXICITY,205
ipilimumab,PLATELET COUNT DECREASED,204
ipilimumab,SEPTIC SHOCK,204
ipilimumab,LIPASE INCREASED,202
ipilimumab,NEOPLASM MALIGNANT,199
ipilimumab,PAIN IN EXTREMITY,199
ipilimumab,CYTOKINE RELEASE SYNDROME,198
ipilimumab,HEPATIC ENZYME INCREASED,198
ipilimumab,DRUG-INDUCED LIVER INJURY,197
ipilimumab,CARDIAC FAILURE,196
ipilimumab,BLOOD CREATININE INCREASED,195
ipilimumab,INTESTINAL PERFORATION,195
ipilimumab,RASH PRURITIC,194
ipilimumab,INSOMNIA,192
ipilimumab,HOSPITALISATION,188
pazopanib,DEATH,4499
pazopanib,DIARRHOEA,3546
pazopanib,FATIGUE,2461
pazopanib,NAUSEA,2396
pazopanib,MALIGNANT NEOPLASM PROGRESSION,1591
pazopanib,DECREASED APPETITE,1421
pazopanib,VOMITING,1386
pazopanib,DRUG INEFFECTIVE,1374
pazopanib,HYPERTENSION,1243
pazopanib,DISEASE PROGRESSION,942
pazopanib,ASTHENIA,919
pazopanib,MALAISE,897
pazopanib,WEIGHT DECREASED,877
pazopanib,DYSPNOEA,833
pazopanib,HAIR COLOUR CHANGES,815
pazopanib,BLOOD PRESSURE INCREASED,775
pazopanib,PRODUCT USE IN UNAPPROVED INDICATION,742
pazopanib,HEADACHE,711
pazopanib,PAIN,670
pazopanib,ABDOMINAL PAIN,515
pazopanib,DYSGEUSIA,501
pazopanib,PYREXIA,490
pazopanib,RASH,488
pazopanib,ABDOMINAL PAIN UPPER,482
pazopanib,PAIN IN EXTREMITY,418
pazopanib,ABDOMINAL DISCOMFORT,412
pazopanib,DEHYDRATION,411
pazopanib,DIZZINESS,402
pazopanib,OFF LABEL USE,395
pazopanib,CONSTIPATION,388
pazopanib,HEPATIC ENZYME INCREASED,383
pazopanib,COUGH,378
pazopanib,ALANINE AMINOTRANSFERASE INCREASED,373
pazopanib,ANAEMIA,369
pazopanib,METASTASES TO LUNG,352
pazopanib,PNEUMONIA,341
pazopanib,BACK PAIN,333
pazopanib,PLATELET COUNT DECREASED,330
pazopanib,ARTHRALGIA,321
pazopanib,STOMATITIS,319
pazopanib,GENERAL PHYSICAL HEALTH DETERIORATION,310
pazopanib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,305
pazopanib,ALOPECIA,299
pazopanib,ASPARTATE AMINOTRANSFERASE INCREASED,293
pazopanib,THROMBOCYTOPENIA,276
pazopanib,PLEURAL EFFUSION,275
pazopanib,RENAL CELL CARCINOMA,273
pazopanib,HEPATIC FUNCTION ABNORMAL,272
pazopanib,NEOPLASM MALIGNANT,260
pazopanib,BLOOD BILIRUBIN INCREASED,255
pazopanib,HYPOTHYROIDISM,237
pazopanib,CHEST PAIN,231
pazopanib,AGEUSIA,225
pazopanib,MUSCLE SPASMS,224
pazopanib,NEOPLASM PROGRESSION,223
pazopanib,RENAL IMPAIRMENT,223
pazopanib,HOSPITALISATION,218
pazopanib,RENAL CANCER,212
pazopanib,EPISTAXIS,210
pazopanib,DRUG INTOLERANCE,209
pazopanib,HEPATOTOXICITY,208
pazopanib,ADVERSE DRUG REACTION,205
pazopanib,GAIT DISTURBANCE,203
pazopanib,LIVER DISORDER,203
pazopanib,PRURITUS,199
pazopanib,DYSPEPSIA,198
pazopanib,JAUNDICE,195
pazopanib,FALL,194
pazopanib,PROTEINURIA,193
pazopanib,CONFUSIONAL STATE,191
pazopanib,BLOOD CREATININE INCREASED,190
pazopanib,FEELING ABNORMAL,187
pazopanib,MYALGIA,186
pazopanib,DRUG DOSE OMISSION,183
pazopanib,OEDEMA PERIPHERAL,182
pazopanib,SKIN DISCOLOURATION,182
pazopanib,CEREBROVASCULAR ACCIDENT,181
pazopanib,DRUG INTERACTION,180
pazopanib,RENAL FAILURE,178
pazopanib,LIVER FUNCTION TEST ABNORMAL,176
pazopanib,PNEUMOTHORAX,176
pazopanib,HOSPICE CARE,175
pazopanib,METASTATIC RENAL CELL CARCINOMA,174
pazopanib,CARDIAC FAILURE,171
pazopanib,ACUTE KIDNEY INJURY,170
pazopanib,PRODUCT USE ISSUE,170
pazopanib,METASTASES TO LIVER,166
pazopanib,METASTASES TO CENTRAL NERVOUS SYSTEM,164
pazopanib,INSOMNIA,161
pazopanib,MYOCARDIAL INFARCTION,160
pazopanib,PULMONARY EMBOLISM,159
pazopanib,ABDOMINAL DISTENSION,157
pazopanib,URINARY TRACT INFECTION,157
pazopanib,ERYTHEMA,156
pazopanib,NEUTROPENIA,156
pazopanib,PERIPHERAL SWELLING,154
pazopanib,METASTASES TO BONE,153
pazopanib,BLISTER,152
pazopanib,THERAPY CESSATION,150
pazopanib,TOXICITY TO VARIOUS AGENTS,149
crizotinib,DEATH,2168
crizotinib,DISEASE PROGRESSION,1221
crizotinib,NEOPLASM PROGRESSION,1125
crizotinib,NAUSEA,1072
crizotinib,DIARRHOEA,801
crizotinib,VOMITING,745
crizotinib,FATIGUE,532
crizotinib,DYSPNOEA,419
crizotinib,CONSTIPATION,411
crizotinib,LUNG NEOPLASM MALIGNANT,407
crizotinib,OEDEMA PERIPHERAL,406
crizotinib,VISUAL IMPAIRMENT,396
crizotinib,OFF LABEL USE,391
crizotinib,DECREASED APPETITE,352
crizotinib,ASTHENIA,316
crizotinib,PNEUMONIA,315
crizotinib,MALAISE,300
crizotinib,DIZZINESS,299
crizotinib,PLEURAL EFFUSION,294
crizotinib,NON-SMALL CELL LUNG CANCER,273
crizotinib,PERIPHERAL SWELLING,267
crizotinib,PYREXIA,246
crizotinib,COUGH,240
crizotinib,MALIGNANT NEOPLASM PROGRESSION,229
crizotinib,NEOPLASM MALIGNANT,222
crizotinib,DYSGEUSIA,193
crizotinib,DRUG INEFFECTIVE,189
crizotinib,RASH,188
crizotinib,OEDEMA,187
crizotinib,WEIGHT DECREASED,182
crizotinib,DYSPHAGIA,175
crizotinib,PAIN,175
crizotinib,PULMONARY EMBOLISM,169
crizotinib,INTERSTITIAL LUNG DISEASE,165
crizotinib,PRODUCT USE ISSUE,164
crizotinib,PRODUCT USE IN UNAPPROVED INDICATION,162
crizotinib,VISION BLURRED,162
crizotinib,DEHYDRATION,161
crizotinib,ALANINE AMINOTRANSFERASE INCREASED,159
crizotinib,HEADACHE,159
crizotinib,RENAL IMPAIRMENT,159
crizotinib,ANAEMIA,156
crizotinib,HYPOTENSION,144
crizotinib,NEUTROPENIA,143
crizotinib,PNEUMONITIS,142
crizotinib,PHOTOPSIA,135
crizotinib,DRUG INTERACTION,131
crizotinib,ASPARTATE AMINOTRANSFERASE INCREASED,129
crizotinib,BLOOD CREATININE INCREASED,127
crizotinib,RENAL FAILURE,126
crizotinib,GENERAL PHYSICAL HEALTH DETERIORATION,121
crizotinib,BRADYCARDIA,119
crizotinib,DRUG RESISTANCE,119
crizotinib,HEPATIC ENZYME INCREASED,116
crizotinib,DYSPEPSIA,115
crizotinib,RESPIRATORY FAILURE,112
crizotinib,ABDOMINAL PAIN,110
crizotinib,DEEP VEIN THROMBOSIS,106
crizotinib,METASTASES TO CENTRAL NERVOUS SYSTEM,106
crizotinib,WEIGHT INCREASED,106
crizotinib,ABDOMINAL DISCOMFORT,105
crizotinib,FALL,105
crizotinib,CONDITION AGGRAVATED,104
crizotinib,CARDIAC FAILURE,103
crizotinib,HEPATIC FUNCTION ABNORMAL,101
crizotinib,ELECTROCARDIOGRAM QT PROLONGED,100
crizotinib,PERICARDIAL EFFUSION,100
crizotinib,ABDOMINAL PAIN UPPER,99
crizotinib,OESOPHAGITIS,99
crizotinib,BACK PAIN,98
crizotinib,WHITE BLOOD CELL COUNT DECREASED,94
crizotinib,CHEST PAIN,92
crizotinib,HEPATOTOXICITY,90
crizotinib,THROMBOCYTOPENIA,89
crizotinib,THROMBOSIS,89
crizotinib,PAIN IN EXTREMITY,88
crizotinib,PULMONARY OEDEMA,88
crizotinib,SEPSIS,87
crizotinib,TRANSAMINASES INCREASED,85
crizotinib,HYPOAESTHESIA,83
crizotinib,ACUTE KIDNEY INJURY,82
crizotinib,ARTHRALGIA,81
crizotinib,STOMATITIS,81
crizotinib,SEIZURE,79
crizotinib,JOINT SWELLING,77
crizotinib,VITREOUS FLOATERS,75
crizotinib,FEBRILE NEUTROPENIA,74
crizotinib,HAEMOGLOBIN DECREASED,74
crizotinib,LIVER DISORDER,73
crizotinib,NEUROPATHY PERIPHERAL,73
crizotinib,CONFUSIONAL STATE,72
crizotinib,HYPONATRAEMIA,71
crizotinib,HYPOXIA,70
crizotinib,NEUTROPHIL COUNT DECREASED,70
crizotinib,SECOND PRIMARY MALIGNANCY,70
crizotinib,GASTROOESOPHAGEAL REFLUX DISEASE,69
crizotinib,HEART RATE DECREASED,69
crizotinib,LIVER FUNCTION TEST ABNORMAL,69
crizotinib,LUNG ADENOCARCINOMA,69
crizotinib,ABDOMINAL DISTENSION,68
trabectedin,NEUTROPENIA,217
trabectedin,ANAEMIA,186
trabectedin,THROMBOCYTOPENIA,173
trabectedin,NAUSEA,166
trabectedin,FEBRILE NEUTROPENIA,153
trabectedin,PANCYTOPENIA,139
trabectedin,VOMITING,130
trabectedin,RHABDOMYOLYSIS,112
trabectedin,ALANINE AMINOTRANSFERASE INCREASED,109
trabectedin,PYREXIA,100
trabectedin,ASPARTATE AMINOTRANSFERASE INCREASED,96
trabectedin,ASTHENIA,94
trabectedin,OFF LABEL USE,94
trabectedin,FATIGUE,90
trabectedin,DISEASE PROGRESSION,87
trabectedin,ACUTE KIDNEY INJURY,82
trabectedin,PLATELET COUNT DECREASED,78
trabectedin,DIARRHOEA,75
trabectedin,LEUKOPENIA,75
trabectedin,BLOOD CREATINE PHOSPHOKINASE INCREASED,66
trabectedin,NEUTROPHIL COUNT DECREASED,66
trabectedin,HEPATOTOXICITY,65
trabectedin,DEATH,61
trabectedin,PNEUMONIA,59
trabectedin,DRUG INEFFECTIVE,58
trabectedin,SEPSIS,57
trabectedin,TRANSAMINASES INCREASED,57
trabectedin,WHITE BLOOD CELL COUNT DECREASED,57
trabectedin,DYSPNOEA,54
trabectedin,HAEMATOTOXICITY,53
trabectedin,DECREASED APPETITE,52
trabectedin,GAMMA-GLUTAMYLTRANSFERASE INCREASED,48
trabectedin,RENAL FAILURE,45
trabectedin,HEPATIC FUNCTION ABNORMAL,44
trabectedin,MALIGNANT NEOPLASM PROGRESSION,43
trabectedin,BONE MARROW FAILURE,42
trabectedin,BLOOD ALKALINE PHOSPHATASE INCREASED,40
trabectedin,MUCOSAL INFLAMMATION,40
trabectedin,ACUTE MYELOID LEUKAEMIA,38
trabectedin,CARDIAC FAILURE,36
trabectedin,ABDOMINAL PAIN,35
trabectedin,BLOOD BILIRUBIN INCREASED,35
trabectedin,CONSTIPATION,34
trabectedin,MALAISE,31
trabectedin,PRODUCT USE IN UNAPPROVED INDICATION,30
trabectedin,MYALGIA,29
trabectedin,DEVICE RELATED INFECTION,28
trabectedin,HAEMOGLOBIN DECREASED,28
trabectedin,ASCITES,27
trabectedin,HEPATIC ENZYME INCREASED,27
trabectedin,HEPATIC FAILURE,27
trabectedin,PLEURAL EFFUSION,27
trabectedin,TOXICITY TO VARIOUS AGENTS,27
trabectedin,DEHYDRATION,24
trabectedin,DRUG INTERACTION,24
trabectedin,PNEUMONITIS,24
trabectedin,SEPTIC SHOCK,24
trabectedin,ATRIAL FIBRILLATION,23
trabectedin,CAPILLARY LEAK SYNDROME,23
trabectedin,EXTRAVASATION,23
trabectedin,INTERSTITIAL LUNG DISEASE,23
trabectedin,OEDEMA PERIPHERAL,23
trabectedin,PRODUCT USE ISSUE,23
trabectedin,RENAL IMPAIRMENT,23
trabectedin,HEPATOCELLULAR INJURY,22
trabectedin,NEUROPATHY PERIPHERAL,22
trabectedin,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,22
trabectedin,UNDERDOSE,22
trabectedin,BLOOD CREATININE INCREASED,21
trabectedin,DISEASE RECURRENCE,21
trabectedin,HYPERSENSITIVITY,20
trabectedin,HYPERTRANSAMINASAEMIA,20
trabectedin,INFECTION,20
trabectedin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,20
trabectedin,RESPIRATORY FAILURE,20
trabectedin,HYPOALBUMINAEMIA,19
trabectedin,HYPOKALAEMIA,19
trabectedin,URINARY TRACT INFECTION,19
trabectedin,HYPOTENSION,18
trabectedin,GENERAL PHYSICAL HEALTH DETERIORATION,17
trabectedin,HYPERTENSION,17
trabectedin,HYPONATRAEMIA,17
trabectedin,INTESTINAL OBSTRUCTION,17
trabectedin,PULMONARY EMBOLISM,17
trabectedin,CHOLESTASIS,16
trabectedin,EJECTION FRACTION DECREASED,16
trabectedin,ENCEPHALOPATHY,16
trabectedin,LEFT VENTRICULAR DYSFUNCTION,16
trabectedin,LIVER DISORDER,16
trabectedin,NEOPLASM PROGRESSION,16
trabectedin,STOMATITIS,16
trabectedin,ADVERSE EVENT,15
trabectedin,CEREBROVASCULAR ACCIDENT,15
trabectedin,DRUG HYPERSENSITIVITY,15
trabectedin,HEADACHE,15
trabectedin,LIVER FUNCTION TEST ABNORMAL,15
trabectedin,LYMPHANGIOLEIOMYOMATOSIS,15
trabectedin,NEUTROPENIC SEPSIS,15
trabectedin,PAIN,15
trabectedin,PULMONARY OEDEMA,15
avelumab,DEATH,284
avelumab,DISEASE PROGRESSION,242
avelumab,OFF LABEL USE,185
avelumab,DIARRHOEA,150
avelumab,INFUSION RELATED REACTION,132
avelumab,PYREXIA,126
avelumab,FATIGUE,111
avelumab,NEOPLASM PROGRESSION,111
avelumab,NAUSEA,98
avelumab,HYPERTENSION,87
avelumab,DYSPNOEA,85
avelumab,CHILLS,83
avelumab,DECREASED APPETITE,76
avelumab,GENERAL PHYSICAL HEALTH DETERIORATION,76
avelumab,HYPOTHYROIDISM,76
avelumab,RASH,75
avelumab,ACUTE KIDNEY INJURY,72
avelumab,MALAISE,70
avelumab,PNEUMONIA,68
avelumab,VOMITING,66
avelumab,INTERSTITIAL LUNG DISEASE,62
avelumab,THROMBOCYTOPENIA,61
avelumab,COLITIS,59
avelumab,ANAEMIA,57
avelumab,PNEUMONITIS,57
avelumab,SEPSIS,56
avelumab,MALIGNANT NEOPLASM PROGRESSION,54
avelumab,FEBRILE NEUTROPENIA,53
avelumab,ADRENAL INSUFFICIENCY,52
avelumab,NEUROPATHY PERIPHERAL,52
avelumab,MYOCARDITIS,43
avelumab,ASTHENIA,42
avelumab,DEHYDRATION,41
avelumab,HYPOTENSION,41
avelumab,BACK PAIN,40
avelumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,40
avelumab,PRURITUS,40
avelumab,NEUTROPENIA,39
avelumab,HEPATIC FUNCTION ABNORMAL,38
avelumab,PULMONARY EMBOLISM,38
avelumab,CONSTIPATION,37
avelumab,DIZZINESS,37
avelumab,DRUG INEFFECTIVE,36
avelumab,HEPATITIS,36
avelumab,MYOSITIS,35
avelumab,HYPONATRAEMIA,34
avelumab,RENAL IMPAIRMENT,33
avelumab,DYSPHONIA,32
avelumab,SKIN TOXICITY,32
avelumab,ABDOMINAL PAIN,31
avelumab,PRODUCT USE IN UNAPPROVED INDICATION,31
avelumab,HAEMOGLOBIN DECREASED,30
avelumab,HYPERTHYROIDISM,30
avelumab,ALANINE AMINOTRANSFERASE INCREASED,29
avelumab,PLATELET COUNT DECREASED,29
avelumab,BLOOD PRESSURE INCREASED,28
avelumab,TRANSAMINASES INCREASED,28
avelumab,PAIN,27
avelumab,ASPARTATE AMINOTRANSFERASE INCREASED,26
avelumab,CONDITION AGGRAVATED,26
avelumab,HAEMATURIA,26
avelumab,RENAL FAILURE,26
avelumab,RESPIRATORY FAILURE,26
avelumab,ATRIAL FIBRILLATION,25
avelumab,COUGH,25
avelumab,FALL,24
avelumab,HEADACHE,24
avelumab,PLEURAL EFFUSION,24
avelumab,SYNCOPE,24
avelumab,ARTHRALGIA,23
avelumab,CONFUSIONAL STATE,23
avelumab,HYPERSENSITIVITY,23
avelumab,STOMATITIS,23
avelumab,URINARY TRACT INFECTION,23
avelumab,WEIGHT DECREASED,23
avelumab,ARTHRITIS,22
avelumab,MUCOSAL INFLAMMATION,22
avelumab,PANCREATITIS,21
avelumab,TREMOR,21
avelumab,BLOOD CREATININE INCREASED,20
avelumab,CARDIAC FAILURE,20
avelumab,DIABETES MELLITUS,20
avelumab,HYPERGLYCAEMIA,20
avelumab,HYPOKALAEMIA,20
avelumab,MYALGIA,20
avelumab,NEUTROPHIL COUNT DECREASED,20
avelumab,OXYGEN SATURATION DECREASED,20
avelumab,CHEST PAIN,19
avelumab,DEVICE RELATED INFECTION,19
avelumab,LIVER DISORDER,19
avelumab,MYASTHENIA GRAVIS,19
avelumab,DYSPHAGIA,18
avelumab,HEPATOTOXICITY,18
avelumab,SEPTIC SHOCK,18
avelumab,THYROIDITIS,18
avelumab,CARDIAC ARREST,17
avelumab,ENCEPHALITIS,16
avelumab,HYPOXIA,16
avelumab,METASTASES TO CENTRAL NERVOUS SYSTEM,16
avelumab,MUSCULAR WEAKNESS,16
lorlatinib,DEATH,714
lorlatinib,NEOPLASM PROGRESSION,542
lorlatinib,OFF LABEL USE,227
lorlatinib,BLOOD CHOLESTEROL INCREASED,134
lorlatinib,DYSPNOEA,130
lorlatinib,WEIGHT INCREASED,121
lorlatinib,OEDEMA PERIPHERAL,118
lorlatinib,HALLUCINATION,116
lorlatinib,HYPERCHOLESTEROLAEMIA,113
lorlatinib,OEDEMA,102
lorlatinib,FATIGUE,95
lorlatinib,PLEURAL EFFUSION,94
lorlatinib,COGNITIVE DISORDER,93
lorlatinib,PNEUMONIA,90
lorlatinib,DIARRHOEA,83
lorlatinib,DISEASE PROGRESSION,81
lorlatinib,PERIPHERAL SWELLING,81
lorlatinib,NEUROPATHY PERIPHERAL,80
lorlatinib,BLOOD TRIGLYCERIDES INCREASED,71
lorlatinib,HYPERLIPIDAEMIA,71
lorlatinib,CONFUSIONAL STATE,68
lorlatinib,HYPERTRIGLYCERIDAEMIA,65
lorlatinib,MEMORY IMPAIRMENT,63
lorlatinib,NAUSEA,63
lorlatinib,PAIN,63
lorlatinib,HEADACHE,60
lorlatinib,DIZZINESS,58
lorlatinib,MALAISE,58
lorlatinib,ASTHENIA,57
lorlatinib,DRUG INEFFECTIVE,57
lorlatinib,PULMONARY EMBOLISM,55
lorlatinib,ARTHRALGIA,51
lorlatinib,PYREXIA,51
lorlatinib,NERVOUS SYSTEM DISORDER,48
lorlatinib,PAIN IN EXTREMITY,48
lorlatinib,HAEMOGLOBIN DECREASED,47
lorlatinib,"HALLUCINATION, AUDITORY",46
lorlatinib,MALIGNANT NEOPLASM PROGRESSION,46
lorlatinib,SPEECH DISORDER,46
lorlatinib,COUGH,45
lorlatinib,GAIT DISTURBANCE,44
lorlatinib,"HALLUCINATION, VISUAL",42
lorlatinib,LOW DENSITY LIPOPROTEIN INCREASED,42
lorlatinib,VISUAL IMPAIRMENT,41
lorlatinib,PERICARDIAL EFFUSION,40
lorlatinib,ANXIETY,39
lorlatinib,GENERAL PHYSICAL HEALTH DETERIORATION,39
lorlatinib,PRODUCT USE IN UNAPPROVED INDICATION,39
lorlatinib,RASH,39
lorlatinib,VOMITING,39
lorlatinib,ANAEMIA,38
lorlatinib,BLOOD GLUCOSE INCREASED,37
lorlatinib,PNEUMONITIS,37
lorlatinib,CONSTIPATION,36
lorlatinib,CARDIAC FAILURE,35
lorlatinib,INSOMNIA,35
lorlatinib,PSYCHOTIC DISORDER,35
lorlatinib,BLOOD PRESSURE INCREASED,34
lorlatinib,FALL,34
lorlatinib,FEELING ABNORMAL,34
lorlatinib,PARAESTHESIA,34
lorlatinib,DEPRESSION,33
lorlatinib,MENTAL DISORDER,33
lorlatinib,THROMBOCYTOPENIA,33
lorlatinib,WEIGHT DECREASED,33
lorlatinib,BACK PAIN,32
lorlatinib,CONDITION AGGRAVATED,32
lorlatinib,COVID-19,32
lorlatinib,DELIRIUM,32
lorlatinib,SEIZURE,32
lorlatinib,DYSPHAGIA,31
lorlatinib,AMNESIA,30
lorlatinib,DYSLIPIDAEMIA,30
lorlatinib,CEREBROVASCULAR ACCIDENT,29
lorlatinib,CARPAL TUNNEL SYNDROME,28
lorlatinib,HYPERTENSION,28
lorlatinib,MUSCULAR WEAKNESS,28
lorlatinib,ASCITES,27
lorlatinib,DRUG RESISTANCE,27
lorlatinib,FLUID RETENTION,27
lorlatinib,MYALGIA,27
lorlatinib,DECREASED APPETITE,26
lorlatinib,ELECTROCARDIOGRAM QT PROLONGED,26
lorlatinib,HYPOAESTHESIA,26
lorlatinib,PLATELET COUNT DECREASED,26
lorlatinib,RENAL IMPAIRMENT,26
lorlatinib,RENAL FAILURE,25
lorlatinib,CHEST PAIN,24
lorlatinib,BLOOD CREATININE INCREASED,23
lorlatinib,BRAIN OEDEMA,23
lorlatinib,DRUG INTERACTION,23
lorlatinib,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,23
lorlatinib,RESPIRATORY FAILURE,23
lorlatinib,DIABETES MELLITUS,22
lorlatinib,DYSARTHRIA,22
lorlatinib,METASTASES TO LIVER,22
lorlatinib,ABDOMINAL DISTENSION,21
lorlatinib,ABDOMINAL PAIN,21
lorlatinib,CEREBRAL INFARCTION,21
lorlatinib,DEEP VEIN THROMBOSIS,21
enzalutamide,FATIGUE,9101
enzalutamide,DEATH,7482
enzalutamide,MALIGNANT NEOPLASM PROGRESSION,5117
enzalutamide,PROSTATIC SPECIFIC ANTIGEN INCREASED,4005
enzalutamide,DRUG INEFFECTIVE,3883
enzalutamide,ASTHENIA,3682
enzalutamide,DECREASED APPETITE,3184
enzalutamide,NAUSEA,3088
enzalutamide,HOT FLUSH,3008
enzalutamide,DIZZINESS,2829
enzalutamide,DIARRHOEA,2598
enzalutamide,BACK PAIN,2106
enzalutamide,UNDERDOSE,1975
enzalutamide,ARTHRALGIA,1893
enzalutamide,CONSTIPATION,1633
enzalutamide,WEIGHT DECREASED,1630
enzalutamide,FALL,1606
enzalutamide,HEADACHE,1527
enzalutamide,PAIN,1502
enzalutamide,MALAISE,1442
enzalutamide,DYSPNOEA,1340
enzalutamide,PERIPHERAL SWELLING,1241
enzalutamide,DYSPHAGIA,1236
enzalutamide,INSOMNIA,1225
enzalutamide,VOMITING,1184
enzalutamide,PAIN IN EXTREMITY,1117
enzalutamide,DRUG DOSE OMISSION,937
enzalutamide,ABDOMINAL DISCOMFORT,924
enzalutamide,SOMNOLENCE,923
enzalutamide,MUSCULAR WEAKNESS,918
enzalutamide,OFF LABEL USE,880
enzalutamide,MYALGIA,873
enzalutamide,CONFUSIONAL STATE,851
enzalutamide,GAIT DISTURBANCE,771
enzalutamide,MEMORY IMPAIRMENT,763
enzalutamide,FEELING ABNORMAL,747
enzalutamide,PROSTATE CANCER,743
enzalutamide,RASH,737
enzalutamide,BONE PAIN,724
enzalutamide,ANAEMIA,715
enzalutamide,DRUG INTERACTION,712
enzalutamide,URINARY TRACT INFECTION,696
enzalutamide,PNEUMONIA,668
enzalutamide,HYPERTENSION,627
enzalutamide,BLOOD PRESSURE INCREASED,625
enzalutamide,TREATMENT NONCOMPLIANCE,606
enzalutamide,BALANCE DISORDER,605
enzalutamide,CEREBROVASCULAR ACCIDENT,589
enzalutamide,PRODUCT SIZE ISSUE,588
enzalutamide,DYSGEUSIA,571
enzalutamide,HYPOAESTHESIA,568
enzalutamide,HYPERHIDROSIS,541
enzalutamide,ABDOMINAL PAIN UPPER,531
enzalutamide,ANXIETY,530
enzalutamide,PARAESTHESIA,512
enzalutamide,DEHYDRATION,511
enzalutamide,PRURITUS,511
enzalutamide,DEPRESSION,509
enzalutamide,GENERAL PHYSICAL HEALTH DETERIORATION,503
enzalutamide,NEUROPATHY PERIPHERAL,490
enzalutamide,HOSPITALISATION,478
enzalutamide,OEDEMA PERIPHERAL,465
enzalutamide,SEIZURE,462
enzalutamide,VISION BLURRED,462
enzalutamide,PYREXIA,459
enzalutamide,METASTASES TO BONE,457
enzalutamide,COUGH,443
enzalutamide,AMNESIA,430
enzalutamide,MUSCLE SPASMS,421
enzalutamide,LOSS OF CONSCIOUSNESS,419
enzalutamide,JOINT SWELLING,388
enzalutamide,CHEST PAIN,387
enzalutamide,WEIGHT INCREASED,379
enzalutamide,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,376
enzalutamide,PRODUCT STORAGE ERROR,372
enzalutamide,MYOCARDIAL INFARCTION,368
enzalutamide,NASOPHARYNGITIS,367
enzalutamide,TREMOR,364
enzalutamide,MUSCULOSKELETAL PAIN,362
enzalutamide,POLLAKIURIA,357
enzalutamide,HAEMOGLOBIN DECREASED,347
enzalutamide,CONDITION AGGRAVATED,332
enzalutamide,CARDIAC FAILURE,325
enzalutamide,ABDOMINAL PAIN,319
enzalutamide,BLOOD URINE PRESENT,314
enzalutamide,HYPOTENSION,310
enzalutamide,ATRIAL FIBRILLATION,308
enzalutamide,HALLUCINATION,304
enzalutamide,PRODUCT DOSE OMISSION,303
enzalutamide,VISUAL IMPAIRMENT,301
enzalutamide,PRODUCT USE COMPLAINT,295
enzalutamide,ALOPECIA,294
enzalutamide,DISEASE PROGRESSION,292
enzalutamide,LETHARGY,292
enzalutamide,HAEMATURIA,286
enzalutamide,PROSTATE CANCER METASTATIC,283
enzalutamide,PRODUCT AVAILABILITY ISSUE,280
enzalutamide,DYSPEPSIA,277
enzalutamide,DRUG INTOLERANCE,274
enzalutamide,PLATELET COUNT DECREASED,266
afatinib,DIARRHOEA,2071
afatinib,MALIGNANT NEOPLASM PROGRESSION,1646
afatinib,RASH,851
afatinib,DEATH,519
afatinib,NAUSEA,482
afatinib,STOMATITIS,481
afatinib,DECREASED APPETITE,444
afatinib,VOMITING,413
afatinib,PARONYCHIA,345
afatinib,DEHYDRATION,335
afatinib,FATIGUE,293
afatinib,METASTASES TO CENTRAL NERVOUS SYSTEM,265
afatinib,OFF LABEL USE,254
afatinib,ASTHENIA,239
afatinib,DYSPNOEA,212
afatinib,WEIGHT DECREASED,206
afatinib,DRUG INEFFECTIVE,200
afatinib,PNEUMONIA,196
afatinib,DRY SKIN,195
afatinib,PLEURAL EFFUSION,183
afatinib,DISEASE PROGRESSION,174
afatinib,PYREXIA,164
afatinib,ACNE,163
afatinib,PRURITUS,154
afatinib,INTERSTITIAL LUNG DISEASE,152
afatinib,DERMATITIS ACNEIFORM,145
afatinib,ALOPECIA,133
afatinib,EPISTAXIS,133
afatinib,DRUG RESISTANCE,128
afatinib,CONSTIPATION,116
afatinib,COUGH,116
afatinib,ANAEMIA,114
afatinib,DIZZINESS,114
afatinib,MUCOSAL INFLAMMATION,113
afatinib,MALAISE,107
afatinib,ABDOMINAL PAIN,103
afatinib,HEADACHE,102
afatinib,ACUTE KIDNEY INJURY,96
afatinib,METASTASES TO BONE,88
afatinib,EGFR GENE MUTATION,86
afatinib,PAIN,86
afatinib,RESPIRATORY FAILURE,85
afatinib,SKIN DISORDER,85
afatinib,SKIN TOXICITY,84
afatinib,DYSPHAGIA,83
afatinib,PNEUMONITIS,82
afatinib,NAIL DISORDER,81
afatinib,DRY MOUTH,79
afatinib,BLOOD CREATININE INCREASED,78
afatinib,PAIN IN EXTREMITY,78
afatinib,METASTASES TO MENINGES,75
afatinib,URINARY TRACT INFECTION,75
afatinib,ORAL PAIN,74
afatinib,FALL,73
afatinib,METASTASES TO LIVER,72
afatinib,DYSGEUSIA,70
afatinib,NEOPLASM PROGRESSION,68
afatinib,HYPOKALAEMIA,66
afatinib,SKIN FISSURES,66
afatinib,SKIN EXFOLIATION,65
afatinib,GENERAL PHYSICAL HEALTH DETERIORATION,63
afatinib,RENAL FAILURE,63
afatinib,HYPOTENSION,60
afatinib,PULMONARY EMBOLISM,60
afatinib,SEPSIS,60
afatinib,ABDOMINAL PAIN UPPER,59
afatinib,BACK PAIN,59
afatinib,ERYTHEMA,59
afatinib,ONYCHOCLASIS,59
afatinib,MUSCLE SPASMS,58
afatinib,NON-SMALL CELL LUNG CANCER,58
afatinib,THERAPY PARTIAL RESPONDER,58
afatinib,RHINORRHOEA,57
afatinib,LUNG DISORDER,54
afatinib,METASTASES TO LUNG,53
afatinib,DRUG INTOLERANCE,52
afatinib,PERIPHERAL SWELLING,52
afatinib,CHEST PAIN,51
afatinib,ABDOMINAL DISCOMFORT,50
afatinib,TOXICITY TO VARIOUS AGENTS,50
afatinib,DRY EYE,49
afatinib,CARDIAC FAILURE,48
afatinib,HYPONATRAEMIA,47
afatinib,OROPHARYNGEAL PAIN,46
afatinib,INFECTION,45
afatinib,NASOPHARYNGITIS,45
afatinib,RASH PUSTULAR,45
afatinib,TREATMENT FAILURE,45
afatinib,DYSPEPSIA,44
afatinib,LUNG NEOPLASM MALIGNANT,44
afatinib,MOUTH ULCERATION,44
afatinib,SEIZURE,42
afatinib,CONFUSIONAL STATE,40
afatinib,GENE MUTATION,40
afatinib,ALANINE AMINOTRANSFERASE INCREASED,39
afatinib,GLOSSODYNIA,38
afatinib,HAEMORRHAGE,36
afatinib,INSOMNIA,36
afatinib,SOMNOLENCE,36
afatinib,BLOOD POTASSIUM DECREASED,35
capecitabine,DIARRHOEA,13326
capecitabine,DEATH,8679
capecitabine,NAUSEA,8241
capecitabine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6692
capecitabine,FATIGUE,6362
capecitabine,VOMITING,6058
capecitabine,DISEASE PROGRESSION,5697
capecitabine,MALIGNANT NEOPLASM PROGRESSION,3384
capecitabine,OFF LABEL USE,3243
capecitabine,ASTHENIA,3189
capecitabine,DECREASED APPETITE,3063
capecitabine,DEHYDRATION,2882
capecitabine,NEUTROPENIA,2767
capecitabine,NEUROPATHY PERIPHERAL,2631
capecitabine,DYSPNOEA,2552
capecitabine,PYREXIA,2359
capecitabine,DRUG INEFFECTIVE,2225
capecitabine,RASH,2217
capecitabine,THROMBOCYTOPENIA,2184
capecitabine,ABDOMINAL PAIN,2176
capecitabine,PAIN,2163
capecitabine,ANAEMIA,2114
capecitabine,STOMATITIS,2096
capecitabine,WEIGHT DECREASED,1959
capecitabine,MUCOSAL INFLAMMATION,1861
capecitabine,CONSTIPATION,1847
capecitabine,PAIN IN EXTREMITY,1834
capecitabine,MALAISE,1709
capecitabine,METASTASES TO LIVER,1610
capecitabine,DIZZINESS,1603
capecitabine,PARAESTHESIA,1568
capecitabine,HEADACHE,1517
capecitabine,ERYTHEMA,1512
capecitabine,SKIN EXFOLIATION,1319
capecitabine,HYPOAESTHESIA,1262
capecitabine,DRY SKIN,1244
capecitabine,PNEUMONIA,1237
capecitabine,METASTASES TO BONE,1160
capecitabine,PLATELET COUNT DECREASED,1155
capecitabine,ABDOMINAL PAIN UPPER,1141
capecitabine,CHEST PAIN,1120
capecitabine,FEBRILE NEUTROPENIA,1095
capecitabine,GENERAL PHYSICAL HEALTH DETERIORATION,1094
capecitabine,SEPSIS,1093
capecitabine,WHITE BLOOD CELL COUNT DECREASED,1071
capecitabine,PULMONARY EMBOLISM,1061
capecitabine,HYPERTENSION,1059
capecitabine,NEOPLASM PROGRESSION,1039
capecitabine,BREAST CANCER METASTATIC,1036
capecitabine,SKIN DISCOLOURATION,1031
capecitabine,LEUKOPENIA,1014
capecitabine,COUGH,978
capecitabine,BACK PAIN,971
capecitabine,INFECTION,942
capecitabine,ALOPECIA,906
capecitabine,FALL,902
capecitabine,TOXICITY TO VARIOUS AGENTS,893
capecitabine,HYPOTENSION,887
capecitabine,ARTHRALGIA,885
capecitabine,BREAST CANCER,884
capecitabine,HYPOKALAEMIA,881
capecitabine,METASTASES TO LUNG,881
capecitabine,PRURITUS,878
capecitabine,DYSPHAGIA,868
capecitabine,METASTASES TO CENTRAL NERVOUS SYSTEM,861
capecitabine,PLEURAL EFFUSION,850
capecitabine,PERIPHERAL SWELLING,831
capecitabine,THERAPY INTERRUPTED,831
capecitabine,HOSPITALISATION,811
capecitabine,URINARY TRACT INFECTION,736
capecitabine,OEDEMA PERIPHERAL,733
capecitabine,BONE MARROW FAILURE,732
capecitabine,NEUROTOXICITY,723
capecitabine,MUSCLE SPASMS,720
capecitabine,BLISTER,712
capecitabine,THERAPY CESSATION,704
capecitabine,ASCITES,702
capecitabine,GAIT DISTURBANCE,698
capecitabine,RENAL FAILURE,698
capecitabine,THROMBOSIS,691
capecitabine,MYELOSUPPRESSION,667
capecitabine,NO ADVERSE EVENT,661
capecitabine,HYPERSENSITIVITY,650
capecitabine,HAEMOGLOBIN DECREASED,649
capecitabine,INSOMNIA,647
capecitabine,ABDOMINAL DISTENSION,646
capecitabine,INTESTINAL OBSTRUCTION,646
capecitabine,GASTROINTESTINAL DISORDER,638
capecitabine,INTENTIONAL PRODUCT USE ISSUE,636
capecitabine,DRUG INTOLERANCE,621
capecitabine,CONFUSIONAL STATE,614
capecitabine,ABDOMINAL DISCOMFORT,611
capecitabine,EPISTAXIS,607
capecitabine,BLOOD BILIRUBIN INCREASED,596
capecitabine,CHILLS,595
capecitabine,ACUTE KIDNEY INJURY,593
capecitabine,COLITIS,577
capecitabine,DEEP VEIN THROMBOSIS,571
capecitabine,SKIN FISSURES,566
capecitabine,HEPATIC FUNCTION ABNORMAL,558
cetuximab,RASH,2164
cetuximab,DIARRHOEA,1948
cetuximab,NAUSEA,1624
cetuximab,OFF LABEL USE,1459
cetuximab,VOMITING,1380
cetuximab,DYSPNOEA,1346
cetuximab,DEHYDRATION,1145
cetuximab,NEUTROPENIA,1136
cetuximab,INFUSION RELATED REACTION,1096
cetuximab,PYREXIA,1095
cetuximab,FATIGUE,1006
cetuximab,DEATH,1002
cetuximab,MALIGNANT NEOPLASM PROGRESSION,954
cetuximab,HYPOTENSION,910
cetuximab,ANAEMIA,869
cetuximab,DERMATITIS ACNEIFORM,817
cetuximab,MUCOSAL INFLAMMATION,817
cetuximab,ASTHENIA,791
cetuximab,DECREASED APPETITE,774
cetuximab,THROMBOCYTOPENIA,673
cetuximab,PNEUMONIA,663
cetuximab,STOMATITIS,643
cetuximab,PRURITUS,630
cetuximab,WEIGHT DECREASED,616
cetuximab,DISEASE PROGRESSION,593
cetuximab,HYPERSENSITIVITY,590
cetuximab,DYSPHAGIA,586
cetuximab,HYPOMAGNESAEMIA,582
cetuximab,FEBRILE NEUTROPENIA,569
cetuximab,PULMONARY EMBOLISM,557
cetuximab,ABDOMINAL PAIN,554
cetuximab,ERYTHEMA,531
cetuximab,CHILLS,525
cetuximab,WHITE BLOOD CELL COUNT DECREASED,523
cetuximab,SEPSIS,512
cetuximab,MALAISE,499
cetuximab,ANAPHYLACTIC REACTION,483
cetuximab,LEUKOPENIA,451
cetuximab,PAIN,423
cetuximab,NEUROPATHY PERIPHERAL,410
cetuximab,NEUTROPHIL COUNT DECREASED,406
cetuximab,DRY SKIN,402
cetuximab,HYPOKALAEMIA,402
cetuximab,PLATELET COUNT DECREASED,382
cetuximab,GENERAL PHYSICAL HEALTH DETERIORATION,369
cetuximab,DIZZINESS,366
cetuximab,INTERSTITIAL LUNG DISEASE,366
cetuximab,RESPIRATORY FAILURE,328
cetuximab,DEEP VEIN THROMBOSIS,316
cetuximab,HAEMOGLOBIN DECREASED,311
cetuximab,SKIN TOXICITY,310
cetuximab,ACNE,304
cetuximab,CONSTIPATION,304
cetuximab,LOSS OF CONSCIOUSNESS,303
cetuximab,HEADACHE,298
cetuximab,CHEST PAIN,296
cetuximab,OXYGEN SATURATION DECREASED,291
cetuximab,TACHYCARDIA,289
cetuximab,BLOOD PRESSURE DECREASED,288
cetuximab,URTICARIA,287
cetuximab,FLUSHING,286
cetuximab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,284
cetuximab,INFECTION,274
cetuximab,HYPONATRAEMIA,273
cetuximab,DRUG INEFFECTIVE,265
cetuximab,PARONYCHIA,254
cetuximab,COUGH,245
cetuximab,RENAL FAILURE,245
cetuximab,HYPERTENSION,244
cetuximab,ALOPECIA,236
cetuximab,SYNCOPE,231
cetuximab,SEPTIC SHOCK,221
cetuximab,CARDIO-RESPIRATORY ARREST,218
cetuximab,HYPOCALCAEMIA,217
cetuximab,MYELOSUPPRESSION,217
cetuximab,SKIN REACTION,216
cetuximab,RADIATION SKIN INJURY,215
cetuximab,BACK PAIN,213
cetuximab,PNEUMONITIS,213
cetuximab,HYPERHIDROSIS,210
cetuximab,SKIN FISSURES,209
cetuximab,ATRIAL FIBRILLATION,208
cetuximab,PLEURAL EFFUSION,206
cetuximab,ACUTE KIDNEY INJURY,205
cetuximab,NEOPLASM PROGRESSION,205
cetuximab,ASPARTATE AMINOTRANSFERASE INCREASED,204
cetuximab,BONE MARROW FAILURE,204
cetuximab,CONFUSIONAL STATE,202
cetuximab,PNEUMONIA ASPIRATION,202
cetuximab,DERMATITIS,199
cetuximab,ALANINE AMINOTRANSFERASE INCREASED,195
cetuximab,SKIN DISORDER,195
cetuximab,URINARY TRACT INFECTION,195
cetuximab,PARAESTHESIA,194
cetuximab,BLOOD CREATININE INCREASED,187
cetuximab,CARDIAC ARREST,186
cetuximab,CHEST DISCOMFORT,186
cetuximab,INTESTINAL OBSTRUCTION,176
cetuximab,MYOCARDIAL INFARCTION,176
cetuximab,PANCYTOPENIA,176
paclitaxel albumin,MALIGNANT NEOPLASM PROGRESSION,61
paclitaxel albumin,MYELOSUPPRESSION,59
paclitaxel albumin,PYREXIA,46
paclitaxel albumin,DEATH,39
paclitaxel albumin,NAUSEA,39
paclitaxel albumin,OFF LABEL USE,39
paclitaxel albumin,DIARRHOEA,34
paclitaxel albumin,PLATELET COUNT DECREASED,33
paclitaxel albumin,NEUTROPHIL COUNT DECREASED,31
paclitaxel albumin,DECREASED APPETITE,30
paclitaxel albumin,NEUTROPENIA,30
paclitaxel albumin,INTERSTITIAL LUNG DISEASE,29
paclitaxel albumin,FEBRILE NEUTROPENIA,28
paclitaxel albumin,PNEUMONIA,27
paclitaxel albumin,WHITE BLOOD CELL COUNT DECREASED,25
paclitaxel albumin,ANAEMIA,24
paclitaxel albumin,VOMITING,23
paclitaxel albumin,THROMBOCYTOPENIA,22
paclitaxel albumin,GASTROINTESTINAL DISORDER,21
paclitaxel albumin,NEUROPATHY PERIPHERAL,21
paclitaxel albumin,ASTHENIA,19
paclitaxel albumin,DEHYDRATION,19
paclitaxel albumin,FATIGUE,19
paclitaxel albumin,INTENTIONAL PRODUCT USE ISSUE,19
paclitaxel albumin,RASH,19
paclitaxel albumin,BONE MARROW FAILURE,18
paclitaxel albumin,DISEASE PROGRESSION,17
paclitaxel albumin,DYSPNOEA,16
paclitaxel albumin,HEPATIC FUNCTION ABNORMAL,16
paclitaxel albumin,PAIN,15
paclitaxel albumin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,15
paclitaxel albumin,GENERAL PHYSICAL HEALTH DETERIORATION,14
paclitaxel albumin,LUNG DISORDER,13
paclitaxel albumin,RESPIRATORY FAILURE,13
paclitaxel albumin,ALANINE AMINOTRANSFERASE INCREASED,12
paclitaxel albumin,INFECTION,12
paclitaxel albumin,MUCOSAL INFLAMMATION,12
paclitaxel albumin,PANCYTOPENIA,12
paclitaxel albumin,SEPSIS,12
paclitaxel albumin,ABDOMINAL PAIN,11
paclitaxel albumin,HYPOAESTHESIA,11
paclitaxel albumin,HYPOKALAEMIA,11
paclitaxel albumin,PNEUMONITIS,11
paclitaxel albumin,ACUTE KIDNEY INJURY,10
paclitaxel albumin,ALOPECIA,10
paclitaxel albumin,IMMUNE-MEDIATED HEPATIC DISORDER,10
paclitaxel albumin,MALAISE,10
paclitaxel albumin,PLEURAL EFFUSION,10
paclitaxel albumin,ARTHRALGIA,9
paclitaxel albumin,HYPOTHYROIDISM,9
paclitaxel albumin,LEUKOPENIA,9
paclitaxel albumin,PRODUCT USE IN UNAPPROVED INDICATION,9
paclitaxel albumin,ASPARTATE AMINOTRANSFERASE INCREASED,8
paclitaxel albumin,CHOLANGITIS,8
paclitaxel albumin,MUSCULAR WEAKNESS,8
paclitaxel albumin,NEUROTOXICITY,8
paclitaxel albumin,TOXICITY TO VARIOUS AGENTS,8
paclitaxel albumin,URINARY TRACT INFECTION,8
paclitaxel albumin,BLOOD CREATININE INCREASED,7
paclitaxel albumin,CHEST DISCOMFORT,7
paclitaxel albumin,GASTROINTESTINAL HAEMORRHAGE,7
paclitaxel albumin,HYPERTENSION,7
paclitaxel albumin,HYPONATRAEMIA,7
paclitaxel albumin,METASTASES TO LIVER,7
paclitaxel albumin,NEOPLASM PROGRESSION,7
paclitaxel albumin,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
paclitaxel albumin,PRURITUS,7
paclitaxel albumin,RENAL IMPAIRMENT,7
paclitaxel albumin,SEPTIC SHOCK,7
paclitaxel albumin,STOMATITIS,7
paclitaxel albumin,ABDOMINAL PAIN UPPER,6
paclitaxel albumin,CARDIAC FAILURE,6
paclitaxel albumin,CEREBROVASCULAR ACCIDENT,6
paclitaxel albumin,CHILLS,6
paclitaxel albumin,CHOLANGITIS SCLEROSING,6
paclitaxel albumin,COLITIS,6
paclitaxel albumin,CONSTIPATION,6
paclitaxel albumin,COUGH,6
paclitaxel albumin,DRUG-INDUCED LIVER INJURY,6
paclitaxel albumin,DYSPHAGIA,6
paclitaxel albumin,HEADACHE,6
paclitaxel albumin,HYPERSENSITIVITY,6
paclitaxel albumin,HYPOXIA,6
paclitaxel albumin,LIVER DISORDER,6
paclitaxel albumin,LYMPHANGIOSIS CARCINOMATOSA,6
paclitaxel albumin,PERICARDIAL EFFUSION,6
paclitaxel albumin,PNEUMONIA ASPIRATION,6
paclitaxel albumin,PROTEINURIA,6
paclitaxel albumin,ABDOMINAL DISTENSION,5
paclitaxel albumin,ADRENAL INSUFFICIENCY,5
paclitaxel albumin,ASCITES,5
paclitaxel albumin,BLOOD GLUCOSE INCREASED,5
paclitaxel albumin,BREAST CANCER,5
paclitaxel albumin,CELLULITIS,5
paclitaxel albumin,CYTOPENIA,5
paclitaxel albumin,DEEP VEIN THROMBOSIS,5
paclitaxel albumin,DIZZINESS,5
paclitaxel albumin,EJECTION FRACTION DECREASED,5
paclitaxel albumin,EPISTAXIS,5
paclitaxel albumin,FAILURE TO THRIVE,5
aflibercept,DEATH,7923
aflibercept,VISUAL IMPAIRMENT,1612
aflibercept,BLINDNESS,1260
aflibercept,ENDOPHTHALMITIS,1211
aflibercept,OFF LABEL USE,1178
aflibercept,VISUAL ACUITY REDUCED,1130
aflibercept,EYE PAIN,989
aflibercept,DRUG INEFFECTIVE,964
aflibercept,VISION BLURRED,946
aflibercept,BLINDNESS UNILATERAL,920
aflibercept,BLINDNESS TRANSIENT,914
aflibercept,PRODUCT DOSE OMISSION ISSUE,858
aflibercept,EYE INFLAMMATION,834
aflibercept,EYE HAEMORRHAGE,742
aflibercept,VITREOUS FLOATERS,633
aflibercept,INTRAOCULAR PRESSURE INCREASED,602
aflibercept,DIARRHOEA,595
aflibercept,RETINAL HAEMORRHAGE,522
aflibercept,HYPERTENSION,503
aflibercept,CATARACT,481
aflibercept,NON-INFECTIOUS ENDOPHTHALMITIS,404
aflibercept,HEADACHE,372
aflibercept,VITRITIS,347
aflibercept,OCULAR HYPERAEMIA,332
aflibercept,UVEITIS,322
aflibercept,CEREBROVASCULAR ACCIDENT,320
aflibercept,PRODUCT USE ISSUE,307
aflibercept,DISEASE PROGRESSION,306
aflibercept,NEUTROPENIA,302
aflibercept,FATIGUE,299
aflibercept,ASTHENIA,285
aflibercept,EYE DISORDER,276
aflibercept,FALL,271
aflibercept,MALAISE,271
aflibercept,INJECTION SITE PAIN,262
aflibercept,VITRECTOMY,258
aflibercept,NAUSEA,256
aflibercept,VITREOUS HAEMORRHAGE,240
aflibercept,LACRIMATION INCREASED,238
aflibercept,EYE IRRITATION,235
aflibercept,MYOCARDIAL INFARCTION,223
aflibercept,VOMITING,221
aflibercept,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,219
aflibercept,DYSPNOEA,218
aflibercept,HOSPITALISATION,216
aflibercept,DRUG DOSE OMISSION,215
aflibercept,EYE INFECTION,208
aflibercept,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,206
aflibercept,PRODUCT DOSE OMISSION,204
aflibercept,MACULAR OEDEMA,202
aflibercept,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,202
aflibercept,RETINAL DETACHMENT,197
aflibercept,PAIN,196
aflibercept,PNEUMONIA,192
aflibercept,PYREXIA,190
aflibercept,RETINAL OEDEMA,190
aflibercept,DEVICE USE ISSUE,178
aflibercept,GENERAL PHYSICAL HEALTH DETERIORATION,176
aflibercept,DIZZINESS,174
aflibercept,CATARACT OPERATION,168
aflibercept,GLAUCOMA,167
aflibercept,PHOTOPHOBIA,167
aflibercept,ABDOMINAL PAIN,164
aflibercept,DECREASED APPETITE,161
aflibercept,PROTEINURIA,159
aflibercept,SUBRETINAL FLUID,159
aflibercept,EYE SWELLING,155
aflibercept,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,155
aflibercept,OCULAR DISCOMFORT,155
aflibercept,REFUSAL OF TREATMENT BY PATIENT,149
aflibercept,ANAEMIA,146
aflibercept,RETINAL ARTERY OCCLUSION,144
aflibercept,BLOOD PRESSURE INCREASED,143
aflibercept,PULMONARY EMBOLISM,141
aflibercept,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,139
aflibercept,CONDITION AGGRAVATED,137
aflibercept,MACULAR DEGENERATION,136
aflibercept,VITREOUS OPACITIES,135
aflibercept,ANTERIOR CHAMBER CELL,132
aflibercept,THROMBOCYTOPENIA,130
aflibercept,AGE-RELATED MACULAR DEGENERATION,129
aflibercept,STOMATITIS,129
aflibercept,MACULAR HOLE,127
aflibercept,UNEVALUABLE EVENT,124
aflibercept,RENAL FAILURE,122
aflibercept,FOREIGN BODY SENSATION IN EYES,120
aflibercept,METAMORPHOPSIA,115
aflibercept,WEIGHT DECREASED,115
aflibercept,CARDIAC FAILURE,114
aflibercept,URINARY TRACT INFECTION,112
aflibercept,ACUTE KIDNEY INJURY,109
aflibercept,HYPOACUSIS,109
aflibercept,INJURY ASSOCIATED WITH DEVICE,109
aflibercept,IRITIS,108
aflibercept,NEUROPATHY PERIPHERAL,108
aflibercept,VISUAL FIELD DEFECT,108
aflibercept,ALOPECIA,107
aflibercept,ATRIAL FIBRILLATION,107
aflibercept,EPISTAXIS,104
aflibercept,TRANSIENT ISCHAEMIC ATTACK,104
sacituzumab govitecan,DISEASE PROGRESSION,905
sacituzumab govitecan,DEATH,461
sacituzumab govitecan,DIARRHOEA,381
sacituzumab govitecan,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,330
sacituzumab govitecan,NEUTROPENIA,315
sacituzumab govitecan,FATIGUE,237
sacituzumab govitecan,OFF LABEL USE,232
sacituzumab govitecan,NAUSEA,182
sacituzumab govitecan,WEIGHT FLUCTUATION,180
sacituzumab govitecan,FEBRILE NEUTROPENIA,179
sacituzumab govitecan,ASTHENIA,159
sacituzumab govitecan,WEIGHT DECREASED,146
sacituzumab govitecan,ALOPECIA,122
sacituzumab govitecan,NEUTROPHIL COUNT DECREASED,109
sacituzumab govitecan,WEIGHT INCREASED,109
sacituzumab govitecan,VOMITING,107
sacituzumab govitecan,CONSTIPATION,103
sacituzumab govitecan,MALAISE,95
sacituzumab govitecan,DYSPNOEA,93
sacituzumab govitecan,HEART RATE INCREASED,86
sacituzumab govitecan,DRUG INEFFECTIVE,81
sacituzumab govitecan,PYREXIA,81
sacituzumab govitecan,ANAEMIA,78
sacituzumab govitecan,PAIN,78
sacituzumab govitecan,HYPOTENSION,77
sacituzumab govitecan,COVID-19,75
sacituzumab govitecan,SEPSIS,73
sacituzumab govitecan,ABDOMINAL PAIN,70
sacituzumab govitecan,THROMBOCYTOPENIA,68
sacituzumab govitecan,COLITIS,62
sacituzumab govitecan,HYPERTENSION,61
sacituzumab govitecan,WHITE BLOOD CELL COUNT DECREASED,61
sacituzumab govitecan,DECREASED APPETITE,57
sacituzumab govitecan,RASH,56
sacituzumab govitecan,PNEUMONIA,55
sacituzumab govitecan,COUGH,54
sacituzumab govitecan,GENERAL PHYSICAL HEALTH DETERIORATION,53
sacituzumab govitecan,HEADACHE,53
sacituzumab govitecan,NEUTROPENIC COLITIS,53
sacituzumab govitecan,DIZZINESS,50
sacituzumab govitecan,SEPTIC SHOCK,48
sacituzumab govitecan,METASTASES TO CENTRAL NERVOUS SYSTEM,44
sacituzumab govitecan,ABDOMINAL PAIN UPPER,43
sacituzumab govitecan,PNEUMONITIS,40
sacituzumab govitecan,DEHYDRATION,39
sacituzumab govitecan,NEUTROPENIC SEPSIS,36
sacituzumab govitecan,SOMNOLENCE,36
sacituzumab govitecan,NASOPHARYNGITIS,35
sacituzumab govitecan,PANCYTOPENIA,35
sacituzumab govitecan,PLEURAL EFFUSION,34
sacituzumab govitecan,PLATELET COUNT DECREASED,33
sacituzumab govitecan,ILL-DEFINED DISORDER,32
sacituzumab govitecan,URINARY TRACT INFECTION,32
sacituzumab govitecan,INFECTION,31
sacituzumab govitecan,NEUTROPHIL COUNT ABNORMAL,31
sacituzumab govitecan,BACK PAIN,30
sacituzumab govitecan,GENERAL PHYSICAL CONDITION ABNORMAL,30
sacituzumab govitecan,METASTASES TO LIVER,30
sacituzumab govitecan,DYSPHAGIA,29
sacituzumab govitecan,PAIN IN EXTREMITY,29
sacituzumab govitecan,ARTHRALGIA,28
sacituzumab govitecan,HAEMOGLOBIN DECREASED,28
sacituzumab govitecan,LEUKOPENIA,28
sacituzumab govitecan,PRODUCT DOSE OMISSION ISSUE,28
sacituzumab govitecan,BREAST CANCER METASTATIC,27
sacituzumab govitecan,MUCOSAL INFLAMMATION,27
sacituzumab govitecan,NEUROPATHY PERIPHERAL,27
sacituzumab govitecan,ACUTE KIDNEY INJURY,26
sacituzumab govitecan,INTENTIONAL DOSE OMISSION,26
sacituzumab govitecan,HYPOKALAEMIA,25
sacituzumab govitecan,HYPERSENSITIVITY,24
sacituzumab govitecan,HYPONATRAEMIA,24
sacituzumab govitecan,NEOPLASM PROGRESSION,24
sacituzumab govitecan,PRURITUS,24
sacituzumab govitecan,INFUSION RELATED REACTION,23
sacituzumab govitecan,MALIGNANT NEOPLASM PROGRESSION,23
sacituzumab govitecan,OROPHARYNGEAL PAIN,23
sacituzumab govitecan,OXYGEN SATURATION DECREASED,22
sacituzumab govitecan,SARS-COV-2 TEST POSITIVE,22
sacituzumab govitecan,FEBRILE BONE MARROW APLASIA,21
sacituzumab govitecan,GAIT DISTURBANCE,21
sacituzumab govitecan,BONE PAIN,20
sacituzumab govitecan,ILLNESS,20
sacituzumab govitecan,RENAL FAILURE,20
sacituzumab govitecan,ANXIETY,19
sacituzumab govitecan,HAEMATOTOXICITY,19
sacituzumab govitecan,MYELOSUPPRESSION,19
sacituzumab govitecan,PRODUCT PREPARATION ISSUE,19
sacituzumab govitecan,DISCOMFORT,18
sacituzumab govitecan,INCORRECT DOSE ADMINISTERED,18
sacituzumab govitecan,LIVER DISORDER,18
sacituzumab govitecan,METASTASES TO BONE,18
sacituzumab govitecan,POOR VENOUS ACCESS,18
sacituzumab govitecan,PRODUCT USE ISSUE,18
sacituzumab govitecan,TRIPLE NEGATIVE BREAST CANCER,18
sacituzumab govitecan,PRODUCTIVE COUGH,17
sacituzumab govitecan,RED BLOOD CELL COUNT DECREASED,17
sacituzumab govitecan,ATRIAL FIBRILLATION,16
sacituzumab govitecan,CHEST PAIN,16
sacituzumab govitecan,FALL,16
eribulin,NEUTROPENIA,823
eribulin,MALIGNANT NEOPLASM PROGRESSION,716
eribulin,FEBRILE NEUTROPENIA,519
eribulin,NEUROPATHY PERIPHERAL,357
eribulin,PYREXIA,306
eribulin,DISEASE PROGRESSION,291
eribulin,FATIGUE,285
eribulin,LEUKOPENIA,254
eribulin,NAUSEA,245
eribulin,METASTASES TO LIVER,232
eribulin,MYELOSUPPRESSION,223
eribulin,ANAEMIA,220
eribulin,METASTASES TO BONE,205
eribulin,ASTHENIA,204
eribulin,DECREASED APPETITE,198
eribulin,INTERSTITIAL LUNG DISEASE,197
eribulin,THROMBOCYTOPENIA,194
eribulin,DIARRHOEA,193
eribulin,NEUTROPHIL COUNT DECREASED,187
eribulin,BREAST CANCER METASTATIC,183
eribulin,DYSPNOEA,182
eribulin,PNEUMONIA,180
eribulin,BREAST CANCER,173
eribulin,WHITE BLOOD CELL COUNT DECREASED,169
eribulin,STOMATITIS,156
eribulin,VOMITING,153
eribulin,ALOPECIA,152
eribulin,DEATH,133
eribulin,MUCOSAL INFLAMMATION,133
eribulin,OFF LABEL USE,128
eribulin,PLEURAL EFFUSION,127
eribulin,NEOPLASM PROGRESSION,120
eribulin,MALAISE,118
eribulin,HEADACHE,117
eribulin,SEPSIS,109
eribulin,COUGH,106
eribulin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,101
eribulin,PLATELET COUNT DECREASED,99
eribulin,DRUG INEFFECTIVE,96
eribulin,METASTASES TO LUNG,95
eribulin,OSTEONECROSIS OF JAW,87
eribulin,PULMONARY EMBOLISM,83
eribulin,ABDOMINAL PAIN,82
eribulin,RASH,81
eribulin,CONSTIPATION,80
eribulin,METASTASES TO CENTRAL NERVOUS SYSTEM,80
eribulin,DRUG INTOLERANCE,75
eribulin,PAIN,75
eribulin,PANCYTOPENIA,75
eribulin,GENERAL PHYSICAL HEALTH DETERIORATION,71
eribulin,URINARY TRACT INFECTION,71
eribulin,METASTASES TO LYMPH NODES,68
eribulin,BACK PAIN,67
eribulin,HYPOAESTHESIA,66
eribulin,WEIGHT DECREASED,66
eribulin,ASCITES,62
eribulin,ASPARTATE AMINOTRANSFERASE INCREASED,61
eribulin,CARDIAC FAILURE,61
eribulin,HAEMATOTOXICITY,61
eribulin,PNEUMONITIS,61
eribulin,ALANINE AMINOTRANSFERASE INCREASED,59
eribulin,PAIN IN EXTREMITY,55
eribulin,BONE PAIN,52
eribulin,HYPERGLYCAEMIA,49
eribulin,PNEUMOTHORAX,49
eribulin,HEPATIC FUNCTION ABNORMAL,48
eribulin,LYMPHOPENIA,48
eribulin,ARTHRALGIA,47
eribulin,DIZZINESS,46
eribulin,COLITIS,45
eribulin,TREMOR,45
eribulin,PSEUDOCIRRHOSIS,44
eribulin,DEHYDRATION,43
eribulin,ELECTROCARDIOGRAM QT PROLONGED,43
eribulin,POLYNEUROPATHY,43
eribulin,HYPOKALAEMIA,41
eribulin,OEDEMA PERIPHERAL,41
eribulin,CHILLS,40
eribulin,ACUTE KIDNEY INJURY,39
eribulin,DYSPHONIA,39
eribulin,PALPITATIONS,39
eribulin,DYSPEPSIA,38
eribulin,HEPATIC FAILURE,38
eribulin,RESPIRATORY FAILURE,37
eribulin,BLOOD CREATININE INCREASED,36
eribulin,CONDITION AGGRAVATED,36
eribulin,PROTEIN TOTAL INCREASED,36
eribulin,BREAST CANCER RECURRENT,35
eribulin,CELLULITIS,35
eribulin,RASH PRURITIC,35
eribulin,FALL,34
eribulin,HAEMOGLOBIN DECREASED,34
eribulin,JAUNDICE,34
eribulin,HYPERTENSION,33
eribulin,HYPONATRAEMIA,33
eribulin,IMMUNOSUPPRESSION,33
eribulin,INFECTION,32
eribulin,EPISTAXIS,31
eribulin,PERIPHERAL SENSORY NEUROPATHY,31
eribulin,SEPTIC SHOCK,31
paclitaxel,DYSPNOEA,5729
paclitaxel,NAUSEA,5676
paclitaxel,DIARRHOEA,5198
paclitaxel,DEATH,4988
paclitaxel,NEUTROPENIA,4959
paclitaxel,FATIGUE,4495
paclitaxel,ANAEMIA,4457
paclitaxel,VOMITING,4042
paclitaxel,OFF LABEL USE,4030
paclitaxel,MALIGNANT NEOPLASM PROGRESSION,4022
paclitaxel,PYREXIA,3745
paclitaxel,NEUROPATHY PERIPHERAL,3676
paclitaxel,DISEASE PROGRESSION,3509
paclitaxel,FEBRILE NEUTROPENIA,3456
paclitaxel,ASTHENIA,2912
paclitaxel,THROMBOCYTOPENIA,2826
paclitaxel,ALOPECIA,2610
paclitaxel,ERYTHEMA,2426
paclitaxel,PNEUMONIA,2268
paclitaxel,DECREASED APPETITE,2262
paclitaxel,RASH,2231
paclitaxel,ABDOMINAL PAIN,2194
paclitaxel,DRUG INEFFECTIVE,2131
paclitaxel,HYPERTENSION,2106
paclitaxel,BACK PAIN,1995
paclitaxel,NEUTROPHIL COUNT DECREASED,1827
paclitaxel,PAIN,1808
paclitaxel,HYPOTENSION,1800
paclitaxel,GENERAL PHYSICAL HEALTH DETERIORATION,1783
paclitaxel,LEUKOPENIA,1775
paclitaxel,MALAISE,1742
paclitaxel,DEHYDRATION,1708
paclitaxel,WHITE BLOOD CELL COUNT DECREASED,1705
paclitaxel,HYPERSENSITIVITY,1700
paclitaxel,COUGH,1624
paclitaxel,CONSTIPATION,1621
paclitaxel,FLUSHING,1620
paclitaxel,SEPSIS,1572
paclitaxel,PLATELET COUNT DECREASED,1543
paclitaxel,INTERSTITIAL LUNG DISEASE,1493
paclitaxel,DIZZINESS,1367
paclitaxel,INFUSION RELATED REACTION,1358
paclitaxel,MYELOSUPPRESSION,1323
paclitaxel,CHEST DISCOMFORT,1285
paclitaxel,PLEURAL EFFUSION,1284
paclitaxel,ARTHRALGIA,1282
paclitaxel,CHEST PAIN,1271
paclitaxel,PULMONARY EMBOLISM,1236
paclitaxel,HEADACHE,1229
paclitaxel,METASTASES TO LIVER,1220
paclitaxel,PNEUMONITIS,1180
paclitaxel,MUCOSAL INFLAMMATION,1173
paclitaxel,NEOPLASM PROGRESSION,1134
paclitaxel,PARAESTHESIA,1133
paclitaxel,TACHYCARDIA,1130
paclitaxel,ACUTE KIDNEY INJURY,1126
paclitaxel,WEIGHT DECREASED,1125
paclitaxel,PANCYTOPENIA,1111
paclitaxel,PRURITUS,1074
paclitaxel,METASTASES TO BONE,1072
paclitaxel,EPISTAXIS,1057
paclitaxel,PRODUCT USE IN UNAPPROVED INDICATION,1046
paclitaxel,INFECTION,998
paclitaxel,URINARY TRACT INFECTION,998
paclitaxel,HYPOKALAEMIA,986
paclitaxel,HAEMOGLOBIN DECREASED,985
paclitaxel,STOMATITIS,978
paclitaxel,OEDEMA PERIPHERAL,915
paclitaxel,MYALGIA,913
paclitaxel,OXYGEN SATURATION DECREASED,908
paclitaxel,RESPIRATORY FAILURE,887
paclitaxel,PAIN IN EXTREMITY,883
paclitaxel,ALANINE AMINOTRANSFERASE INCREASED,862
paclitaxel,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,839
paclitaxel,ASCITES,835
paclitaxel,CHILLS,834
paclitaxel,BREAST CANCER METASTATIC,823
paclitaxel,HYPONATRAEMIA,819
paclitaxel,HYPOAESTHESIA,814
paclitaxel,HYPOXIA,802
paclitaxel,BREAST CANCER,785
paclitaxel,CARDIAC FAILURE,779
paclitaxel,BONE MARROW FAILURE,770
paclitaxel,LOSS OF CONSCIOUSNESS,751
paclitaxel,BONE PAIN,748
paclitaxel,ABDOMINAL PAIN UPPER,735
paclitaxel,NEUROTOXICITY,729
paclitaxel,ASPARTATE AMINOTRANSFERASE INCREASED,726
paclitaxel,METASTASES TO LUNG,726
paclitaxel,HYPERHIDROSIS,719
paclitaxel,SEPTIC SHOCK,711
paclitaxel,SYNCOPE,708
paclitaxel,DEEP VEIN THROMBOSIS,703
paclitaxel,DYSPHAGIA,701
paclitaxel,POLYNEUROPATHY,701
paclitaxel,METASTASES TO CENTRAL NERVOUS SYSTEM,694
paclitaxel,CONDITION AGGRAVATED,682
paclitaxel,FEELING HOT,679
paclitaxel,ANXIETY,675
paclitaxel,ANAPHYLACTIC REACTION,657
sodium chloride,DEATH,21163
sodium chloride,DRUG INEFFECTIVE,14094
sodium chloride,OFF LABEL USE,11703
sodium chloride,NAUSEA,11438
sodium chloride,HYPOTENSION,10673
sodium chloride,DYSPNOEA,10578
sodium chloride,VOMITING,10363
sodium chloride,PNEUMONIA,9567
sodium chloride,FATIGUE,9269
sodium chloride,SEIZURE,9193
sodium chloride,DIARRHOEA,8795
sodium chloride,PYREXIA,8754
sodium chloride,HEADACHE,7740
sodium chloride,PAIN,7274
sodium chloride,FALL,7200
sodium chloride,MALAISE,7064
sodium chloride,PERITONITIS,7041
sodium chloride,ASTHENIA,6940
sodium chloride,DIZZINESS,6600
sodium chloride,ABDOMINAL PAIN,6150
sodium chloride,DEHYDRATION,6127
sodium chloride,HYPERTENSION,5705
sodium chloride,CONDITION AGGRAVATED,5545
sodium chloride,RASH,5449
sodium chloride,SEPSIS,5285
sodium chloride,INFECTION,5070
sodium chloride,ACUTE KIDNEY INJURY,4964
sodium chloride,PERITONITIS BACTERIAL,4960
sodium chloride,CONSTIPATION,4589
sodium chloride,PERITONEAL DIALYSIS COMPLICATION,4584
sodium chloride,WEIGHT DECREASED,4563
sodium chloride,FLUID OVERLOAD,4502
sodium chloride,ANAEMIA,4494
sodium chloride,COUGH,4413
sodium chloride,DRUG INTERACTION,4269
sodium chloride,ABDOMINAL DISTENSION,4227
sodium chloride,DECREASED APPETITE,4219
sodium chloride,MYOCARDIAL INFARCTION,4102
sodium chloride,CARDIAC ARREST,4098
sodium chloride,MUSCLE SPASMS,4009
sodium chloride,URINARY TRACT INFECTION,3976
sodium chloride,CONFUSIONAL STATE,3938
sodium chloride,PRURITUS,3927
sodium chloride,GENERAL PHYSICAL HEALTH DETERIORATION,3908
sodium chloride,SOMNOLENCE,3819
sodium chloride,CHEST PAIN,3773
sodium chloride,MATERNAL EXPOSURE DURING PREGNANCY,3695
sodium chloride,ANXIETY,3668
sodium chloride,WEIGHT INCREASED,3666
sodium chloride,PERIPHERAL SWELLING,3531
sodium chloride,ARTHRALGIA,3514
sodium chloride,THROMBOCYTOPENIA,3370
sodium chloride,BACK PAIN,3311
sodium chloride,PAIN IN EXTREMITY,3234
sodium chloride,CEREBROVASCULAR ACCIDENT,3204
sodium chloride,RENAL FAILURE,3196
sodium chloride,SWELLING,3123
sodium chloride,PRODUCT USE IN UNAPPROVED INDICATION,3058
sodium chloride,DRUG HYPERSENSITIVITY,3006
sodium chloride,FLUID RETENTION,2885
sodium chloride,HYPONATRAEMIA,2826
sodium chloride,EPILEPSY,2819
sodium chloride,TOXICITY TO VARIOUS AGENTS,2816
sodium chloride,NASOPHARYNGITIS,2783
sodium chloride,INSOMNIA,2779
sodium chloride,WHITE BLOOD CELL COUNT DECREASED,2772
sodium chloride,CHILLS,2728
sodium chloride,RESPIRATORY FAILURE,2724
sodium chloride,FOETAL EXPOSURE DURING PREGNANCY,2682
sodium chloride,ABDOMINAL PAIN UPPER,2634
sodium chloride,TREMOR,2621
sodium chloride,LOSS OF CONSCIOUSNESS,2608
sodium chloride,CARDIAC FAILURE,2565
sodium chloride,SINUSITIS,2525
sodium chloride,DEPRESSION,2521
sodium chloride,BLOOD PRESSURE INCREASED,2511
sodium chloride,MYELOSUPPRESSION,2511
sodium chloride,ABDOMINAL DISCOMFORT,2505
sodium chloride,HYPERSENSITIVITY,2491
sodium chloride,PROCEDURAL PAIN,2490
sodium chloride,TACHYCARDIA,2490
sodium chloride,OEDEMA PERIPHERAL,2471
sodium chloride,GAIT DISTURBANCE,2456
sodium chloride,CARDIAC DISORDER,2454
sodium chloride,HAEMOGLOBIN DECREASED,2444
sodium chloride,COVID-19,2438
sodium chloride,ERYTHEMA,2433
sodium chloride,PRODUCT USE ISSUE,2393
sodium chloride,NEUTROPENIA,2339
sodium chloride,PLATELET COUNT DECREASED,2307
sodium chloride,INFUSION RELATED REACTION,2279
sodium chloride,BLOOD PRESSURE DECREASED,2230
sodium chloride,CHEST DISCOMFORT,2177
sodium chloride,FEBRILE NEUTROPENIA,2154
sodium chloride,FEELING ABNORMAL,2145
sodium chloride,ATRIAL FIBRILLATION,2126
sodium chloride,OVERDOSE,2118
sodium chloride,URTICARIA,2089
sodium chloride,GENERALISED TONIC-CLONIC SEIZURE,2022
sodium chloride,STATUS EPILEPTICUS,2016
encorafenib,DEATH,779
encorafenib,OFF LABEL USE,774
encorafenib,NAUSEA,612
encorafenib,FATIGUE,531
encorafenib,PRODUCT USE IN UNAPPROVED INDICATION,512
encorafenib,DIARRHOEA,471
encorafenib,NEOPLASM PROGRESSION,444
encorafenib,PYREXIA,443
encorafenib,VOMITING,354
encorafenib,RASH,350
encorafenib,DISEASE PROGRESSION,228
encorafenib,ARTHRALGIA,214
encorafenib,SEROUS RETINAL DETACHMENT,206
encorafenib,MALAISE,204
encorafenib,DECREASED APPETITE,196
encorafenib,ASTHENIA,171
encorafenib,VISION BLURRED,164
encorafenib,ACUTE KIDNEY INJURY,158
encorafenib,CONSTIPATION,158
encorafenib,PAIN,151
encorafenib,HEADACHE,138
encorafenib,ANAEMIA,132
encorafenib,VISUAL IMPAIRMENT,132
encorafenib,ABDOMINAL PAIN,130
encorafenib,MYALGIA,121
encorafenib,PRURITUS,120
encorafenib,MALIGNANT NEOPLASM PROGRESSION,111
encorafenib,DYSPNOEA,108
encorafenib,CHILLS,100
encorafenib,DEHYDRATION,98
encorafenib,DRUG INEFFECTIVE,92
encorafenib,ABDOMINAL PAIN UPPER,91
encorafenib,COLITIS,87
encorafenib,DYSPHAGIA,86
encorafenib,WEIGHT DECREASED,84
encorafenib,DIZZINESS,83
encorafenib,SECOND PRIMARY MALIGNANCY,82
encorafenib,ALOPECIA,75
encorafenib,HYPOTENSION,75
encorafenib,PAIN IN EXTREMITY,75
encorafenib,RENAL IMPAIRMENT,74
encorafenib,BLOOD CREATINE PHOSPHOKINASE INCREASED,73
encorafenib,SEIZURE,71
encorafenib,ILLNESS,70
encorafenib,ALANINE AMINOTRANSFERASE INCREASED,67
encorafenib,BLOOD CREATININE INCREASED,66
encorafenib,RENAL FAILURE,65
encorafenib,RETINAL DETACHMENT,65
encorafenib,ABDOMINAL DISCOMFORT,64
encorafenib,HOSPICE CARE,64
encorafenib,PERIPHERAL SWELLING,63
encorafenib,PRODUCT DOSE OMISSION,63
encorafenib,ASPARTATE AMINOTRANSFERASE INCREASED,62
encorafenib,BACK PAIN,62
encorafenib,NEUROPATHY PERIPHERAL,62
encorafenib,URINARY TRACT INFECTION,62
encorafenib,HEPATIC FUNCTION ABNORMAL,61
encorafenib,LIVER DISORDER,61
encorafenib,UVEITIS,58
encorafenib,DRY SKIN,57
encorafenib,MUSCLE SPASMS,57
encorafenib,GENERAL PHYSICAL HEALTH DETERIORATION,56
encorafenib,DRUG INTOLERANCE,54
encorafenib,PRODUCT USE ISSUE,54
encorafenib,PNEUMONIA,52
encorafenib,FALL,51
encorafenib,HYPOACUSIS,51
encorafenib,HEPATIC ENZYME INCREASED,50
encorafenib,HYPERTENSION,50
encorafenib,SEPSIS,50
encorafenib,INSOMNIA,49
encorafenib,THERAPY INTERRUPTED,49
encorafenib,COVID-19,48
encorafenib,CONFUSIONAL STATE,47
encorafenib,DERMATITIS ACNEIFORM,47
encorafenib,PRODUCT DOSE OMISSION ISSUE,47
encorafenib,HYPERSENSITIVITY,46
encorafenib,INFECTION,45
encorafenib,RASH MACULO-PAPULAR,44
encorafenib,SEROUS RETINOPATHY,43
encorafenib,ERYTHEMA,42
encorafenib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,42
encorafenib,COUGH,41
encorafenib,MEMORY IMPAIRMENT,40
encorafenib,SOMNOLENCE,40
encorafenib,INTERSTITIAL LUNG DISEASE,39
encorafenib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,38
encorafenib,PANCREATITIS,38
encorafenib,RENAL DISORDER,38
encorafenib,THERAPY CESSATION,38
encorafenib,ACNE,36
encorafenib,LIVER FUNCTION TEST INCREASED,36
encorafenib,INTESTINAL OBSTRUCTION,35
encorafenib,MUSCULAR WEAKNESS,35
encorafenib,HOSPITALISATION,34
encorafenib,UNDERDOSE,34
encorafenib,C-REACTIVE PROTEIN INCREASED,33
encorafenib,FEELING ABNORMAL,33
encorafenib,HEPATITIS,33
encorafenib,ADVERSE DRUG REACTION,32
everolimus,DEATH,6291
everolimus,MALIGNANT NEOPLASM PROGRESSION,4316
everolimus,DIARRHOEA,3867
everolimus,FATIGUE,3651
everolimus,STOMATITIS,3118
everolimus,NAUSEA,2669
everolimus,DYSPNOEA,2574
everolimus,DRUG INEFFECTIVE,2213
everolimus,PYREXIA,2195
everolimus,DECREASED APPETITE,2023
everolimus,VOMITING,2015
everolimus,COUGH,1894
everolimus,RASH,1881
everolimus,MALAISE,1865
everolimus,WEIGHT DECREASED,1831
everolimus,ASTHENIA,1826
everolimus,PNEUMONIA,1645
everolimus,PAIN,1513
everolimus,ANAEMIA,1437
everolimus,DISEASE PROGRESSION,1405
everolimus,OFF LABEL USE,1331
everolimus,HEADACHE,1322
everolimus,ABDOMINAL PAIN,1155
everolimus,METASTASES TO LIVER,1120
everolimus,PNEUMONITIS,1111
everolimus,PRODUCT USE IN UNAPPROVED INDICATION,1073
everolimus,DEHYDRATION,1051
everolimus,GENERAL PHYSICAL HEALTH DETERIORATION,1033
everolimus,NEOPLASM PROGRESSION,1016
everolimus,OEDEMA PERIPHERAL,1010
everolimus,PLEURAL EFFUSION,1010
everolimus,BLOOD PRESSURE INCREASED,967
everolimus,METASTASES TO BONE,951
everolimus,HYPERTENSION,940
everolimus,DIZZINESS,915
everolimus,ARTHRALGIA,884
everolimus,PRURITUS,848
everolimus,PERIPHERAL SWELLING,846
everolimus,HAEMOGLOBIN DECREASED,822
everolimus,BACK PAIN,817
everolimus,ABDOMINAL PAIN UPPER,799
everolimus,BLOOD GLUCOSE INCREASED,793
everolimus,CONSTIPATION,789
everolimus,BLOOD CREATININE INCREASED,778
everolimus,PAIN IN EXTREMITY,768
everolimus,THROMBOCYTOPENIA,761
everolimus,EPISTAXIS,753
everolimus,NEOPLASM MALIGNANT,748
everolimus,ORAL PAIN,737
everolimus,RENAL IMPAIRMENT,736
everolimus,ACUTE KIDNEY INJURY,730
everolimus,INTERSTITIAL LUNG DISEASE,721
everolimus,URINARY TRACT INFECTION,714
everolimus,PLATELET COUNT DECREASED,711
everolimus,MUCOSAL INFLAMMATION,701
everolimus,RENAL FAILURE,698
everolimus,BREAST CANCER,668
everolimus,BREAST CANCER METASTATIC,662
everolimus,DRUG INTERACTION,652
everolimus,SEIZURE,640
everolimus,METASTASES TO LUNG,616
everolimus,MOUTH ULCERATION,602
everolimus,NEUTROPENIA,601
everolimus,HYPERGLYCAEMIA,591
everolimus,FALL,576
everolimus,LUNG DISORDER,556
everolimus,CHEST PAIN,544
everolimus,TOXICITY TO VARIOUS AGENTS,541
everolimus,INFECTION,534
everolimus,NASOPHARYNGITIS,525
everolimus,DRUG INTOLERANCE,522
everolimus,ASCITES,509
everolimus,DIABETES MELLITUS,501
everolimus,INSOMNIA,488
everolimus,ABDOMINAL DISCOMFORT,484
everolimus,SEPSIS,482
everolimus,HYPOTENSION,480
everolimus,ERYTHEMA,476
everolimus,BLOOD CHOLESTEROL INCREASED,470
everolimus,ACNE,458
everolimus,WHITE BLOOD CELL COUNT DECREASED,451
everolimus,DYSGEUSIA,440
everolimus,ABDOMINAL DISTENSION,439
everolimus,RESPIRATORY FAILURE,431
everolimus,FEELING ABNORMAL,426
everolimus,PRODUCT USE ISSUE,424
everolimus,DRY SKIN,421
everolimus,GAIT DISTURBANCE,413
everolimus,OROPHARYNGEAL PAIN,405
everolimus,CONFUSIONAL STATE,401
everolimus,OSTEONECROSIS OF JAW,399
everolimus,DYSPHAGIA,398
everolimus,ALOPECIA,391
everolimus,C-REACTIVE PROTEIN INCREASED,390
everolimus,BONE PAIN,389
everolimus,OEDEMA,388
everolimus,PULMONARY EMBOLISM,388
everolimus,ANXIETY,385
everolimus,COVID-19,382
everolimus,CHILLS,379
vinorelbine,NEUTROPENIA,995
vinorelbine,MALIGNANT NEOPLASM PROGRESSION,954
vinorelbine,DISEASE PROGRESSION,884
vinorelbine,OFF LABEL USE,855
vinorelbine,NAUSEA,778
vinorelbine,DIARRHOEA,721
vinorelbine,FATIGUE,671
vinorelbine,DEATH,608
vinorelbine,VOMITING,578
vinorelbine,ANAEMIA,545
vinorelbine,FEBRILE NEUTROPENIA,537
vinorelbine,DYSPNOEA,528
vinorelbine,PYREXIA,526
vinorelbine,DRUG INEFFECTIVE,489
vinorelbine,THROMBOCYTOPENIA,475
vinorelbine,ASTHENIA,433
vinorelbine,DECREASED APPETITE,332
vinorelbine,NEUROPATHY PERIPHERAL,327
vinorelbine,CONSTIPATION,323
vinorelbine,COUGH,323
vinorelbine,PNEUMONIA,312
vinorelbine,METASTASES TO LIVER,311
vinorelbine,METASTASES TO BONE,306
vinorelbine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,295
vinorelbine,BREAST CANCER METASTATIC,286
vinorelbine,PAIN,278
vinorelbine,NEOPLASM PROGRESSION,277
vinorelbine,PLEURAL EFFUSION,276
vinorelbine,MUCOSAL INFLAMMATION,274
vinorelbine,PRODUCT USE IN UNAPPROVED INDICATION,269
vinorelbine,RASH,260
vinorelbine,LEUKOPENIA,259
vinorelbine,BREAST CANCER,254
vinorelbine,GENERAL PHYSICAL HEALTH DETERIORATION,238
vinorelbine,HEADACHE,231
vinorelbine,WEIGHT DECREASED,222
vinorelbine,ABDOMINAL PAIN,209
vinorelbine,METASTASES TO LUNG,208
vinorelbine,ALOPECIA,207
vinorelbine,SEPSIS,196
vinorelbine,PULMONARY EMBOLISM,193
vinorelbine,PANCYTOPENIA,186
vinorelbine,DIZZINESS,182
vinorelbine,METASTASES TO CENTRAL NERVOUS SYSTEM,181
vinorelbine,INFECTION,180
vinorelbine,NEUTROPENIC SEPSIS,179
vinorelbine,STOMATITIS,177
vinorelbine,BONE MARROW FAILURE,173
vinorelbine,WHITE BLOOD CELL COUNT DECREASED,171
vinorelbine,MALAISE,164
vinorelbine,OSTEONECROSIS OF JAW,162
vinorelbine,ACUTE KIDNEY INJURY,160
vinorelbine,ASCITES,156
vinorelbine,METASTASES TO LYMPH NODES,150
vinorelbine,HAEMATOTOXICITY,148
vinorelbine,BACK PAIN,145
vinorelbine,PNEUMONITIS,144
vinorelbine,DEHYDRATION,139
vinorelbine,EJECTION FRACTION DECREASED,139
vinorelbine,CHEST PAIN,137
vinorelbine,ALANINE AMINOTRANSFERASE INCREASED,136
vinorelbine,PAIN IN EXTREMITY,136
vinorelbine,HYPERTENSION,130
vinorelbine,INTERSTITIAL LUNG DISEASE,124
vinorelbine,SEPTIC SHOCK,124
vinorelbine,PARAESTHESIA,123
vinorelbine,ERYTHEMA,119
vinorelbine,OEDEMA PERIPHERAL,118
vinorelbine,DRUG INTOLERANCE,117
vinorelbine,CONDITION AGGRAVATED,115
vinorelbine,ARTHRALGIA,114
vinorelbine,RESPIRATORY FAILURE,114
vinorelbine,BONE PAIN,113
vinorelbine,TOXICITY TO VARIOUS AGENTS,111
vinorelbine,PLATELET COUNT DECREASED,110
vinorelbine,ASPARTATE AMINOTRANSFERASE INCREASED,109
vinorelbine,DISEASE RECURRENCE,109
vinorelbine,HYPOKALAEMIA,108
vinorelbine,PRURITUS,108
vinorelbine,HYPERSENSITIVITY,107
vinorelbine,DYSPNOEA EXERTIONAL,105
vinorelbine,HYPOAESTHESIA,105
vinorelbine,HYPOTENSION,105
vinorelbine,MYELOSUPPRESSION,104
vinorelbine,CONFUSIONAL STATE,100
vinorelbine,HAEMOGLOBIN DECREASED,100
vinorelbine,OSTEONECROSIS,100
vinorelbine,NEUTROPHIL COUNT DECREASED,99
vinorelbine,PERIPHERAL SWELLING,94
vinorelbine,HEPATOTOXICITY,93
vinorelbine,DYSPEPSIA,92
vinorelbine,DYSPHAGIA,92
vinorelbine,DRUG RESISTANCE,90
vinorelbine,BLOOD CREATININE INCREASED,88
vinorelbine,CHILLS,86
vinorelbine,ABDOMINAL PAIN UPPER,85
vinorelbine,RENAL IMPAIRMENT,84
vinorelbine,BLOOD LACTATE DEHYDROGENASE INCREASED,82
vinorelbine,CARDIAC FAILURE,82
vinorelbine,DEEP VEIN THROMBOSIS,82
pemetrexed,MALIGNANT NEOPLASM PROGRESSION,2568
pemetrexed,OFF LABEL USE,1772
pemetrexed,ANAEMIA,1699
pemetrexed,NAUSEA,1563
pemetrexed,DEATH,1497
pemetrexed,DIARRHOEA,1463
pemetrexed,NEUTROPENIA,1356
pemetrexed,THROMBOCYTOPENIA,1289
pemetrexed,PANCYTOPENIA,1232
pemetrexed,FATIGUE,1226
pemetrexed,VOMITING,1173
pemetrexed,DYSPNOEA,1146
pemetrexed,PYREXIA,1059
pemetrexed,DISEASE PROGRESSION,1011
pemetrexed,PNEUMONIA,993
pemetrexed,FEBRILE NEUTROPENIA,955
pemetrexed,RASH,931
pemetrexed,ASTHENIA,906
pemetrexed,DECREASED APPETITE,827
pemetrexed,ACUTE KIDNEY INJURY,824
pemetrexed,GENERAL PHYSICAL HEALTH DETERIORATION,794
pemetrexed,DRUG INEFFECTIVE,722
pemetrexed,INTERSTITIAL LUNG DISEASE,662
pemetrexed,DEHYDRATION,611
pemetrexed,RENAL FAILURE,580
pemetrexed,PLATELET COUNT DECREASED,577
pemetrexed,PLEURAL EFFUSION,571
pemetrexed,SEPSIS,560
pemetrexed,CONSTIPATION,529
pemetrexed,PNEUMONITIS,521
pemetrexed,PULMONARY EMBOLISM,514
pemetrexed,LEUKOPENIA,498
pemetrexed,NEOPLASM PROGRESSION,481
pemetrexed,RESPIRATORY FAILURE,458
pemetrexed,WHITE BLOOD CELL COUNT DECREASED,457
pemetrexed,MUCOSAL INFLAMMATION,438
pemetrexed,BONE MARROW FAILURE,416
pemetrexed,RENAL IMPAIRMENT,416
pemetrexed,COUGH,389
pemetrexed,BLOOD CREATININE INCREASED,388
pemetrexed,NEUTROPHIL COUNT DECREASED,380
pemetrexed,HAEMOGLOBIN DECREASED,371
pemetrexed,WEIGHT DECREASED,371
pemetrexed,HYPOTENSION,361
pemetrexed,MALAISE,360
pemetrexed,PAIN,348
pemetrexed,OEDEMA PERIPHERAL,342
pemetrexed,HYPERTENSION,336
pemetrexed,ABDOMINAL PAIN,331
pemetrexed,DIZZINESS,328
pemetrexed,MYELOSUPPRESSION,322
pemetrexed,HEADACHE,321
pemetrexed,SEPTIC SHOCK,310
pemetrexed,EPISTAXIS,306
pemetrexed,PRURITUS,302
pemetrexed,TUBULOINTERSTITIAL NEPHRITIS,299
pemetrexed,COLITIS,295
pemetrexed,HAEMOPTYSIS,287
pemetrexed,INFECTION,284
pemetrexed,CHEST PAIN,282
pemetrexed,ERYTHEMA,282
pemetrexed,CONDITION AGGRAVATED,279
pemetrexed,DRUG RESISTANCE,277
pemetrexed,HYPOKALAEMIA,277
pemetrexed,HYPONATRAEMIA,271
pemetrexed,NON-SMALL CELL LUNG CANCER,269
pemetrexed,ATRIAL FIBRILLATION,268
pemetrexed,ALANINE AMINOTRANSFERASE INCREASED,262
pemetrexed,NEUROPATHY PERIPHERAL,256
pemetrexed,THERAPY PARTIAL RESPONDER,253
pemetrexed,ASPARTATE AMINOTRANSFERASE INCREASED,251
pemetrexed,STOMATITIS,248
pemetrexed,CONFUSIONAL STATE,243
pemetrexed,BACK PAIN,237
pemetrexed,METASTASES TO CENTRAL NERVOUS SYSTEM,230
pemetrexed,HEPATIC FUNCTION ABNORMAL,228
pemetrexed,DYSPHAGIA,226
pemetrexed,DEEP VEIN THROMBOSIS,223
pemetrexed,PRODUCT USE IN UNAPPROVED INDICATION,220
pemetrexed,TOXICITY TO VARIOUS AGENTS,220
pemetrexed,HEPATITIS,219
pemetrexed,HAEMATOTOXICITY,218
pemetrexed,RENAL FAILURE ACUTE,217
pemetrexed,ARTHRALGIA,215
pemetrexed,LUNG DISORDER,195
pemetrexed,MYOCARDIAL INFARCTION,191
pemetrexed,PERICARDIAL EFFUSION,186
pemetrexed,TACHYCARDIA,183
pemetrexed,CARDIAC FAILURE,182
pemetrexed,CEREBROVASCULAR ACCIDENT,182
pemetrexed,HEPATOCELLULAR INJURY,182
pemetrexed,C-REACTIVE PROTEIN INCREASED,176
pemetrexed,DRUG INTERACTION,176
pemetrexed,HYPOTHYROIDISM,176
pemetrexed,ALOPECIA,171
pemetrexed,FEBRILE BONE MARROW APLASIA,171
pemetrexed,NEPHROPATHY TOXIC,171
pemetrexed,HEPATOTOXICITY,168
pemetrexed,PROTEINURIA,168
pemetrexed,SYNCOPE,167
binimetinib,OFF LABEL USE,733
binimetinib,DEATH,583
binimetinib,NAUSEA,548
binimetinib,PRODUCT USE IN UNAPPROVED INDICATION,510
binimetinib,FATIGUE,464
binimetinib,DIARRHOEA,431
binimetinib,PYREXIA,409
binimetinib,RASH,322
binimetinib,VOMITING,319
binimetinib,NEOPLASM PROGRESSION,318
binimetinib,SEROUS RETINAL DETACHMENT,209
binimetinib,DISEASE PROGRESSION,198
binimetinib,ARTHRALGIA,172
binimetinib,MALAISE,164
binimetinib,DECREASED APPETITE,162
binimetinib,VISION BLURRED,161
binimetinib,CONSTIPATION,141
binimetinib,ACUTE KIDNEY INJURY,137
binimetinib,ASTHENIA,129
binimetinib,VISUAL IMPAIRMENT,128
binimetinib,ANAEMIA,120
binimetinib,PAIN,111
binimetinib,DYSPNOEA,108
binimetinib,ABDOMINAL PAIN,106
binimetinib,MYALGIA,104
binimetinib,HEADACHE,103
binimetinib,PRURITUS,100
binimetinib,MALIGNANT NEOPLASM PROGRESSION,99
binimetinib,COLITIS,93
binimetinib,CHILLS,88
binimetinib,DEHYDRATION,83
binimetinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,82
binimetinib,DIZZINESS,79
binimetinib,DRUG INEFFECTIVE,78
binimetinib,ABDOMINAL PAIN UPPER,77
binimetinib,HYPOTENSION,73
binimetinib,ALOPECIA,72
binimetinib,ALANINE AMINOTRANSFERASE INCREASED,69
binimetinib,SEIZURE,67
binimetinib,PRODUCT DOSE OMISSION,65
binimetinib,WEIGHT DECREASED,65
binimetinib,RENAL IMPAIRMENT,64
binimetinib,URINARY TRACT INFECTION,63
binimetinib,ASPARTATE AMINOTRANSFERASE INCREASED,61
binimetinib,HEPATIC FUNCTION ABNORMAL,61
binimetinib,RETINAL DETACHMENT,61
binimetinib,BLOOD CREATININE INCREASED,60
binimetinib,ABDOMINAL DISCOMFORT,59
binimetinib,LIVER DISORDER,59
binimetinib,PERIPHERAL SWELLING,58
binimetinib,DYSPHAGIA,57
binimetinib,PAIN IN EXTREMITY,56
binimetinib,RENAL FAILURE,55
binimetinib,HYPERTENSION,53
binimetinib,SECOND PRIMARY MALIGNANCY,53
binimetinib,HEPATIC ENZYME INCREASED,51
binimetinib,CONFUSIONAL STATE,50
binimetinib,DRY SKIN,50
binimetinib,MUSCLE SPASMS,49
binimetinib,DRUG INTOLERANCE,48
binimetinib,NEUROPATHY PERIPHERAL,48
binimetinib,UVEITIS,48
binimetinib,PNEUMONIA,47
binimetinib,ILLNESS,45
binimetinib,BACK PAIN,44
binimetinib,SEROUS RETINOPATHY,44
binimetinib,GENERAL PHYSICAL HEALTH DETERIORATION,42
binimetinib,RASH MACULO-PAPULAR,42
binimetinib,FALL,40
binimetinib,MUSCULAR WEAKNESS,40
binimetinib,PRODUCT USE ISSUE,39
binimetinib,HOSPICE CARE,37
binimetinib,RENAL DISORDER,37
binimetinib,SEPSIS,37
binimetinib,COVID-19,34
binimetinib,DERMATITIS ACNEIFORM,34
binimetinib,INTERSTITIAL LUNG DISEASE,34
binimetinib,LIVER FUNCTION TEST INCREASED,34
binimetinib,PNEUMONITIS,34
binimetinib,ADVERSE EVENT,33
binimetinib,ERYTHEMA,33
binimetinib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,33
binimetinib,HYPERSENSITIVITY,33
binimetinib,PRODUCT DOSE OMISSION ISSUE,33
binimetinib,THERAPY INTERRUPTED,33
binimetinib,COUGH,32
binimetinib,HEPATITIS,32
binimetinib,INFECTION,32
binimetinib,MEMORY IMPAIRMENT,32
binimetinib,SOMNOLENCE,32
binimetinib,CARDIAC FAILURE,31
binimetinib,EYE DISORDER,31
binimetinib,INSOMNIA,31
binimetinib,OEDEMA PERIPHERAL,31
binimetinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,31
binimetinib,RETINOPATHY,31
binimetinib,ADVERSE DRUG REACTION,30
binimetinib,PANCREATITIS,30
binimetinib,EJECTION FRACTION DECREASED,29
binimetinib,HYPOACUSIS,29
carboplatin,NAUSEA,6181
carboplatin,ALOPECIA,6094
carboplatin,NEUTROPENIA,6012
carboplatin,ANAEMIA,5981
carboplatin,OFF LABEL USE,5968
carboplatin,FEBRILE NEUTROPENIA,5338
carboplatin,DIARRHOEA,5201
carboplatin,DYSPNOEA,5016
carboplatin,THROMBOCYTOPENIA,4947
carboplatin,MALIGNANT NEOPLASM PROGRESSION,4826
carboplatin,DISEASE PROGRESSION,4714
carboplatin,VOMITING,4653
carboplatin,PYREXIA,4083
carboplatin,FATIGUE,4005
carboplatin,DEATH,3833
carboplatin,ASTHENIA,3070
carboplatin,DRUG INEFFECTIVE,3024
carboplatin,PANCYTOPENIA,2890
carboplatin,PNEUMONIA,2723
carboplatin,RASH,2497
carboplatin,SEPSIS,2453
carboplatin,DECREASED APPETITE,2321
carboplatin,NEUTROPHIL COUNT DECREASED,2303
carboplatin,DEHYDRATION,2257
carboplatin,PLATELET COUNT DECREASED,2247
carboplatin,ABDOMINAL PAIN,2192
carboplatin,WHITE BLOOD CELL COUNT DECREASED,2142
carboplatin,PRODUCT USE IN UNAPPROVED INDICATION,2140
carboplatin,HAIR TEXTURE ABNORMAL,2091
carboplatin,HAIR COLOUR CHANGES,2088
carboplatin,ERYTHEMA,2080
carboplatin,HYPOTENSION,2063
carboplatin,PAIN,2024
carboplatin,NEUROPATHY PERIPHERAL,2014
carboplatin,HAIR DISORDER,1948
carboplatin,MADAROSIS,1935
carboplatin,CONSTIPATION,1889
carboplatin,LEUKOPENIA,1882
carboplatin,GENERAL PHYSICAL HEALTH DETERIORATION,1821
carboplatin,ACUTE KIDNEY INJURY,1797
carboplatin,PSYCHOLOGICAL TRAUMA,1793
carboplatin,MALAISE,1616
carboplatin,MUCOSAL INFLAMMATION,1584
carboplatin,PRURITUS,1556
carboplatin,COUGH,1516
carboplatin,HYPERTENSION,1515
carboplatin,MYELOSUPPRESSION,1515
carboplatin,ANXIETY,1488
carboplatin,HYPERSENSITIVITY,1466
carboplatin,INFECTION,1448
carboplatin,PULMONARY EMBOLISM,1405
carboplatin,HAEMOGLOBIN DECREASED,1382
carboplatin,HYPOKALAEMIA,1381
carboplatin,PLEURAL EFFUSION,1375
carboplatin,DIZZINESS,1364
carboplatin,INTERSTITIAL LUNG DISEASE,1350
carboplatin,RESPIRATORY FAILURE,1235
carboplatin,NEOPLASM PROGRESSION,1225
carboplatin,CHEST PAIN,1224
carboplatin,WEIGHT DECREASED,1172
carboplatin,HEADACHE,1168
carboplatin,BONE MARROW FAILURE,1118
carboplatin,BACK PAIN,1114
carboplatin,HYPONATRAEMIA,1103
carboplatin,RENAL FAILURE,1102
carboplatin,TACHYCARDIA,1091
carboplatin,FLUSHING,1085
carboplatin,PNEUMONITIS,1068
carboplatin,SEPTIC SHOCK,1053
carboplatin,ATRIAL FIBRILLATION,1048
carboplatin,ARTHRALGIA,1019
carboplatin,EMOTIONAL DISTRESS,982
carboplatin,DYSPHAGIA,966
carboplatin,URINARY TRACT INFECTION,961
carboplatin,CONDITION AGGRAVATED,946
carboplatin,INFUSION RELATED REACTION,901
carboplatin,DEEP VEIN THROMBOSIS,890
carboplatin,EPISTAXIS,890
carboplatin,TOXICITY TO VARIOUS AGENTS,884
carboplatin,CONFUSIONAL STATE,867
carboplatin,CHILLS,861
carboplatin,PARAESTHESIA,861
carboplatin,RENAL IMPAIRMENT,860
carboplatin,COLITIS,853
carboplatin,ACUTE MYELOID LEUKAEMIA,846
carboplatin,NEUTROPENIC SEPSIS,832
carboplatin,OEDEMA PERIPHERAL,820
carboplatin,HAEMATOTOXICITY,816
carboplatin,BLOOD CREATININE INCREASED,812
carboplatin,ALANINE AMINOTRANSFERASE INCREASED,808
carboplatin,CHEST DISCOMFORT,779
carboplatin,STOMATITIS,765
carboplatin,SYNCOPE,758
carboplatin,PAIN IN EXTREMITY,749
carboplatin,THERAPY PARTIAL RESPONDER,746
carboplatin,DISEASE RECURRENCE,732
carboplatin,OXYGEN SATURATION DECREASED,726
carboplatin,ASPARTATE AMINOTRANSFERASE INCREASED,710
carboplatin,MYELODYSPLASTIC SYNDROME,709
carboplatin,HYPOMAGNESAEMIA,708
abiraterone,DEATH,5849
abiraterone,FATIGUE,2160
abiraterone,PROSTATIC SPECIFIC ANTIGEN INCREASED,1938
abiraterone,DRUG INEFFECTIVE,1901
abiraterone,THERAPY CESSATION,1582
abiraterone,DISEASE PROGRESSION,1200
abiraterone,ASTHENIA,1078
abiraterone,HOSPITALISATION,1009
abiraterone,HOT FLUSH,1000
abiraterone,OFF LABEL USE,939
abiraterone,NAUSEA,926
abiraterone,DIARRHOEA,845
abiraterone,FALL,845
abiraterone,PROSTATE CANCER,807
abiraterone,DIZZINESS,745
abiraterone,DYSPNOEA,727
abiraterone,DECREASED APPETITE,711
abiraterone,PNEUMONIA,696
abiraterone,HYPERTENSION,693
abiraterone,URINARY TRACT INFECTION,688
abiraterone,MALIGNANT NEOPLASM PROGRESSION,663
abiraterone,HYPOKALAEMIA,621
abiraterone,VOMITING,620
abiraterone,PROSTATE CANCER METASTATIC,598
abiraterone,PAIN,576
abiraterone,ANAEMIA,568
abiraterone,DRUG DOSE OMISSION,557
abiraterone,WEIGHT DECREASED,544
abiraterone,MALAISE,540
abiraterone,ARTHRALGIA,489
abiraterone,CONSTIPATION,482
abiraterone,OEDEMA PERIPHERAL,480
abiraterone,INCORRECT DOSE ADMINISTERED,473
abiraterone,THERAPY INTERRUPTED,473
abiraterone,BACK PAIN,459
abiraterone,HEADACHE,428
abiraterone,PERIPHERAL SWELLING,420
abiraterone,DYSPHAGIA,403
abiraterone,ADVERSE EVENT,385
abiraterone,DEHYDRATION,376
abiraterone,PAIN IN EXTREMITY,371
abiraterone,METASTASES TO BONE,364
abiraterone,SEPSIS,358
abiraterone,WEIGHT INCREASED,355
abiraterone,ATRIAL FIBRILLATION,349
abiraterone,MYOCARDIAL INFARCTION,332
abiraterone,MUSCULAR WEAKNESS,331
abiraterone,BLOOD PRESSURE INCREASED,330
abiraterone,PYREXIA,329
abiraterone,GENERAL PHYSICAL HEALTH DETERIORATION,307
abiraterone,THROMBOCYTOPENIA,305
abiraterone,DRUG INTERACTION,301
abiraterone,ACUTE KIDNEY INJURY,298
abiraterone,CARDIAC FAILURE,298
abiraterone,RASH,294
abiraterone,CONFUSIONAL STATE,289
abiraterone,CEREBROVASCULAR ACCIDENT,284
abiraterone,INSOMNIA,271
abiraterone,BLOOD GLUCOSE INCREASED,256
abiraterone,ALANINE AMINOTRANSFERASE INCREASED,246
abiraterone,HOSPICE CARE,245
abiraterone,CHEST PAIN,242
abiraterone,OSTEONECROSIS OF JAW,240
abiraterone,HYPOTENSION,239
abiraterone,BLOOD POTASSIUM DECREASED,233
abiraterone,COVID-19,232
abiraterone,SYNCOPE,229
abiraterone,COUGH,226
abiraterone,HAEMATURIA,223
abiraterone,ADVERSE DRUG REACTION,221
abiraterone,BONE PAIN,221
abiraterone,MUSCLE SPASMS,218
abiraterone,MYALGIA,218
abiraterone,OEDEMA,217
abiraterone,FEELING ABNORMAL,216
abiraterone,HEPATIC ENZYME INCREASED,216
abiraterone,HAEMOGLOBIN DECREASED,215
abiraterone,ABDOMINAL PAIN,209
abiraterone,PLATELET COUNT DECREASED,209
abiraterone,RENAL FAILURE,209
abiraterone,ABDOMINAL DISCOMFORT,204
abiraterone,PRODUCT DOSE OMISSION,204
abiraterone,INFECTION,199
abiraterone,HEPATIC FUNCTION ABNORMAL,198
abiraterone,RHABDOMYOLYSIS,197
abiraterone,DIABETES MELLITUS,195
abiraterone,GAIT DISTURBANCE,194
abiraterone,ABDOMINAL PAIN UPPER,191
abiraterone,PULMONARY EMBOLISM,190
abiraterone,FLUID RETENTION,189
abiraterone,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,189
abiraterone,CARDIAC DISORDER,186
abiraterone,ASPARTATE AMINOTRANSFERASE INCREASED,185
abiraterone,CONDITION AGGRAVATED,178
abiraterone,HYPERHIDROSIS,178
abiraterone,BLOOD ALKALINE PHOSPHATASE INCREASED,177
abiraterone,JOINT SWELLING,177
abiraterone,CARDIAC FAILURE CONGESTIVE,169
abiraterone,LIVER DISORDER,164
abiraterone,PLEURAL EFFUSION,164
denosumab,OFF LABEL USE,35462
denosumab,DEATH,18647
denosumab,OSTEONECROSIS OF JAW,8933
denosumab,ARTHRALGIA,7972
denosumab,FATIGUE,6479
denosumab,PAIN IN EXTREMITY,6463
denosumab,BACK PAIN,6328
denosumab,PAIN,6285
denosumab,NAUSEA,4628
denosumab,FALL,4433
denosumab,DIARRHOEA,4416
denosumab,RASH,3888
denosumab,MYALGIA,3884
denosumab,BONE PAIN,3719
denosumab,ASTHENIA,3527
denosumab,MALAISE,3441
denosumab,DYSPNOEA,3191
denosumab,HEADACHE,3074
denosumab,HYPOCALCAEMIA,3031
denosumab,TOOTH DISORDER,2941
denosumab,PRODUCT STORAGE ERROR,2746
denosumab,DRUG INEFFECTIVE,2633
denosumab,PRURITUS,2572
denosumab,DIZZINESS,2557
denosumab,PAIN IN JAW,2533
denosumab,SPINAL FRACTURE,2399
denosumab,MUSCLE SPASMS,2357
denosumab,PNEUMONIA,2312
denosumab,URINARY TRACT INFECTION,2289
denosumab,HOSPITALISATION,2286
denosumab,VOMITING,2244
denosumab,WEIGHT DECREASED,2225
denosumab,GAIT DISTURBANCE,2169
denosumab,ALOPECIA,2143
denosumab,DECREASED APPETITE,2143
denosumab,PYREXIA,2118
denosumab,CONSTIPATION,1936
denosumab,MALIGNANT NEOPLASM PROGRESSION,1884
denosumab,ANAEMIA,1753
denosumab,COUGH,1749
denosumab,MUSCULOSKELETAL PAIN,1728
denosumab,HYPERTENSION,1722
denosumab,FEELING ABNORMAL,1669
denosumab,INSOMNIA,1647
denosumab,PARAESTHESIA,1604
denosumab,MOBILITY DECREASED,1572
denosumab,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1541
denosumab,METASTASES TO BONE,1541
denosumab,HYPOAESTHESIA,1505
denosumab,DRUG DOSE OMISSION,1461
denosumab,TOOTH EXTRACTION,1459
denosumab,FRACTURE,1418
denosumab,FEMUR FRACTURE,1391
denosumab,NEUTROPENIA,1385
denosumab,WHITE BLOOD CELL COUNT DECREASED,1326
denosumab,PERIPHERAL SWELLING,1278
denosumab,ERYTHEMA,1272
denosumab,ADVERSE EVENT,1255
denosumab,ADVERSE DRUG REACTION,1254
denosumab,HIP FRACTURE,1248
denosumab,ACCIDENTAL EXPOSURE TO PRODUCT,1225
denosumab,ABDOMINAL PAIN,1156
denosumab,DISEASE PROGRESSION,1156
denosumab,NASOPHARYNGITIS,1134
denosumab,TOOTHACHE,1131
denosumab,INJECTION SITE PAIN,1116
denosumab,ABDOMINAL PAIN UPPER,1090
denosumab,OSTEOPOROSIS,1075
denosumab,GENERAL PHYSICAL HEALTH DETERIORATION,1063
denosumab,ANXIETY,1045
denosumab,MUSCULAR WEAKNESS,1044
denosumab,ARTHRITIS,1023
denosumab,BONE DENSITY DECREASED,1020
denosumab,DEPRESSION,1020
denosumab,BLOOD CALCIUM DECREASED,1019
denosumab,TOOTH FRACTURE,1012
denosumab,ABDOMINAL DISCOMFORT,1011
denosumab,NEUROPATHY PERIPHERAL,1009
denosumab,INFECTION,1002
denosumab,CYSTITIS,1001
denosumab,INFLUENZA LIKE ILLNESS,1001
denosumab,IMPAIRED HEALING,987
denosumab,CEREBROVASCULAR ACCIDENT,984
denosumab,URTICARIA,980
denosumab,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,953
denosumab,UNEVALUABLE EVENT,952
denosumab,NEOPLASM PROGRESSION,947
denosumab,WEIGHT INCREASED,946
denosumab,CHEST PAIN,936
denosumab,HYPERSENSITIVITY,929
denosumab,DRY SKIN,925
denosumab,BLOOD PRESSURE INCREASED,923
denosumab,CONDITION AGGRAVATED,909
denosumab,STOMATITIS,900
denosumab,JAW DISORDER,898
denosumab,OEDEMA PERIPHERAL,896
denosumab,NECK PAIN,884
denosumab,HOT FLUSH,877
denosumab,INTERCEPTED PRODUCT ADMINISTRATION ERROR,875
denosumab,ATYPICAL FEMUR FRACTURE,872
everolimus,DEATH,6291
everolimus,MALIGNANT NEOPLASM PROGRESSION,4316
everolimus,DIARRHOEA,3867
everolimus,FATIGUE,3651
everolimus,STOMATITIS,3118
everolimus,NAUSEA,2669
everolimus,DYSPNOEA,2574
everolimus,DRUG INEFFECTIVE,2213
everolimus,PYREXIA,2195
everolimus,DECREASED APPETITE,2023
everolimus,VOMITING,2015
everolimus,COUGH,1894
everolimus,RASH,1881
everolimus,MALAISE,1865
everolimus,WEIGHT DECREASED,1831
everolimus,ASTHENIA,1826
everolimus,PNEUMONIA,1645
everolimus,PAIN,1513
everolimus,ANAEMIA,1437
everolimus,DISEASE PROGRESSION,1405
everolimus,OFF LABEL USE,1331
everolimus,HEADACHE,1322
everolimus,ABDOMINAL PAIN,1155
everolimus,METASTASES TO LIVER,1120
everolimus,PNEUMONITIS,1111
everolimus,PRODUCT USE IN UNAPPROVED INDICATION,1073
everolimus,DEHYDRATION,1051
everolimus,GENERAL PHYSICAL HEALTH DETERIORATION,1033
everolimus,NEOPLASM PROGRESSION,1016
everolimus,OEDEMA PERIPHERAL,1010
everolimus,PLEURAL EFFUSION,1010
everolimus,BLOOD PRESSURE INCREASED,967
everolimus,METASTASES TO BONE,951
everolimus,HYPERTENSION,940
everolimus,DIZZINESS,915
everolimus,ARTHRALGIA,884
everolimus,PRURITUS,848
everolimus,PERIPHERAL SWELLING,846
everolimus,HAEMOGLOBIN DECREASED,822
everolimus,BACK PAIN,817
everolimus,ABDOMINAL PAIN UPPER,799
everolimus,BLOOD GLUCOSE INCREASED,793
everolimus,CONSTIPATION,789
everolimus,BLOOD CREATININE INCREASED,778
everolimus,PAIN IN EXTREMITY,768
everolimus,THROMBOCYTOPENIA,761
everolimus,EPISTAXIS,753
everolimus,NEOPLASM MALIGNANT,748
everolimus,ORAL PAIN,737
everolimus,RENAL IMPAIRMENT,736
everolimus,ACUTE KIDNEY INJURY,730
everolimus,INTERSTITIAL LUNG DISEASE,721
everolimus,URINARY TRACT INFECTION,714
everolimus,PLATELET COUNT DECREASED,711
everolimus,MUCOSAL INFLAMMATION,701
everolimus,RENAL FAILURE,698
everolimus,BREAST CANCER,668
everolimus,BREAST CANCER METASTATIC,662
everolimus,DRUG INTERACTION,652
everolimus,SEIZURE,640
everolimus,METASTASES TO LUNG,616
everolimus,MOUTH ULCERATION,602
everolimus,NEUTROPENIA,601
everolimus,HYPERGLYCAEMIA,591
everolimus,FALL,576
everolimus,LUNG DISORDER,556
everolimus,CHEST PAIN,544
everolimus,TOXICITY TO VARIOUS AGENTS,541
everolimus,INFECTION,534
everolimus,NASOPHARYNGITIS,525
everolimus,DRUG INTOLERANCE,522
everolimus,ASCITES,509
everolimus,DIABETES MELLITUS,501
everolimus,INSOMNIA,488
everolimus,ABDOMINAL DISCOMFORT,484
everolimus,SEPSIS,482
everolimus,HYPOTENSION,480
everolimus,ERYTHEMA,476
everolimus,BLOOD CHOLESTEROL INCREASED,470
everolimus,ACNE,458
everolimus,WHITE BLOOD CELL COUNT DECREASED,451
everolimus,DYSGEUSIA,440
everolimus,ABDOMINAL DISTENSION,439
everolimus,RESPIRATORY FAILURE,431
everolimus,FEELING ABNORMAL,426
everolimus,PRODUCT USE ISSUE,424
everolimus,DRY SKIN,421
everolimus,GAIT DISTURBANCE,413
everolimus,OROPHARYNGEAL PAIN,405
everolimus,CONFUSIONAL STATE,401
everolimus,OSTEONECROSIS OF JAW,399
everolimus,DYSPHAGIA,398
everolimus,ALOPECIA,391
everolimus,C-REACTIVE PROTEIN INCREASED,390
everolimus,BONE PAIN,389
everolimus,OEDEMA,388
everolimus,PULMONARY EMBOLISM,388
everolimus,ANXIETY,385
everolimus,COVID-19,382
everolimus,CHILLS,379
filgrastim,FEBRILE NEUTROPENIA,4073
filgrastim,NEUTROPENIA,3482
filgrastim,PYREXIA,3003
filgrastim,OFF LABEL USE,2736
filgrastim,DEATH,2647
filgrastim,DIARRHOEA,2395
filgrastim,NAUSEA,2140
filgrastim,FATIGUE,1921
filgrastim,PNEUMONIA,1905
filgrastim,THROMBOCYTOPENIA,1892
filgrastim,ANAEMIA,1787
filgrastim,WHITE BLOOD CELL COUNT DECREASED,1686
filgrastim,VOMITING,1532
filgrastim,SEPSIS,1524
filgrastim,DYSPNOEA,1292
filgrastim,PANCYTOPENIA,1271
filgrastim,PLATELET COUNT DECREASED,1233
filgrastim,BONE PAIN,1122
filgrastim,ASTHENIA,1108
filgrastim,DRUG INEFFECTIVE,1103
filgrastim,INFECTION,1012
filgrastim,RASH,997
filgrastim,NEUTROPHIL COUNT DECREASED,958
filgrastim,PAIN,897
filgrastim,DISEASE PROGRESSION,873
filgrastim,HYPOTENSION,852
filgrastim,MUCOSAL INFLAMMATION,819
filgrastim,LEUKOPENIA,807
filgrastim,ABDOMINAL PAIN,799
filgrastim,DECREASED APPETITE,781
filgrastim,BACK PAIN,757
filgrastim,CONSTIPATION,737
filgrastim,HEADACHE,736
filgrastim,MALAISE,736
filgrastim,HAEMOGLOBIN DECREASED,727
filgrastim,COUGH,720
filgrastim,SEPTIC SHOCK,693
filgrastim,NEUROPATHY PERIPHERAL,650
filgrastim,WEIGHT DECREASED,622
filgrastim,ARTHRALGIA,617
filgrastim,ACUTE KIDNEY INJURY,609
filgrastim,DIZZINESS,584
filgrastim,STOMATITIS,566
filgrastim,DEHYDRATION,564
filgrastim,RESPIRATORY FAILURE,562
filgrastim,PRODUCT USE IN UNAPPROVED INDICATION,552
filgrastim,ALOPECIA,541
filgrastim,PLEURAL EFFUSION,541
filgrastim,HYPOKALAEMIA,540
filgrastim,RENAL FAILURE,501
filgrastim,PRURITUS,488
filgrastim,URINARY TRACT INFECTION,480
filgrastim,BACTERIAL INFECTION,474
filgrastim,CHEST PAIN,463
filgrastim,BONE MARROW FAILURE,462
filgrastim,CONDITION AGGRAVATED,447
filgrastim,CHILLS,444
filgrastim,ATRIAL FIBRILLATION,439
filgrastim,HYPOXIA,436
filgrastim,GENERAL PHYSICAL HEALTH DETERIORATION,435
filgrastim,PAIN IN EXTREMITY,433
filgrastim,ACUTE MYELOID LEUKAEMIA,423
filgrastim,CELLULITIS,421
filgrastim,CLOSTRIDIUM DIFFICILE COLITIS,403
filgrastim,MALIGNANT NEOPLASM PROGRESSION,401
filgrastim,OEDEMA PERIPHERAL,395
filgrastim,NEUTROPENIC SEPSIS,393
filgrastim,HYPERTENSION,391
filgrastim,INSOMNIA,389
filgrastim,CYTOKINE RELEASE SYNDROME,385
filgrastim,MYALGIA,378
filgrastim,DEEP VEIN THROMBOSIS,375
filgrastim,TACHYCARDIA,369
filgrastim,PLASMA CELL MYELOMA,366
filgrastim,ALANINE AMINOTRANSFERASE INCREASED,363
filgrastim,PULMONARY EMBOLISM,363
filgrastim,MYELODYSPLASTIC SYNDROME,353
filgrastim,HOSPITALISATION,352
filgrastim,EPISTAXIS,346
filgrastim,CARDIAC FAILURE,344
filgrastim,CONFUSIONAL STATE,343
filgrastim,HYPONATRAEMIA,341
filgrastim,ERYTHEMA,339
filgrastim,FALL,336
filgrastim,SYNCOPE,326
filgrastim,WHITE BLOOD CELL COUNT INCREASED,326
filgrastim,MULTIPLE ORGAN DYSFUNCTION SYNDROME,324
filgrastim,FUNGAL INFECTION,319
filgrastim,PRODUCT STORAGE ERROR,317
filgrastim,BLOOD CREATININE INCREASED,316
filgrastim,INTERSTITIAL LUNG DISEASE,309
filgrastim,COVID-19,308
filgrastim,CYTOMEGALOVIRUS INFECTION,308
filgrastim,ASPARTATE AMINOTRANSFERASE INCREASED,306
filgrastim,THROMBOSIS,297
filgrastim,VIRAL INFECTION,295
filgrastim,ABDOMINAL PAIN UPPER,294
filgrastim,COLITIS,293
filgrastim,AGRANULOCYTOSIS,291
filgrastim,RENAL IMPAIRMENT,291
fluorouracil,DIARRHOEA,7832
fluorouracil,NAUSEA,5712
fluorouracil,NEUTROPENIA,5712
fluorouracil,VOMITING,4620
fluorouracil,PYREXIA,3502
fluorouracil,FATIGUE,3457
fluorouracil,OFF LABEL USE,3348
fluorouracil,THROMBOCYTOPENIA,3300
fluorouracil,DISEASE PROGRESSION,3224
fluorouracil,NEUROPATHY PERIPHERAL,3168
fluorouracil,FEBRILE NEUTROPENIA,3161
fluorouracil,ANAEMIA,2940
fluorouracil,ASTHENIA,2871
fluorouracil,DEATH,2788
fluorouracil,DECREASED APPETITE,2387
fluorouracil,DYSPNOEA,2345
fluorouracil,ABDOMINAL PAIN,2253
fluorouracil,MUCOSAL INFLAMMATION,2221
fluorouracil,MALIGNANT NEOPLASM PROGRESSION,2176
fluorouracil,DEHYDRATION,2025
fluorouracil,LEUKOPENIA,1929
fluorouracil,STOMATITIS,1859
fluorouracil,DRUG INEFFECTIVE,1779
fluorouracil,RASH,1747
fluorouracil,GENERAL PHYSICAL HEALTH DETERIORATION,1590
fluorouracil,PULMONARY EMBOLISM,1542
fluorouracil,SEPSIS,1496
fluorouracil,HYPERTENSION,1475
fluorouracil,MALAISE,1403
fluorouracil,PNEUMONIA,1368
fluorouracil,PAIN,1347
fluorouracil,ALOPECIA,1338
fluorouracil,HYPOTENSION,1296
fluorouracil,INTERSTITIAL LUNG DISEASE,1288
fluorouracil,ACUTE KIDNEY INJURY,1281
fluorouracil,PARAESTHESIA,1218
fluorouracil,WEIGHT DECREASED,1212
fluorouracil,WHITE BLOOD CELL COUNT DECREASED,1199
fluorouracil,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1192
fluorouracil,NEUTROPHIL COUNT DECREASED,1179
fluorouracil,CONSTIPATION,1142
fluorouracil,HYPOKALAEMIA,1126
fluorouracil,CHEST PAIN,1070
fluorouracil,NEUROTOXICITY,1069
fluorouracil,ERYTHEMA,1050
fluorouracil,NEOPLASM PROGRESSION,1048
fluorouracil,DIZZINESS,1041
fluorouracil,CHILLS,1039
fluorouracil,METASTASES TO LIVER,1013
fluorouracil,PLATELET COUNT DECREASED,1011
fluorouracil,TOXICITY TO VARIOUS AGENTS,999
fluorouracil,HEADACHE,898
fluorouracil,DEEP VEIN THROMBOSIS,892
fluorouracil,HAEMOGLOBIN DECREASED,876
fluorouracil,RENAL FAILURE,874
fluorouracil,HYPERSENSITIVITY,862
fluorouracil,SEPTIC SHOCK,856
fluorouracil,BONE MARROW FAILURE,841
fluorouracil,DERMATITIS ACNEIFORM,804
fluorouracil,INFECTION,803
fluorouracil,PRODUCT USE IN UNAPPROVED INDICATION,799
fluorouracil,PANCYTOPENIA,796
fluorouracil,PRURITUS,792
fluorouracil,CONDITION AGGRAVATED,788
fluorouracil,SKIN TOXICITY,742
fluorouracil,RESPIRATORY FAILURE,736
fluorouracil,COUGH,720
fluorouracil,DYSPHAGIA,717
fluorouracil,BACK PAIN,714
fluorouracil,EPISTAXIS,711
fluorouracil,MYELOSUPPRESSION,684
fluorouracil,PLEURAL EFFUSION,679
fluorouracil,ABDOMINAL PAIN UPPER,671
fluorouracil,HYPOMAGNESAEMIA,653
fluorouracil,TACHYCARDIA,653
fluorouracil,ATRIAL FIBRILLATION,649
fluorouracil,ASCITES,647
fluorouracil,CARDIAC FAILURE,643
fluorouracil,HYPONATRAEMIA,643
fluorouracil,PROTEINURIA,623
fluorouracil,URINARY TRACT INFECTION,612
fluorouracil,METASTASES TO LUNG,609
fluorouracil,INTESTINAL OBSTRUCTION,598
fluorouracil,RENAL IMPAIRMENT,595
fluorouracil,FALL,593
fluorouracil,OEDEMA PERIPHERAL,586
fluorouracil,POLYNEUROPATHY,574
fluorouracil,BLOOD CREATININE INCREASED,560
fluorouracil,CONFUSIONAL STATE,549
fluorouracil,SYNCOPE,536
fluorouracil,HAEMATOTOXICITY,534
fluorouracil,PERIPHERAL SENSORY NEUROPATHY,534
fluorouracil,COLITIS,523
fluorouracil,CARDIOTOXICITY,514
fluorouracil,HYPOAESTHESIA,511
fluorouracil,ALANINE AMINOTRANSFERASE INCREASED,510
fluorouracil,ARTHRALGIA,510
fluorouracil,INFUSION RELATED REACTION,506
fluorouracil,HAEMORRHAGE,504
fluorouracil,LOSS OF CONSCIOUSNESS,500
doxorubicin,FEBRILE NEUTROPENIA,10127
doxorubicin,OFF LABEL USE,8261
doxorubicin,NEUTROPENIA,7372
doxorubicin,DISEASE PROGRESSION,5960
doxorubicin,ALOPECIA,5353
doxorubicin,PYREXIA,5064
doxorubicin,DRUG INEFFECTIVE,4296
doxorubicin,ANAEMIA,4250
doxorubicin,THROMBOCYTOPENIA,4242
doxorubicin,NAUSEA,4190
doxorubicin,DEATH,3789
doxorubicin,PRODUCT USE IN UNAPPROVED INDICATION,3366
doxorubicin,SEPSIS,3363
doxorubicin,PNEUMONIA,3314
doxorubicin,VOMITING,3294
doxorubicin,DIARRHOEA,3293
doxorubicin,FATIGUE,3060
doxorubicin,DYSPNOEA,2749
doxorubicin,INFECTION,2582
doxorubicin,PANCYTOPENIA,2574
doxorubicin,MUCOSAL INFLAMMATION,2471
doxorubicin,MALIGNANT NEOPLASM PROGRESSION,2437
doxorubicin,NEUROPATHY PERIPHERAL,2413
doxorubicin,PAIN,2254
doxorubicin,ASTHENIA,2137
doxorubicin,PSYCHOLOGICAL TRAUMA,2130
doxorubicin,WHITE BLOOD CELL COUNT DECREASED,1905
doxorubicin,LEUKOPENIA,1856
doxorubicin,ACUTE MYELOID LEUKAEMIA,1731
doxorubicin,SEPTIC SHOCK,1700
doxorubicin,ABDOMINAL PAIN,1673
doxorubicin,INTERSTITIAL LUNG DISEASE,1660
doxorubicin,PLATELET COUNT DECREASED,1657
doxorubicin,HYPOTENSION,1620
doxorubicin,MYELODYSPLASTIC SYNDROME,1559
doxorubicin,CARDIAC FAILURE,1526
doxorubicin,TOXICITY TO VARIOUS AGENTS,1494
doxorubicin,ANXIETY,1464
doxorubicin,NEUTROPHIL COUNT DECREASED,1464
doxorubicin,CONSTIPATION,1454
doxorubicin,RESPIRATORY FAILURE,1444
doxorubicin,DECREASED APPETITE,1404
doxorubicin,ACUTE KIDNEY INJURY,1371
doxorubicin,BONE MARROW FAILURE,1370
doxorubicin,STOMATITIS,1367
doxorubicin,PRODUCT USE ISSUE,1336
doxorubicin,GENERAL PHYSICAL HEALTH DETERIORATION,1330
doxorubicin,HAIR COLOUR CHANGES,1329
doxorubicin,HAIR TEXTURE ABNORMAL,1318
doxorubicin,PLEURAL EFFUSION,1310
doxorubicin,PULMONARY EMBOLISM,1298
doxorubicin,HAEMATOTOXICITY,1276
doxorubicin,CARDIOTOXICITY,1268
doxorubicin,NEOPLASM PROGRESSION,1257
doxorubicin,HAIR DISORDER,1252
doxorubicin,HEADACHE,1217
doxorubicin,COUGH,1205
doxorubicin,DEHYDRATION,1188
doxorubicin,EMOTIONAL DISTRESS,1187
doxorubicin,SECOND PRIMARY MALIGNANCY,1167
doxorubicin,RASH,1162
doxorubicin,MADAROSIS,1144
doxorubicin,DIFFUSE LARGE B-CELL LYMPHOMA,1113
doxorubicin,WEIGHT DECREASED,1103
doxorubicin,HAEMOGLOBIN DECREASED,1101
doxorubicin,RENAL FAILURE,1101
doxorubicin,HYPERTENSION,1079
doxorubicin,CONDITION AGGRAVATED,1049
doxorubicin,MALAISE,1036
doxorubicin,BACK PAIN,1021
doxorubicin,MYELOSUPPRESSION,989
doxorubicin,DISEASE RECURRENCE,971
doxorubicin,DIZZINESS,970
doxorubicin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,966
doxorubicin,DEEP VEIN THROMBOSIS,963
doxorubicin,EJECTION FRACTION DECREASED,954
doxorubicin,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,950
doxorubicin,ATRIAL FIBRILLATION,918
doxorubicin,TUMOUR LYSIS SYNDROME,916
doxorubicin,COVID-19,899
doxorubicin,CARDIOMYOPATHY,895
doxorubicin,BONE PAIN,892
doxorubicin,URINARY TRACT INFECTION,870
doxorubicin,PLASMA CELL MYELOMA,869
doxorubicin,HYPOKALAEMIA,862
doxorubicin,NEUTROPENIC SEPSIS,843
doxorubicin,IMPAIRED QUALITY OF LIFE,841
doxorubicin,ARTHRALGIA,840
doxorubicin,LYMPHADENOPATHY,834
doxorubicin,PNEUMONITIS,811
doxorubicin,CHILLS,797
doxorubicin,TACHYCARDIA,790
doxorubicin,INFUSION RELATED REACTION,772
doxorubicin,ALANINE AMINOTRANSFERASE INCREASED,735
doxorubicin,PNEUMOCYSTIS JIROVECII PNEUMONIA,735
doxorubicin,BLOOD LACTATE DEHYDROGENASE INCREASED,733
doxorubicin,HYPONATRAEMIA,732
doxorubicin,MULTIPLE ORGAN DYSFUNCTION SYNDROME,718
doxorubicin,HEPATITIS B,712
doxorubicin,CYTOPENIA,709
gemcitabine,DISEASE PROGRESSION,4062
gemcitabine,OFF LABEL USE,3913
gemcitabine,THROMBOCYTOPENIA,3687
gemcitabine,NEUTROPENIA,3252
gemcitabine,ANAEMIA,3150
gemcitabine,MALIGNANT NEOPLASM PROGRESSION,2933
gemcitabine,NAUSEA,2917
gemcitabine,PYREXIA,2759
gemcitabine,DEATH,2565
gemcitabine,VOMITING,2365
gemcitabine,FATIGUE,2318
gemcitabine,DIARRHOEA,2249
gemcitabine,DRUG INEFFECTIVE,2047
gemcitabine,DYSPNOEA,1874
gemcitabine,FEBRILE NEUTROPENIA,1760
gemcitabine,ASTHENIA,1699
gemcitabine,PNEUMONIA,1435
gemcitabine,ABDOMINAL PAIN,1401
gemcitabine,SEPSIS,1269
gemcitabine,PANCYTOPENIA,1232
gemcitabine,LEUKOPENIA,1194
gemcitabine,PLATELET COUNT DECREASED,1187
gemcitabine,NEUROPATHY PERIPHERAL,1167
gemcitabine,DECREASED APPETITE,1155
gemcitabine,GENERAL PHYSICAL HEALTH DETERIORATION,1132
gemcitabine,RASH,1032
gemcitabine,PULMONARY EMBOLISM,1030
gemcitabine,DEHYDRATION,1026
gemcitabine,NEOPLASM PROGRESSION,1023
gemcitabine,ACUTE KIDNEY INJURY,963
gemcitabine,PLEURAL EFFUSION,949
gemcitabine,CONSTIPATION,928
gemcitabine,PAIN,896
gemcitabine,THROMBOTIC MICROANGIOPATHY,865
gemcitabine,PRODUCT USE IN UNAPPROVED INDICATION,859
gemcitabine,OEDEMA PERIPHERAL,851
gemcitabine,HAEMOGLOBIN DECREASED,808
gemcitabine,WHITE BLOOD CELL COUNT DECREASED,798
gemcitabine,NEUTROPHIL COUNT DECREASED,716
gemcitabine,DEEP VEIN THROMBOSIS,706
gemcitabine,INFECTION,706
gemcitabine,WEIGHT DECREASED,698
gemcitabine,HYPOTENSION,696
gemcitabine,COUGH,694
gemcitabine,TOXICITY TO VARIOUS AGENTS,677
gemcitabine,HYPERTENSION,652
gemcitabine,ASCITES,651
gemcitabine,MALAISE,638
gemcitabine,MYELOSUPPRESSION,626
gemcitabine,RENAL FAILURE,616
gemcitabine,INTERSTITIAL LUNG DISEASE,613
gemcitabine,METASTASES TO LIVER,604
gemcitabine,DIZZINESS,594
gemcitabine,MUCOSAL INFLAMMATION,592
gemcitabine,ERYTHEMA,589
gemcitabine,RESPIRATORY FAILURE,570
gemcitabine,BONE MARROW FAILURE,562
gemcitabine,CHILLS,555
gemcitabine,HEADACHE,543
gemcitabine,HAEMATOTOXICITY,541
gemcitabine,URINARY TRACT INFECTION,535
gemcitabine,ALOPECIA,523
gemcitabine,PNEUMONITIS,522
gemcitabine,CONDITION AGGRAVATED,513
gemcitabine,ALANINE AMINOTRANSFERASE INCREASED,502
gemcitabine,PRURITUS,494
gemcitabine,CHEST PAIN,483
gemcitabine,SEPTIC SHOCK,483
gemcitabine,CONFUSIONAL STATE,442
gemcitabine,ASPARTATE AMINOTRANSFERASE INCREASED,438
gemcitabine,CHOLANGITIS,434
gemcitabine,HYPONATRAEMIA,434
gemcitabine,BACK PAIN,427
gemcitabine,DISEASE RECURRENCE,425
gemcitabine,PAIN IN EXTREMITY,424
gemcitabine,CARDIAC FAILURE,423
gemcitabine,EPISTAXIS,422
gemcitabine,DRUG INTOLERANCE,417
gemcitabine,TREATMENT FAILURE,412
gemcitabine,GASTROINTESTINAL HAEMORRHAGE,411
gemcitabine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,410
gemcitabine,HYPOKALAEMIA,397
gemcitabine,BLOOD CREATININE INCREASED,396
gemcitabine,NEUTROPENIC SEPSIS,392
gemcitabine,METASTASES TO LUNG,387
gemcitabine,NEUROTOXICITY,382
gemcitabine,PARAESTHESIA,379
gemcitabine,STOMATITIS,366
gemcitabine,RENAL IMPAIRMENT,365
gemcitabine,ATRIAL FIBRILLATION,356
gemcitabine,TACHYCARDIA,351
gemcitabine,METASTASES TO BONE,349
gemcitabine,PANCREATIC CARCINOMA METASTATIC,348
gemcitabine,HYPERSENSITIVITY,346
gemcitabine,ABDOMINAL PAIN UPPER,344
gemcitabine,PANCREATIC CARCINOMA,344
gemcitabine,COLITIS,333
gemcitabine,ARTHRALGIA,332
gemcitabine,CYTOKINE RELEASE SYNDROME,321
gemcitabine,DRUG RESISTANCE,320
regorafenib,OFF LABEL USE,1852
regorafenib,FATIGUE,1619
regorafenib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1353
regorafenib,DIARRHOEA,1314
regorafenib,DECREASED APPETITE,1013
regorafenib,ASTHENIA,866
regorafenib,DEATH,771
regorafenib,DYSPHONIA,771
regorafenib,NAUSEA,743
regorafenib,PYREXIA,700
regorafenib,PAIN IN EXTREMITY,692
regorafenib,HYPERTENSION,655
regorafenib,WEIGHT DECREASED,593
regorafenib,VOMITING,524
regorafenib,RASH,518
regorafenib,PAIN,480
regorafenib,HEPATOCELLULAR CARCINOMA,471
regorafenib,NEUROPATHY PERIPHERAL,453
regorafenib,ABDOMINAL PAIN,446
regorafenib,DEHYDRATION,432
regorafenib,DYSPNOEA,423
regorafenib,BLOOD PRESSURE INCREASED,422
regorafenib,BLISTER,405
regorafenib,HEADACHE,401
regorafenib,MALAISE,385
regorafenib,CONSTIPATION,382
regorafenib,DRUG INEFFECTIVE,372
regorafenib,COLON CANCER,332
regorafenib,ABDOMINAL PAIN UPPER,330
regorafenib,GAIT DISTURBANCE,314
regorafenib,METASTASES TO LUNG,312
regorafenib,SKIN EXFOLIATION,311
regorafenib,STOMATITIS,305
regorafenib,HOSPITALISATION,301
regorafenib,COLORECTAL CANCER METASTATIC,297
regorafenib,COLORECTAL CANCER,279
regorafenib,ERYTHEMA,275
regorafenib,DISEASE PROGRESSION,264
regorafenib,BACK PAIN,263
regorafenib,METASTASES TO LIVER,256
regorafenib,BLOOD BILIRUBIN INCREASED,253
regorafenib,GENERAL PHYSICAL HEALTH DETERIORATION,250
regorafenib,PLATELET COUNT DECREASED,246
regorafenib,DRY SKIN,242
regorafenib,DIZZINESS,223
regorafenib,PERIPHERAL SWELLING,199
regorafenib,ARTHRALGIA,198
regorafenib,PNEUMONIA,193
regorafenib,ASCITES,190
regorafenib,COUGH,190
regorafenib,MUSCLE SPASMS,190
regorafenib,CONFUSIONAL STATE,183
regorafenib,ANAEMIA,179
regorafenib,HEPATIC FUNCTION ABNORMAL,173
regorafenib,HYPOAESTHESIA,163
regorafenib,ASPARTATE AMINOTRANSFERASE INCREASED,161
regorafenib,ORAL PAIN,161
regorafenib,PRODUCT USE IN UNAPPROVED INDICATION,161
regorafenib,ALOPECIA,159
regorafenib,DRY MOUTH,159
regorafenib,MALIGNANT NEOPLASM PROGRESSION,154
regorafenib,CHEST PAIN,148
regorafenib,MUCOSAL INFLAMMATION,146
regorafenib,PRURITUS,142
regorafenib,URINARY TRACT INFECTION,141
regorafenib,THROMBOCYTOPENIA,140
regorafenib,MYALGIA,139
regorafenib,HYPERKERATOSIS,138
regorafenib,JAUNDICE,136
regorafenib,ALANINE AMINOTRANSFERASE INCREASED,135
regorafenib,ADVERSE DRUG REACTION,134
regorafenib,OROPHARYNGEAL PAIN,133
regorafenib,SEPSIS,132
regorafenib,PARAESTHESIA,131
regorafenib,FALL,130
regorafenib,OEDEMA PERIPHERAL,130
regorafenib,HEPATIC FAILURE,124
regorafenib,INSOMNIA,122
regorafenib,ABDOMINAL DISTENSION,121
regorafenib,EPISTAXIS,117
regorafenib,GASTROINTESTINAL STROMAL TUMOUR,116
regorafenib,DRUG INTOLERANCE,114
regorafenib,SKIN FISSURES,109
regorafenib,LIVER DISORDER,106
regorafenib,DYSPHAGIA,105
regorafenib,RENAL IMPAIRMENT,105
regorafenib,CHILLS,104
regorafenib,HYPOTENSION,104
regorafenib,CARCINOEMBRYONIC ANTIGEN INCREASED,100
regorafenib,GAIT INABILITY,100
regorafenib,BURNING SENSATION,99
regorafenib,MUSCULAR WEAKNESS,98
regorafenib,ABDOMINAL DISCOMFORT,97
regorafenib,RECTAL CANCER,96
regorafenib,MOBILITY DECREASED,95
regorafenib,FEELING ABNORMAL,91
regorafenib,ACUTE KIDNEY INJURY,90
regorafenib,HEPATIC ENCEPHALOPATHY,90
regorafenib,RASH GENERALISED,88
regorafenib,NEUTROPENIA,86
selpercatinib,DEATH,62
selpercatinib,MALIGNANT NEOPLASM PROGRESSION,58
selpercatinib,FATIGUE,37
selpercatinib,RASH,35
selpercatinib,DIARRHOEA,30
selpercatinib,PYREXIA,26
selpercatinib,HYPERSENSITIVITY,25
selpercatinib,BLOOD CREATININE INCREASED,24
selpercatinib,COUGH,23
selpercatinib,HEPATIC FUNCTION ABNORMAL,22
selpercatinib,HYPERTENSION,22
selpercatinib,PULMONARY EMBOLISM,22
selpercatinib,ALANINE AMINOTRANSFERASE INCREASED,21
selpercatinib,ASCITES,21
selpercatinib,ASPARTATE AMINOTRANSFERASE INCREASED,20
selpercatinib,ELECTROCARDIOGRAM QT PROLONGED,20
selpercatinib,GENERAL PHYSICAL HEALTH DETERIORATION,20
selpercatinib,DRUG INEFFECTIVE,19
selpercatinib,DRY MOUTH,18
selpercatinib,HEADACHE,18
selpercatinib,URINARY TRACT INFECTION,17
selpercatinib,NAUSEA,16
selpercatinib,ASTHENIA,15
selpercatinib,INFECTION,15
selpercatinib,PLEURAL EFFUSION,15
selpercatinib,BLOOD PRESSURE INCREASED,14
selpercatinib,LIVER FUNCTION TEST INCREASED,14
selpercatinib,OEDEMA PERIPHERAL,14
selpercatinib,THROMBOCYTOPENIA,14
selpercatinib,PLATELET COUNT DECREASED,13
selpercatinib,HAEMATURIA,12
selpercatinib,HEPATIC FAILURE,12
selpercatinib,HEPATOTOXICITY,12
selpercatinib,INFLAMMATORY MARKER INCREASED,12
selpercatinib,PROTEINURIA,12
selpercatinib,FEBRILE INFECTION,11
selpercatinib,HEPATIC ENZYME INCREASED,11
selpercatinib,OFF LABEL USE,11
selpercatinib,TUMOUR ASSOCIATED FEVER,11
selpercatinib,URINARY TRACT INFECTION ENTEROCOCCAL,11
selpercatinib,VOMITING,11
selpercatinib,DECREASED APPETITE,9
selpercatinib,OEDEMA,9
selpercatinib,THERAPY INTERRUPTED,9
selpercatinib,WEIGHT DECREASED,9
selpercatinib,ABDOMINAL PAIN,8
selpercatinib,DYSPHAGIA,8
selpercatinib,NEUTROPENIA,8
selpercatinib,WEIGHT INCREASED,8
selpercatinib,ANXIETY,7
selpercatinib,COVID-19,7
selpercatinib,DISEASE PROGRESSION,7
selpercatinib,DRUG-INDUCED LIVER INJURY,7
selpercatinib,GASTROOESOPHAGEAL REFLUX DISEASE,7
selpercatinib,LIVER DISORDER,7
selpercatinib,PNEUMONIA,7
selpercatinib,ABDOMINAL DISTENSION,6
selpercatinib,ANAEMIA,6
selpercatinib,ARTHRALGIA,6
selpercatinib,CHEST PAIN,6
selpercatinib,CONSTIPATION,6
selpercatinib,CUSHING^S SYNDROME,6
selpercatinib,DEEP VEIN THROMBOSIS,6
selpercatinib,DYSPNOEA,6
selpercatinib,PARAESTHESIA,6
selpercatinib,PERICARDIAL EFFUSION,6
selpercatinib,RENAL FAILURE,6
selpercatinib,SEPSIS,6
selpercatinib,STOMATITIS,6
selpercatinib,THERAPY PARTIAL RESPONDER,6
selpercatinib,TRANSAMINASES INCREASED,6
selpercatinib,ALOPECIA,5
selpercatinib,BLOOD ALKALINE PHOSPHATASE INCREASED,5
selpercatinib,BLOOD BILIRUBIN INCREASED,5
selpercatinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
selpercatinib,CEREBROVASCULAR ACCIDENT,5
selpercatinib,DEHYDRATION,5
selpercatinib,DIVERTICULITIS,5
selpercatinib,DRY SKIN,5
selpercatinib,DYSPHONIA,5
selpercatinib,FEMUR FRACTURE,5
selpercatinib,HOSPITALISATION,5
selpercatinib,HYPERTRANSAMINASAEMIA,5
selpercatinib,JOINT SWELLING,5
selpercatinib,MALAISE,5
selpercatinib,MEDULLARY THYROID CANCER,5
selpercatinib,NEOPLASM PROGRESSION,5
selpercatinib,PERIPHERAL SWELLING,5
selpercatinib,PNEUMONITIS,5
selpercatinib,PULMONARY OEDEMA,5
selpercatinib,SWELLING FACE,5
selpercatinib,WHITE BLOOD CELL COUNT DECREASED,5
selpercatinib,ABDOMINAL PAIN UPPER,4
selpercatinib,ACUTE KIDNEY INJURY,4
selpercatinib,CHEST DISCOMFORT,4
selpercatinib,CHYLOTHORAX,4
selpercatinib,DIZZINESS,4
selpercatinib,DRUG INTERACTION,4
selpercatinib,EPISTAXIS,4
selpercatinib,GAIT DISTURBANCE,4
remdesivir,OFF LABEL USE,1894
remdesivir,ALANINE AMINOTRANSFERASE INCREASED,1071
remdesivir,DEATH,790
remdesivir,COVID-19,782
remdesivir,ASPARTATE AMINOTRANSFERASE INCREASED,735
remdesivir,ACUTE KIDNEY INJURY,658
remdesivir,BRADYCARDIA,640
remdesivir,DRUG INEFFECTIVE,579
remdesivir,RESPIRATORY FAILURE,472
remdesivir,LIVER FUNCTION TEST INCREASED,465
remdesivir,COVID-19 PNEUMONIA,453
remdesivir,BLOOD CREATININE INCREASED,364
remdesivir,CONDITION AGGRAVATED,307
remdesivir,PNEUMONIA,291
remdesivir,HYPOTENSION,286
remdesivir,HYPOXIA,265
remdesivir,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,258
remdesivir,CARDIAC ARREST,257
remdesivir,SEPTIC SHOCK,255
remdesivir,RENAL IMPAIRMENT,254
remdesivir,DYSPNOEA,244
remdesivir,HEPATIC ENZYME INCREASED,228
remdesivir,THERAPY CESSATION,224
remdesivir,OXYGEN SATURATION DECREASED,215
remdesivir,MULTIPLE ORGAN DYSFUNCTION SYNDROME,214
remdesivir,TRANSAMINASES INCREASED,203
remdesivir,MATERNAL EXPOSURE DURING PREGNANCY,196
remdesivir,PRODUCT USE IN UNAPPROVED INDICATION,186
remdesivir,PYREXIA,173
remdesivir,ACUTE RESPIRATORY FAILURE,167
remdesivir,RENAL FAILURE,166
remdesivir,ACUTE RESPIRATORY DISTRESS SYNDROME,165
remdesivir,SEPSIS,164
remdesivir,BRONCHOPULMONARY ASPERGILLOSIS,155
remdesivir,DRUG INTERACTION,154
remdesivir,INFUSION SITE EXTRAVASATION,143
remdesivir,FOETAL EXPOSURE DURING PREGNANCY,137
remdesivir,INFUSION RELATED REACTION,135
remdesivir,GENERAL PHYSICAL HEALTH DETERIORATION,133
remdesivir,NO ADVERSE EVENT,131
remdesivir,EXPOSURE DURING PREGNANCY,123
remdesivir,GLOMERULAR FILTRATION RATE DECREASED,122
remdesivir,SINUS BRADYCARDIA,122
remdesivir,ATRIAL FIBRILLATION,120
remdesivir,PULMONARY EMBOLISM,117
remdesivir,THERAPY INTERRUPTED,116
remdesivir,PRODUCT USE ISSUE,112
remdesivir,PNEUMOTHORAX,111
remdesivir,PNEUMONIA BACTERIAL,110
remdesivir,THROMBOCYTOPENIA,107
remdesivir,NAUSEA,106
remdesivir,PREMATURE DELIVERY,106
remdesivir,INTENTIONAL PRODUCT USE ISSUE,105
remdesivir,PREMATURE BABY,102
remdesivir,SHOCK,100
remdesivir,INTERNATIONAL NORMALISED RATIO INCREASED,95
remdesivir,TACHYCARDIA,92
remdesivir,CARDIO-RESPIRATORY ARREST,91
remdesivir,DISEASE PROGRESSION,91
remdesivir,HEPATIC FUNCTION ABNORMAL,91
remdesivir,RASH,91
remdesivir,HEART RATE DECREASED,88
remdesivir,ELECTROCARDIOGRAM QT PROLONGED,87
remdesivir,BLOOD ALKALINE PHOSPHATASE INCREASED,80
remdesivir,PRODUCT PREPARATION ERROR,80
remdesivir,RESPIRATORY DISTRESS,79
remdesivir,SARS-COV-2 TEST POSITIVE,79
remdesivir,VOMITING,79
remdesivir,COUGH,78
remdesivir,BLOOD BILIRUBIN INCREASED,76
remdesivir,PULSELESS ELECTRICAL ACTIVITY,76
remdesivir,HYPERTENSION,70
remdesivir,MUCORMYCOSIS,69
remdesivir,LEUKOPENIA,68
remdesivir,THERAPY NON-RESPONDER,68
remdesivir,DIARRHOEA,67
remdesivir,CHILLS,66
remdesivir,RESPIRATORY DISORDER,66
remdesivir,GASTROINTESTINAL HAEMORRHAGE,65
remdesivir,HYPERTRANSAMINASAEMIA,65
remdesivir,ASTHENIA,64
remdesivir,DISSEMINATED INTRAVASCULAR COAGULATION,64
remdesivir,HYPERGLYCAEMIA,64
remdesivir,METABOLIC ACIDOSIS,62
remdesivir,PNEUMONIA ASPIRATION,62
remdesivir,BLOOD UREA INCREASED,61
remdesivir,DRUG-INDUCED LIVER INJURY,61
remdesivir,HAEMODIALYSIS,61
remdesivir,DEEP VEIN THROMBOSIS,60
remdesivir,PAIN,60
remdesivir,ASPERGILLUS INFECTION,59
remdesivir,HYPERKALAEMIA,59
remdesivir,LIVER INJURY,59
remdesivir,SHOCK HAEMORRHAGIC,59
remdesivir,ANAEMIA,58
remdesivir,BLOOD PRESSURE DECREASED,58
remdesivir,PNEUMOMEDIASTINUM,58
remdesivir,STAPHYLOCOCCAL INFECTION,58
remdesivir,ACUTE MYOCARDIAL INFARCTION,57
remdesivir,HAEMOGLOBIN DECREASED,57
enoxaparin,OFF LABEL USE,3862
enoxaparin,DYSPNOEA,3522
enoxaparin,NAUSEA,3328
enoxaparin,DIARRHOEA,3231
enoxaparin,PYREXIA,3229
enoxaparin,ANAEMIA,3165
enoxaparin,FATIGUE,2753
enoxaparin,THROMBOCYTOPENIA,2730
enoxaparin,VOMITING,2653
enoxaparin,PNEUMONIA,2631
enoxaparin,ACUTE KIDNEY INJURY,2582
enoxaparin,DEATH,2574
enoxaparin,PULMONARY EMBOLISM,2425
enoxaparin,HYPOTENSION,2268
enoxaparin,ASTHENIA,2080
enoxaparin,PAIN,2012
enoxaparin,DEEP VEIN THROMBOSIS,1947
enoxaparin,DRUG INTERACTION,1947
enoxaparin,FALL,1926
enoxaparin,HAEMORRHAGE,1879
enoxaparin,DRUG INEFFECTIVE,1814
enoxaparin,HAEMOGLOBIN DECREASED,1767
enoxaparin,ABDOMINAL PAIN,1729
enoxaparin,NEUTROPENIA,1710
enoxaparin,HEADACHE,1693
enoxaparin,SEPSIS,1666
enoxaparin,RENAL FAILURE,1610
enoxaparin,RASH,1594
enoxaparin,DIZZINESS,1546
enoxaparin,EXPOSURE DURING PREGNANCY,1453
enoxaparin,HAEMATOMA,1434
enoxaparin,GENERAL PHYSICAL HEALTH DETERIORATION,1409
enoxaparin,THROMBOSIS,1388
enoxaparin,CONDITION AGGRAVATED,1357
enoxaparin,ATRIAL FIBRILLATION,1345
enoxaparin,MALAISE,1345
enoxaparin,CONFUSIONAL STATE,1331
enoxaparin,GASTROINTESTINAL HAEMORRHAGE,1320
enoxaparin,DECREASED APPETITE,1267
enoxaparin,OEDEMA PERIPHERAL,1256
enoxaparin,URINARY TRACT INFECTION,1228
enoxaparin,DEHYDRATION,1216
enoxaparin,PRURITUS,1197
enoxaparin,ARTHRALGIA,1195
enoxaparin,COUGH,1195
enoxaparin,RESPIRATORY FAILURE,1192
enoxaparin,PAIN IN EXTREMITY,1191
enoxaparin,CHEST PAIN,1182
enoxaparin,FOETAL EXPOSURE DURING PREGNANCY,1158
enoxaparin,FEBRILE NEUTROPENIA,1154
enoxaparin,TACHYCARDIA,1127
enoxaparin,WEIGHT DECREASED,1108
enoxaparin,HYPERTENSION,1074
enoxaparin,BACK PAIN,1066
enoxaparin,MATERNAL EXPOSURE DURING PREGNANCY,1057
enoxaparin,ANXIETY,1023
enoxaparin,CONSTIPATION,1001
enoxaparin,CEREBROVASCULAR ACCIDENT,970
enoxaparin,PLEURAL EFFUSION,962
enoxaparin,ALANINE AMINOTRANSFERASE INCREASED,961
enoxaparin,HAEMATURIA,929
enoxaparin,CARDIAC ARREST,924
enoxaparin,PANCYTOPENIA,919
enoxaparin,PLATELET COUNT DECREASED,917
enoxaparin,SYNCOPE,906
enoxaparin,ERYTHEMA,903
enoxaparin,SOMNOLENCE,887
enoxaparin,HYPOKALAEMIA,858
enoxaparin,RENAL FAILURE ACUTE,857
enoxaparin,PRODUCT USE IN UNAPPROVED INDICATION,850
enoxaparin,CONTUSION,846
enoxaparin,MYOCARDIAL INFARCTION,841
enoxaparin,INTERNATIONAL NORMALISED RATIO INCREASED,828
enoxaparin,HYPOXIA,820
enoxaparin,HYPONATRAEMIA,815
enoxaparin,EPISTAXIS,809
enoxaparin,INJECTION SITE PAIN,797
enoxaparin,BLOOD CREATININE INCREASED,790
enoxaparin,CHILLS,789
enoxaparin,PREMATURE BABY,788
enoxaparin,ABDOMINAL PAIN UPPER,781
enoxaparin,LEUKOPENIA,781
enoxaparin,ASPARTATE AMINOTRANSFERASE INCREASED,776
enoxaparin,SEPTIC SHOCK,774
enoxaparin,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,768
enoxaparin,CHOLESTASIS,754
enoxaparin,DISEASE PROGRESSION,751
enoxaparin,LOSS OF CONSCIOUSNESS,751
enoxaparin,HEPATOCELLULAR INJURY,748
enoxaparin,CARDIAC FAILURE,722
enoxaparin,INFECTION,713
enoxaparin,COVID-19,712
enoxaparin,INSOMNIA,697
enoxaparin,HEPARIN-INDUCED THROMBOCYTOPENIA,694
enoxaparin,RASH MACULO-PAPULAR,694
enoxaparin,RENAL IMPAIRMENT,693
enoxaparin,MALIGNANT NEOPLASM PROGRESSION,687
enoxaparin,BRADYCARDIA,673
enoxaparin,CEREBRAL HAEMORRHAGE,655
enoxaparin,CARDIO-RESPIRATORY ARREST,648
irinotecan,DIARRHOEA,5981
irinotecan,NAUSEA,3350
irinotecan,NEUTROPENIA,3205
irinotecan,VOMITING,2912
irinotecan,DISEASE PROGRESSION,2813
irinotecan,OFF LABEL USE,2403
irinotecan,DEATH,2139
irinotecan,FATIGUE,2061
irinotecan,PYREXIA,1716
irinotecan,FEBRILE NEUTROPENIA,1669
irinotecan,ASTHENIA,1653
irinotecan,ANAEMIA,1639
irinotecan,THROMBOCYTOPENIA,1618
irinotecan,DECREASED APPETITE,1517
irinotecan,ABDOMINAL PAIN,1463
irinotecan,NEUROPATHY PERIPHERAL,1455
irinotecan,MALIGNANT NEOPLASM PROGRESSION,1391
irinotecan,DEHYDRATION,1341
irinotecan,HYPERTENSION,1112
irinotecan,DYSPNOEA,1015
irinotecan,LEUKOPENIA,1005
irinotecan,DRUG INEFFECTIVE,1002
irinotecan,RASH,984
irinotecan,PULMONARY EMBOLISM,961
irinotecan,STOMATITIS,960
irinotecan,GENERAL PHYSICAL HEALTH DETERIORATION,915
irinotecan,MUCOSAL INFLAMMATION,870
irinotecan,SEPSIS,784
irinotecan,WEIGHT DECREASED,777
irinotecan,NEUTROPHIL COUNT DECREASED,746
irinotecan,CONSTIPATION,734
irinotecan,MALAISE,722
irinotecan,NEOPLASM PROGRESSION,718
irinotecan,WHITE BLOOD CELL COUNT DECREASED,715
irinotecan,PNEUMONIA,681
irinotecan,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,654
irinotecan,HYPOKALAEMIA,631
irinotecan,HYPOTENSION,627
irinotecan,ALOPECIA,611
irinotecan,METASTASES TO LIVER,600
irinotecan,PRODUCT USE IN UNAPPROVED INDICATION,590
irinotecan,PAIN,585
irinotecan,INTERSTITIAL LUNG DISEASE,582
irinotecan,MYELOSUPPRESSION,556
irinotecan,PROTEINURIA,537
irinotecan,TOXICITY TO VARIOUS AGENTS,537
irinotecan,BONE MARROW FAILURE,532
irinotecan,PLATELET COUNT DECREASED,526
irinotecan,DEEP VEIN THROMBOSIS,521
irinotecan,HAEMOGLOBIN DECREASED,516
irinotecan,EPISTAXIS,512
irinotecan,ACUTE KIDNEY INJURY,493
irinotecan,DERMATITIS ACNEIFORM,493
irinotecan,PARAESTHESIA,476
irinotecan,DIZZINESS,468
irinotecan,INTESTINAL OBSTRUCTION,467
irinotecan,HEADACHE,465
irinotecan,NEUROTOXICITY,465
irinotecan,CHILLS,464
irinotecan,INFECTION,454
irinotecan,ASCITES,436
irinotecan,HYPERSENSITIVITY,426
irinotecan,COLORECTAL CANCER METASTATIC,393
irinotecan,ABDOMINAL PAIN UPPER,391
irinotecan,HYPOMAGNESAEMIA,383
irinotecan,SKIN TOXICITY,380
irinotecan,DYSARTHRIA,379
irinotecan,SEPTIC SHOCK,376
irinotecan,PANCYTOPENIA,375
irinotecan,CONDITION AGGRAVATED,357
irinotecan,CHEST PAIN,344
irinotecan,BACK PAIN,342
irinotecan,PRURITUS,338
irinotecan,URINARY TRACT INFECTION,336
irinotecan,ILEUS,333
irinotecan,METASTASES TO LUNG,332
irinotecan,RENAL FAILURE,326
irinotecan,ERYTHEMA,319
irinotecan,CONFUSIONAL STATE,311
irinotecan,HAEMATOTOXICITY,308
irinotecan,COLITIS,304
irinotecan,INFUSION RELATED REACTION,304
irinotecan,RESPIRATORY FAILURE,300
irinotecan,ALANINE AMINOTRANSFERASE INCREASED,297
irinotecan,HYPERHIDROSIS,295
irinotecan,HAEMORRHAGE,293
irinotecan,HYPONATRAEMIA,291
irinotecan,DRY SKIN,288
irinotecan,TACHYCARDIA,286
irinotecan,OEDEMA PERIPHERAL,284
irinotecan,BLOOD CREATININE INCREASED,281
irinotecan,GASTROINTESTINAL TOXICITY,278
irinotecan,ASPARTATE AMINOTRANSFERASE INCREASED,277
irinotecan,PERIPHERAL SENSORY NEUROPATHY,276
irinotecan,DYSPHAGIA,274
irinotecan,GASTROINTESTINAL HAEMORRHAGE,265
irinotecan,TREATMENT FAILURE,261
irinotecan,POLYNEUROPATHY,260
irinotecan,GASTROINTESTINAL DISORDER,259
irinotecan,ATRIAL FIBRILLATION,258
nintedanib,DIARRHOEA,7707
nintedanib,NAUSEA,3626
nintedanib,DYSPNOEA,2888
nintedanib,DECREASED APPETITE,2366
nintedanib,DEATH,2239
nintedanib,VOMITING,2204
nintedanib,FATIGUE,2190
nintedanib,WEIGHT DECREASED,2163
nintedanib,COUGH,2006
nintedanib,IDIOPATHIC PULMONARY FIBROSIS,1603
nintedanib,CONSTIPATION,1469
nintedanib,ABDOMINAL PAIN UPPER,1408
nintedanib,ASTHENIA,1321
nintedanib,HEADACHE,1310
nintedanib,ABDOMINAL DISCOMFORT,1199
nintedanib,PNEUMONIA,1116
nintedanib,DIZZINESS,1043
nintedanib,PRODUCTIVE COUGH,881
nintedanib,MALAISE,824
nintedanib,ABDOMINAL PAIN,762
nintedanib,FLATULENCE,713
nintedanib,OXYGEN SATURATION DECREASED,680
nintedanib,DYSPNOEA EXERTIONAL,668
nintedanib,MALIGNANT NEOPLASM PROGRESSION,663
nintedanib,FALL,604
nintedanib,DEHYDRATION,595
nintedanib,EPISTAXIS,580
nintedanib,OFF LABEL USE,566
nintedanib,PAIN,522
nintedanib,CHEST PAIN,503
nintedanib,COVID-19,493
nintedanib,HYPERTENSION,490
nintedanib,HEPATIC ENZYME INCREASED,483
nintedanib,PYREXIA,481
nintedanib,FEELING ABNORMAL,471
nintedanib,GASTROINTESTINAL DISORDER,440
nintedanib,NASOPHARYNGITIS,422
nintedanib,ABDOMINAL DISTENSION,419
nintedanib,DYSPEPSIA,410
nintedanib,BACK PAIN,406
nintedanib,ARTHRALGIA,405
nintedanib,DRUG INEFFECTIVE,405
nintedanib,ILLNESS,385
nintedanib,RESPIRATORY FAILURE,372
nintedanib,HAEMATOCHEZIA,370
nintedanib,BLOOD PRESSURE INCREASED,361
nintedanib,RASH,357
nintedanib,INSOMNIA,356
nintedanib,GASTROOESOPHAGEAL REFLUX DISEASE,352
nintedanib,INTERSTITIAL LUNG DISEASE,351
nintedanib,GASTRIC DISORDER,348
nintedanib,GENERAL PHYSICAL HEALTH DETERIORATION,342
nintedanib,URINARY TRACT INFECTION,339
nintedanib,MUSCLE SPASMS,337
nintedanib,DEPRESSION,330
nintedanib,ANAEMIA,316
nintedanib,CEREBROVASCULAR ACCIDENT,315
nintedanib,PULMONARY EMBOLISM,314
nintedanib,PERIPHERAL SWELLING,311
nintedanib,HYPOTENSION,310
nintedanib,PAIN IN EXTREMITY,305
nintedanib,DRUG INTOLERANCE,303
nintedanib,LUNG DISORDER,287
nintedanib,ALOPECIA,279
nintedanib,LIVER DISORDER,271
nintedanib,ANXIETY,267
nintedanib,PRURITUS,264
nintedanib,PNEUMOTHORAX,262
nintedanib,GASTROINTESTINAL HAEMORRHAGE,258
nintedanib,PULMONARY FIBROSIS,249
nintedanib,DRY MOUTH,248
nintedanib,CHEST DISCOMFORT,245
nintedanib,DISEASE PROGRESSION,245
nintedanib,RECTAL HAEMORRHAGE,245
nintedanib,HAEMOPTYSIS,243
nintedanib,MYOCARDIAL INFARCTION,234
nintedanib,TASTE DISORDER,230
nintedanib,CONTUSION,228
nintedanib,WEIGHT INCREASED,226
nintedanib,FAECES DISCOLOURED,222
nintedanib,LIVER FUNCTION TEST INCREASED,222
nintedanib,SEPSIS,221
nintedanib,INFECTION,220
nintedanib,ABNORMAL LOSS OF WEIGHT,219
nintedanib,ATRIAL FIBRILLATION,211
nintedanib,RHINORRHOEA,211
nintedanib,FAECES SOFT,209
nintedanib,INFLUENZA,208
nintedanib,PULMONARY HYPERTENSION,200
nintedanib,GAIT DISTURBANCE,199
nintedanib,HYPOXIA,194
nintedanib,SOMNOLENCE,194
nintedanib,MUSCULAR WEAKNESS,192
nintedanib,BRONCHITIS,191
nintedanib,DYSGEUSIA,190
nintedanib,LOSS OF CONSCIOUSNESS,188
nintedanib,CONDITION AGGRAVATED,187
nintedanib,DYSPHONIA,186
nintedanib,AGEUSIA,185
nintedanib,OEDEMA PERIPHERAL,185
plerixafor,FEBRILE NEUTROPENIA,133
plerixafor,DIARRHOEA,97
plerixafor,PYREXIA,85
plerixafor,NAUSEA,80
plerixafor,MUCOSAL INFLAMMATION,75
plerixafor,THROMBOCYTOPENIA,70
plerixafor,OFF LABEL USE,65
plerixafor,PNEUMONIA,53
plerixafor,DRUG INEFFECTIVE,51
plerixafor,DEATH,50
plerixafor,VOMITING,49
plerixafor,INFECTION,43
plerixafor,NEUTROPENIA,43
plerixafor,HYPOTENSION,41
plerixafor,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,41
plerixafor,THERAPY NON-RESPONDER,41
plerixafor,FATIGUE,39
plerixafor,ANAEMIA,38
plerixafor,DYSPNOEA,35
plerixafor,SEPSIS,33
plerixafor,PANCYTOPENIA,31
plerixafor,BONE PAIN,30
plerixafor,PLEURAL EFFUSION,30
plerixafor,ASCITES,28
plerixafor,RENAL FAILURE,27
plerixafor,HEADACHE,26
plerixafor,PRODUCT USE IN UNAPPROVED INDICATION,26
plerixafor,ABDOMINAL PAIN,25
plerixafor,PLASMA CELL MYELOMA,25
plerixafor,VENOOCCLUSIVE LIVER DISEASE,25
plerixafor,ACUTE KIDNEY INJURY,24
plerixafor,RESPIRATORY FAILURE,24
plerixafor,BLOOD STEM CELL HARVEST FAILURE,23
plerixafor,ASTHENIA,22
plerixafor,ACUTE MYELOID LEUKAEMIA,21
plerixafor,HYPOKALAEMIA,21
plerixafor,PLATELET COUNT DECREASED,21
plerixafor,TREATMENT FAILURE,21
plerixafor,CYTOMEGALOVIRUS INFECTION,20
plerixafor,DISEASE PROGRESSION,20
plerixafor,DIZZINESS,20
plerixafor,NEUROPATHY PERIPHERAL,20
plerixafor,SEPTIC SHOCK,20
plerixafor,BACK PAIN,19
plerixafor,ESCHERICHIA INFECTION,19
plerixafor,PERICARDIAL EFFUSION,19
plerixafor,RASH,19
plerixafor,STOMATITIS,19
plerixafor,WHITE BLOOD CELL COUNT DECREASED,19
plerixafor,CONSTIPATION,18
plerixafor,PULMONARY EMBOLISM,18
plerixafor,HERPES SIMPLEX,17
plerixafor,TOXICITY TO VARIOUS AGENTS,17
plerixafor,ATRIAL FIBRILLATION,16
plerixafor,CHEST PAIN,16
plerixafor,DEHYDRATION,16
plerixafor,FUNGAL INFECTION,16
plerixafor,INSOMNIA,16
plerixafor,PULMONARY OEDEMA,16
plerixafor,TACHYCARDIA,16
plerixafor,COUGH,15
plerixafor,DECREASED APPETITE,15
plerixafor,DEEP VEIN THROMBOSIS,15
plerixafor,CHILLS,14
plerixafor,HYPERTENSION,14
plerixafor,HYPOXIA,14
plerixafor,LEUKOCYTOSIS,14
plerixafor,WEIGHT INCREASED,14
plerixafor,ARTHRALGIA,13
plerixafor,HYPERSENSITIVITY,13
plerixafor,MYELODYSPLASTIC SYNDROME,13
plerixafor,PAIN,13
plerixafor,PALPITATIONS,13
plerixafor,STAPHYLOCOCCAL INFECTION,13
plerixafor,THERAPEUTIC RESPONSE DECREASED,13
plerixafor,THROMBOTIC MICROANGIOPATHY,13
plerixafor,CELLULITIS,12
plerixafor,CLOSTRIDIUM DIFFICILE COLITIS,12
plerixafor,ENGRAFT FAILURE,12
plerixafor,LEUKOPENIA,12
plerixafor,PARAESTHESIA,12
plerixafor,SEIZURE,12
plerixafor,THROMBOSIS,12
plerixafor,ACUTE GRAFT VERSUS HOST DISEASE,11
plerixafor,APLASIA,11
plerixafor,BONE MARROW FAILURE,11
plerixafor,CYTOPENIA,11
plerixafor,HERPES ZOSTER,11
plerixafor,MALIGNANT NEOPLASM PROGRESSION,11
plerixafor,ADVERSE EVENT,10
plerixafor,ANAPHYLACTIC SHOCK,10
plerixafor,BLOOD STEM CELL TRANSPLANT FAILURE,10
plerixafor,CYTOMEGALOVIRUS INFECTION REACTIVATION,10
plerixafor,GRAFT VERSUS HOST DISEASE,10
plerixafor,HAEMOGLOBIN DECREASED,10
plerixafor,HYPOMAGNESAEMIA,10
plerixafor,HYPONATRAEMIA,10
plerixafor,MALAISE,10
plerixafor,NASOPHARYNGITIS,10
plerixafor,OEDEMA PERIPHERAL,10
alpelisib,HYPERGLYCAEMIA,1468
alpelisib,RASH,1333
alpelisib,DIARRHOEA,1277
alpelisib,BLOOD GLUCOSE INCREASED,1054
alpelisib,DEATH,860
alpelisib,NAUSEA,832
alpelisib,FATIGUE,802
alpelisib,DECREASED APPETITE,526
alpelisib,WEIGHT DECREASED,479
alpelisib,MALIGNANT NEOPLASM PROGRESSION,457
alpelisib,VOMITING,456
alpelisib,STOMATITIS,334
alpelisib,ASTHENIA,325
alpelisib,DRUG INEFFECTIVE,305
alpelisib,PYREXIA,267
alpelisib,PRURITUS,240
alpelisib,PAIN,220
alpelisib,DISEASE PROGRESSION,211
alpelisib,DIABETES MELLITUS,208
alpelisib,MALAISE,205
alpelisib,BREAST CANCER METASTATIC,199
alpelisib,ALOPECIA,197
alpelisib,DYSPNOEA,193
alpelisib,DEHYDRATION,190
alpelisib,DRY MOUTH,188
alpelisib,HEADACHE,174
alpelisib,METASTASES TO LIVER,167
alpelisib,METASTASES TO BONE,162
alpelisib,HYPERSENSITIVITY,148
alpelisib,DIZZINESS,136
alpelisib,BREAST CANCER,132
alpelisib,ABDOMINAL DISCOMFORT,127
alpelisib,DIABETIC KETOACIDOSIS,126
alpelisib,ILLNESS,126
alpelisib,ORAL PAIN,126
alpelisib,DRUG INTOLERANCE,125
alpelisib,PNEUMONIA,120
alpelisib,PRODUCT DOSE OMISSION ISSUE,119
alpelisib,ABDOMINAL PAIN UPPER,114
alpelisib,TASTE DISORDER,113
alpelisib,COVID-19,110
alpelisib,DRY SKIN,107
alpelisib,FEELING ABNORMAL,104
alpelisib,CONSTIPATION,102
alpelisib,ABDOMINAL PAIN,99
alpelisib,BLOOD CREATININE INCREASED,94
alpelisib,OFF LABEL USE,93
alpelisib,DYSPHAGIA,92
alpelisib,ERYTHEMA,91
alpelisib,URTICARIA,91
alpelisib,FEEDING DISORDER,90
alpelisib,COUGH,89
alpelisib,BLOOD GLUCOSE ABNORMAL,88
alpelisib,PERIPHERAL SWELLING,84
alpelisib,MUCOSAL INFLAMMATION,83
alpelisib,BACK PAIN,82
alpelisib,EATING DISORDER,81
alpelisib,URINARY TRACT INFECTION,81
alpelisib,GENERAL PHYSICAL HEALTH DETERIORATION,79
alpelisib,PRODUCT USE IN UNAPPROVED INDICATION,76
alpelisib,TUMOUR MARKER INCREASED,75
alpelisib,NEUTROPENIA,73
alpelisib,PLEURAL EFFUSION,73
alpelisib,CHILLS,68
alpelisib,INSOMNIA,68
alpelisib,MUSCLE SPASMS,67
alpelisib,NEOPLASM MALIGNANT,64
alpelisib,PAIN IN EXTREMITY,64
alpelisib,DYSGEUSIA,63
alpelisib,DYSPEPSIA,63
alpelisib,THIRST,63
alpelisib,VISION BLURRED,63
alpelisib,ARTHRALGIA,61
alpelisib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,61
alpelisib,RENAL IMPAIRMENT,61
alpelisib,COLITIS,60
alpelisib,SKIN EXFOLIATION,60
alpelisib,SWELLING FACE,59
alpelisib,GLYCOSYLATED HAEMOGLOBIN INCREASED,58
alpelisib,RASH PRURITIC,56
alpelisib,LIP SWELLING,55
alpelisib,FALL,54
alpelisib,GAIT DISTURBANCE,54
alpelisib,SOMNOLENCE,54
alpelisib,ADVERSE DRUG REACTION,53
alpelisib,HYPERTENSION,50
alpelisib,METASTASES TO LUNG,50
alpelisib,PRODUCT USE ISSUE,50
alpelisib,CONFUSIONAL STATE,49
alpelisib,INCORRECT DOSE ADMINISTERED,48
alpelisib,ABDOMINAL DISTENSION,47
alpelisib,BLISTER,47
alpelisib,HYPOTENSION,46
alpelisib,INFECTION,46
alpelisib,SWELLING,46
alpelisib,THERAPY INTERRUPTED,46
alpelisib,ANAEMIA,45
alpelisib,THERAPY CESSATION,45
alpelisib,TOXICITY TO VARIOUS AGENTS,45
alpelisib,KETOACIDOSIS,43
rucaparib,FATIGUE,2470
rucaparib,NAUSEA,2204
rucaparib,MALIGNANT NEOPLASM PROGRESSION,1168
rucaparib,DECREASED APPETITE,774
rucaparib,VOMITING,765
rucaparib,DIARRHOEA,764
rucaparib,CONSTIPATION,756
rucaparib,ASTHENIA,645
rucaparib,ADVERSE EVENT,560
rucaparib,CARBOHYDRATE ANTIGEN 125 INCREASED,557
rucaparib,DYSGEUSIA,554
rucaparib,ANAEMIA,540
rucaparib,PLATELET COUNT DECREASED,523
rucaparib,PRODUCT DOSE OMISSION ISSUE,520
rucaparib,DRUG INEFFECTIVE,488
rucaparib,HEADACHE,424
rucaparib,MALAISE,396
rucaparib,DIZZINESS,388
rucaparib,DYSPNOEA,387
rucaparib,ABDOMINAL PAIN,385
rucaparib,PRODUCT DOSE OMISSION,362
rucaparib,ABDOMINAL PAIN UPPER,357
rucaparib,HAEMOGLOBIN DECREASED,350
rucaparib,ABDOMINAL DISCOMFORT,333
rucaparib,DEATH,326
rucaparib,WHITE BLOOD CELL COUNT DECREASED,307
rucaparib,WEIGHT DECREASED,286
rucaparib,PAIN,283
rucaparib,RED BLOOD CELL COUNT DECREASED,275
rucaparib,TASTE DISORDER,265
rucaparib,DRUG INTOLERANCE,264
rucaparib,BLOOD CREATININE INCREASED,261
rucaparib,TUMOUR MARKER INCREASED,258
rucaparib,INSOMNIA,253
rucaparib,PRURITUS,248
rucaparib,OFF LABEL USE,238
rucaparib,PRODUCT USE IN UNAPPROVED INDICATION,232
rucaparib,UNDERDOSE,231
rucaparib,NEUROPATHY PERIPHERAL,220
rucaparib,ARTHRALGIA,217
rucaparib,DRUG DOSE OMISSION,217
rucaparib,ABDOMINAL DISTENSION,210
rucaparib,BLOOD COUNT ABNORMAL,197
rucaparib,DEHYDRATION,194
rucaparib,RASH,191
rucaparib,BACK PAIN,187
rucaparib,THROMBOCYTOPENIA,184
rucaparib,COUGH,176
rucaparib,PAIN IN EXTREMITY,175
rucaparib,HEPATIC ENZYME INCREASED,174
rucaparib,PERIPHERAL SWELLING,174
rucaparib,PHOTOSENSITIVITY REACTION,169
rucaparib,FEELING ABNORMAL,165
rucaparib,LABORATORY TEST ABNORMAL,161
rucaparib,TOXICITY TO VARIOUS AGENTS,161
rucaparib,ANXIETY,158
rucaparib,PRESCRIBED UNDERDOSE,155
rucaparib,SOMNOLENCE,155
rucaparib,URINARY TRACT INFECTION,154
rucaparib,DYSPEPSIA,153
rucaparib,OVARIAN CANCER RECURRENT,153
rucaparib,ALOPECIA,148
rucaparib,DEPRESSION,140
rucaparib,LIVER FUNCTION TEST INCREASED,139
rucaparib,PYREXIA,137
rucaparib,ALANINE AMINOTRANSFERASE INCREASED,136
rucaparib,THERAPY PARTIAL RESPONDER,132
rucaparib,GAIT DISTURBANCE,131
rucaparib,ASPARTATE AMINOTRANSFERASE INCREASED,125
rucaparib,STOMATITIS,122
rucaparib,FLATULENCE,119
rucaparib,NASOPHARYNGITIS,119
rucaparib,DRY MOUTH,109
rucaparib,MYALGIA,108
rucaparib,FALL,107
rucaparib,PRODUCT DOSE OMISSION IN ERROR,106
rucaparib,RENAL FUNCTION TEST ABNORMAL,105
rucaparib,ACCIDENTAL UNDERDOSE,102
rucaparib,DRY SKIN,98
rucaparib,NEUTROPENIA,96
rucaparib,INTESTINAL OBSTRUCTION,89
rucaparib,RENAL IMPAIRMENT,88
rucaparib,BLOOD MAGNESIUM DECREASED,85
rucaparib,MUSCLE SPASMS,85
rucaparib,HYPOPHAGIA,84
rucaparib,BLOOD PRESSURE INCREASED,83
rucaparib,HYPOAESTHESIA,83
rucaparib,MUSCULAR WEAKNESS,82
rucaparib,PARAESTHESIA,82
rucaparib,WEIGHT INCREASED,82
rucaparib,PNEUMONIA,81
rucaparib,TREMOR,78
rucaparib,HOT FLUSH,77
rucaparib,CONTUSION,76
rucaparib,GASTROOESOPHAGEAL REFLUX DISEASE,75
rucaparib,SUNBURN,75
rucaparib,BONE PAIN,74
rucaparib,RENAL DISORDER,73
rucaparib,HYPERTENSION,71
rucaparib,MEMORY IMPAIRMENT,68
temozolomide,DISEASE PROGRESSION,1847
temozolomide,DEATH,1777
temozolomide,THROMBOCYTOPENIA,1656
temozolomide,OFF LABEL USE,1523
temozolomide,NAUSEA,1488
temozolomide,FATIGUE,1153
temozolomide,DRUG INEFFECTIVE,1125
temozolomide,VOMITING,1061
temozolomide,PRODUCT USE IN UNAPPROVED INDICATION,1054
temozolomide,NEUTROPENIA,1024
temozolomide,MALIGNANT NEOPLASM PROGRESSION,968
temozolomide,DIARRHOEA,766
temozolomide,FEBRILE NEUTROPENIA,742
temozolomide,PLATELET COUNT DECREASED,721
temozolomide,ANAEMIA,711
temozolomide,ASTHENIA,693
temozolomide,PYREXIA,683
temozolomide,HEADACHE,602
temozolomide,SEIZURE,554
temozolomide,PANCYTOPENIA,553
temozolomide,INFECTION,526
temozolomide,CONSTIPATION,524
temozolomide,PNEUMONIA,472
temozolomide,PULMONARY EMBOLISM,449
temozolomide,NEOPLASM PROGRESSION,430
temozolomide,HAEMORRHAGE,428
temozolomide,CONFUSIONAL STATE,423
temozolomide,DEHYDRATION,396
temozolomide,DECREASED APPETITE,394
temozolomide,WEIGHT DECREASED,383
temozolomide,WHITE BLOOD CELL COUNT DECREASED,382
temozolomide,RASH,376
temozolomide,FALL,373
temozolomide,DYSPNOEA,360
temozolomide,ATRIAL FIBRILLATION,356
temozolomide,CONVULSION,345
temozolomide,LYMPHOPENIA,341
temozolomide,SEPSIS,341
temozolomide,BONE MARROW FAILURE,334
temozolomide,CYTOPENIA,328
temozolomide,LEUKOPENIA,326
temozolomide,PAIN,324
temozolomide,ABDOMINAL PAIN,317
temozolomide,ASPERGILLUS INFECTION,314
temozolomide,DEEP VEIN THROMBOSIS,289
temozolomide,DISEASE RECURRENCE,246
temozolomide,HYPERTENSION,246
temozolomide,MALAISE,245
temozolomide,PRODUCT USE ISSUE,242
temozolomide,HAEMOGLOBIN DECREASED,238
temozolomide,HOSPITALISATION,236
temozolomide,DIZZINESS,235
temozolomide,GENERAL PHYSICAL HEALTH DETERIORATION,235
temozolomide,HYPOTENSION,235
temozolomide,TOXICITY TO VARIOUS AGENTS,235
temozolomide,GAIT DISTURBANCE,233
temozolomide,METASTASES TO LIVER,233
temozolomide,BRAIN OEDEMA,232
temozolomide,GLIOBLASTOMA,228
temozolomide,ALANINE AMINOTRANSFERASE INCREASED,217
temozolomide,MYELOSUPPRESSION,212
temozolomide,MUSCULAR WEAKNESS,206
temozolomide,NEUTROPHIL COUNT DECREASED,206
temozolomide,URINARY TRACT INFECTION,203
temozolomide,HEMIPARESIS,200
temozolomide,SOMNOLENCE,190
temozolomide,MENTAL STATUS CHANGES,189
temozolomide,COUGH,188
temozolomide,DYSPHAGIA,187
temozolomide,LYMPHOCYTE COUNT DECREASED,184
temozolomide,PRURITUS,180
temozolomide,HAEMATOTOXICITY,176
temozolomide,DRUG INTERACTION,172
temozolomide,HOSPICE CARE,168
temozolomide,CHILLS,163
temozolomide,CONDITION AGGRAVATED,161
temozolomide,PAIN IN EXTREMITY,161
temozolomide,TUMOUR PSEUDOPROGRESSION,160
temozolomide,APLASTIC ANAEMIA,159
temozolomide,GLIOBLASTOMA MULTIFORME,159
temozolomide,HYPERGLYCAEMIA,157
temozolomide,THROMBOSIS,156
temozolomide,HYPONATRAEMIA,155
temozolomide,HYPOKALAEMIA,154
temozolomide,THERAPY CESSATION,154
temozolomide,CHEST PAIN,150
temozolomide,ARTHRALGIA,149
temozolomide,ACUTE KIDNEY INJURY,148
temozolomide,ASPARTATE AMINOTRANSFERASE INCREASED,147
temozolomide,EPISTAXIS,147
temozolomide,BACK PAIN,146
temozolomide,APHASIA,145
temozolomide,OEDEMA PERIPHERAL,143
temozolomide,ERYTHEMA,140
temozolomide,LETHARGY,137
temozolomide,ALOPECIA,136
temozolomide,CEREBRAL HAEMORRHAGE,133
temozolomide,TREATMENT FAILURE,133
temozolomide,THERAPY PARTIAL RESPONDER,131
temozolomide,MUCOSAL INFLAMMATION,127
oxaliplatin,DIARRHOEA,6599
oxaliplatin,NAUSEA,5125
oxaliplatin,VOMITING,4389
oxaliplatin,NEUTROPENIA,3943
oxaliplatin,DISEASE PROGRESSION,3693
oxaliplatin,NEUROPATHY PERIPHERAL,3679
oxaliplatin,OFF LABEL USE,3431
oxaliplatin,THROMBOCYTOPENIA,3284
oxaliplatin,DYSPNOEA,3161
oxaliplatin,PYREXIA,2887
oxaliplatin,FATIGUE,2478
oxaliplatin,ASTHENIA,2340
oxaliplatin,ANAEMIA,2279
oxaliplatin,DEATH,2206
oxaliplatin,ABDOMINAL PAIN,2089
oxaliplatin,DECREASED APPETITE,1946
oxaliplatin,FEBRILE NEUTROPENIA,1729
oxaliplatin,PARAESTHESIA,1708
oxaliplatin,DEHYDRATION,1656
oxaliplatin,RASH,1506
oxaliplatin,HYPOTENSION,1503
oxaliplatin,MALAISE,1478
oxaliplatin,MALIGNANT NEOPLASM PROGRESSION,1453
oxaliplatin,DRUG INEFFECTIVE,1443
oxaliplatin,NEUROTOXICITY,1423
oxaliplatin,HYPERTENSION,1401
oxaliplatin,ERYTHEMA,1383
oxaliplatin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1307
oxaliplatin,MUCOSAL INFLAMMATION,1283
oxaliplatin,GENERAL PHYSICAL HEALTH DETERIORATION,1266
oxaliplatin,HYPERSENSITIVITY,1260
oxaliplatin,LEUKOPENIA,1255
oxaliplatin,CHILLS,1245
oxaliplatin,ACUTE KIDNEY INJURY,1201
oxaliplatin,SEPSIS,1198
oxaliplatin,PLATELET COUNT DECREASED,1163
oxaliplatin,PRURITUS,1115
oxaliplatin,PNEUMONIA,1076
oxaliplatin,STOMATITIS,1053
oxaliplatin,PULMONARY EMBOLISM,1017
oxaliplatin,INTERSTITIAL LUNG DISEASE,998
oxaliplatin,WHITE BLOOD CELL COUNT DECREASED,978
oxaliplatin,PRODUCT USE IN UNAPPROVED INDICATION,932
oxaliplatin,DIZZINESS,929
oxaliplatin,WEIGHT DECREASED,905
oxaliplatin,NEUTROPHIL COUNT DECREASED,885
oxaliplatin,TOXICITY TO VARIOUS AGENTS,879
oxaliplatin,PAIN,869
oxaliplatin,HYPOKALAEMIA,862
oxaliplatin,INFUSION RELATED REACTION,856
oxaliplatin,CONSTIPATION,844
oxaliplatin,MYELOSUPPRESSION,842
oxaliplatin,CHEST PAIN,829
oxaliplatin,METASTASES TO LIVER,795
oxaliplatin,BONE MARROW FAILURE,789
oxaliplatin,HYPERHIDROSIS,789
oxaliplatin,TACHYCARDIA,781
oxaliplatin,NEOPLASM PROGRESSION,739
oxaliplatin,ASCITES,723
oxaliplatin,FLUSHING,706
oxaliplatin,HAEMOGLOBIN DECREASED,679
oxaliplatin,SEPTIC SHOCK,675
oxaliplatin,HYPOAESTHESIA,674
oxaliplatin,OXYGEN SATURATION DECREASED,674
oxaliplatin,LOSS OF CONSCIOUSNESS,653
oxaliplatin,POLYNEUROPATHY,652
oxaliplatin,INFECTION,640
oxaliplatin,CONDITION AGGRAVATED,626
oxaliplatin,RESPIRATORY FAILURE,620
oxaliplatin,RENAL FAILURE,616
oxaliplatin,COUGH,614
oxaliplatin,DEEP VEIN THROMBOSIS,609
oxaliplatin,PERIPHERAL SENSORY NEUROPATHY,609
oxaliplatin,DYSPHAGIA,607
oxaliplatin,PANCYTOPENIA,598
oxaliplatin,BACK PAIN,592
oxaliplatin,TREMOR,577
oxaliplatin,SKIN TOXICITY,570
oxaliplatin,DERMATITIS ACNEIFORM,565
oxaliplatin,DYSARTHRIA,565
oxaliplatin,ABDOMINAL PAIN UPPER,558
oxaliplatin,HEADACHE,549
oxaliplatin,CHEST DISCOMFORT,545
oxaliplatin,MUSCLE SPASMS,544
oxaliplatin,ANAPHYLACTIC REACTION,526
oxaliplatin,INTESTINAL OBSTRUCTION,505
oxaliplatin,HAEMATOTOXICITY,504
oxaliplatin,PLEURAL EFFUSION,504
oxaliplatin,VENOOCCLUSIVE LIVER DISEASE,481
oxaliplatin,LARYNGOSPASM,473
oxaliplatin,ATRIAL FIBRILLATION,472
oxaliplatin,CARDIAC ARREST,469
oxaliplatin,PROTEINURIA,468
oxaliplatin,EPISTAXIS,465
oxaliplatin,HYPOMAGNESAEMIA,459
oxaliplatin,BLOOD PRESSURE INCREASED,453
oxaliplatin,ARTERIOSPASM CORONARY,450
oxaliplatin,ASPARTATE AMINOTRANSFERASE INCREASED,449
oxaliplatin,CONFUSIONAL STATE,440
oxaliplatin,HEPATIC FUNCTION ABNORMAL,438
sotorasib,NON-SMALL CELL LUNG CANCER,310
sotorasib,DISEASE PROGRESSION,293
sotorasib,DEATH,209
sotorasib,DIARRHOEA,207
sotorasib,OFF LABEL USE,123
sotorasib,NAUSEA,72
sotorasib,FATIGUE,67
sotorasib,NON-SMALL CELL LUNG CANCER METASTATIC,57
sotorasib,HEPATOTOXICITY,56
sotorasib,DRUG INEFFECTIVE,47
sotorasib,ALANINE AMINOTRANSFERASE INCREASED,46
sotorasib,ASPARTATE AMINOTRANSFERASE INCREASED,46
sotorasib,HEPATIC FUNCTION ABNORMAL,44
sotorasib,LUNG NEOPLASM MALIGNANT,39
sotorasib,DECREASED APPETITE,35
sotorasib,HEPATIC ENZYME INCREASED,35
sotorasib,DYSPNOEA,34
sotorasib,LIVER FUNCTION TEST INCREASED,34
sotorasib,VOMITING,34
sotorasib,HEPATIC CYTOLYSIS,33
sotorasib,ASTHENIA,27
sotorasib,ADVERSE EVENT,26
sotorasib,LUNG ADENOCARCINOMA,26
sotorasib,CHOLESTASIS,25
sotorasib,PNEUMONIA,25
sotorasib,CONSTIPATION,23
sotorasib,LIVER DISORDER,22
sotorasib,BLOOD ALKALINE PHOSPHATASE INCREASED,21
sotorasib,COLITIS,21
sotorasib,COUGH,21
sotorasib,PAIN,21
sotorasib,PULMONARY EMBOLISM,21
sotorasib,PNEUMONITIS,20
sotorasib,PYREXIA,20
sotorasib,ABDOMINAL PAIN,19
sotorasib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,19
sotorasib,ANAEMIA,18
sotorasib,HOSPITALISATION,18
sotorasib,MALAISE,18
sotorasib,MYALGIA,18
sotorasib,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,17
sotorasib,GENERAL PHYSICAL HEALTH DETERIORATION,17
sotorasib,THERAPY PARTIAL RESPONDER,17
sotorasib,DEHYDRATION,16
sotorasib,LUNG CANCER METASTATIC,16
sotorasib,SOMNOLENCE,16
sotorasib,ADVERSE DRUG REACTION,15
sotorasib,BLOOD BILIRUBIN INCREASED,15
sotorasib,DRUG-INDUCED LIVER INJURY,15
sotorasib,PLEURAL EFFUSION,15
sotorasib,PRODUCT STORAGE ERROR,15
sotorasib,ACUTE KIDNEY INJURY,14
sotorasib,ARTHRALGIA,14
sotorasib,DRUG INTERACTION,13
sotorasib,WEIGHT DECREASED,13
sotorasib,COLORECTAL CANCER METASTATIC,12
sotorasib,HEADACHE,12
sotorasib,HYPOKALAEMIA,12
sotorasib,MALIGNANT NEOPLASM PROGRESSION,12
sotorasib,UNEVALUABLE EVENT,12
sotorasib,ABDOMINAL DISCOMFORT,11
sotorasib,BACK PAIN,11
sotorasib,CEREBROVASCULAR ACCIDENT,11
sotorasib,DRUG INTOLERANCE,11
sotorasib,FALL,11
sotorasib,HEPATITIS,11
sotorasib,HYPERTRANSAMINASAEMIA,11
sotorasib,METASTASES TO CENTRAL NERVOUS SYSTEM,11
sotorasib,NEOPLASM PROGRESSION,11
sotorasib,PAIN IN EXTREMITY,11
sotorasib,JAUNDICE,10
sotorasib,OEDEMA PERIPHERAL,10
sotorasib,PANCREATITIS,10
sotorasib,PRODUCT DOSE OMISSION ISSUE,10
sotorasib,RASH,10
sotorasib,THERAPY NON-RESPONDER,10
sotorasib,COVID-19,9
sotorasib,HOSPICE CARE,9
sotorasib,NEUROPATHY PERIPHERAL,9
sotorasib,PERICARDIAL EFFUSION,9
sotorasib,ACUTE RESPIRATORY DISTRESS SYNDROME,8
sotorasib,DEPRESSION,8
sotorasib,HEPATIC FAILURE,8
sotorasib,INTERSTITIAL LUNG DISEASE,8
sotorasib,OEDEMA,8
sotorasib,THERAPY CESSATION,8
sotorasib,ANXIETY,7
sotorasib,AUTOIMMUNE HEPATITIS,7
sotorasib,BLOOD CREATININE INCREASED,7
sotorasib,CARDIAC FAILURE,7
sotorasib,CHEST PAIN,7
sotorasib,DYSPHAGIA,7
sotorasib,GASTROINTESTINAL TOXICITY,7
sotorasib,GASTROOESOPHAGEAL REFLUX DISEASE,7
sotorasib,HYPOCALCAEMIA,7
sotorasib,LIVER FUNCTION TEST ABNORMAL,7
sotorasib,METASTASES TO BONE,7
sotorasib,MUSCLE SPASMS,7
sotorasib,NEOPLASM MALIGNANT,7
sotorasib,PLATELET COUNT DECREASED,7
